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ABSTRACT 
Streptococcus pneumoniae causes a wide variety of diseases, ranging from relatively mild 
but very common mucosal diseases like otitis media and pneumonia to rarer but 
severe invasive diseases like bacteraemia and meningitis. These diseases cause a 
considerable burden worldwide. Nasopharyngeal carriage is a prerequisite for 
pneumococcal otitis media and viral respiratory infection contributes to its 
pathogenesis. Nasopharyngeal carriage also comprises the reservoir of 
pneumococcal strains for their spread in the population. Pneumococcal carriage is 
most prevalent in children. In planning effective long-term prevention strategies 
against pneumococcal diseases it is essential to have knowledge on the natural 
cause of pneumococcal carriage and on how the carriage progresses to disease.  
This study describes the natural course of pneumococcal nasopharyngeal carriage 
in a prospective follow-up of Finnish children from 2 to 24 months of age before 
the start of pneumococcal vaccinations. Special attention was focused on the 
dynamics of pneumococcal carriage during health and respiratory infection and 
development of pneumococcal acute otitis media (AOM). 
Almost all children carried pneumococci at least once during the first two year of 
life and in average the prevalence of carriage was 27%. The frequency of 
pneumococcal carriage clearly increased with age and with respiratory infection. 
There was no significant association between pneumococcal carriage and sex or 
season, but antimicrobial treatment temporarily decreased carriage frequency. 
During pneumococcal AOM, S. pneumoniae and especially the serotype found in the 
middle ear fluid was practically always found in the nasopharynx, but only half of 
the serotypes carried during clinical AOM were found to cause the disease. The 
hazard of carriage acquisition was about three times higher in association with the 
onset of a new respiratory infection as compared to health. The hazard of 
pneumococcal AOM media was significantly higher during carriage acquired 
around the onset of respiratory infection as compared to carriage acquired more 
than one month before or more than one week after the onset of respiratory 
infection. Of all pneumococcal AOM events, almost 80% were caused by a 
serotype acquired within one month before the sickness onset. Preceding episodes 
of homologous carriage episodes decreased the hazard of pneumococcal AOM. 
The pneumococcal AOM hazard during concurrent pneumococcal carriage and 
respiratory infection did not depend on age. 
The natural course of pneumococcal carriage in Finnish children is similar as 
observed in other industrialised countries. Viral respiratory infection is an 
important factor for acquisition of carriage and its progression to AOM. Age, 
respiratory infection and antimicrobial treatment should be considered when the 
results of carriage studies are interpreted. Nasopharyngeal carriage during AOM 
can be used as information in monitoring the serotypes causing AOM, and the use 
of a negative nasopharyngeal finding could be considered in excluding 
pneumococcal AOM in clinical praxis. Carriage studies are important tools in 
planning and evaluating methods for preventing pneumococcal AOM. 
TIIVISTELMÄ 
Pneumokokkibakteeri aiheuttaa laajan kirjon erilaisia sairauksia, alkaen suhteellisen 
lievistä mutta erittäin yleisistä limakalvojen sairauksista kuten välikorvatulehdus ja 
pinnallinen keuhkokuume harvinaisempiin mutta vakaviin sairauksiin kuten 
verenmyrkytys ja aivokalvontulehdus. Näiden sairauksien aiheuttama tautitaakka on 
maailmanlaajuisesti merkittävä. Nenänielukantajuus on edellytys pneumokokin 
aiheuttaman välikorvatulehduksen synnylle ja viruksen aiheuttama 
hengitystietulehdus myötävaikuttaa taudin kehittymiseen. Nenänielukantajuus 
toimii myös pneumokokkikantojen varastona, jota kautta pneumokokit leviävät 
väestössä. Pnemokokkikantajuus on yleisintä lapsilla. Tieto 
pneumokokkikantajuuden luontaisesta kulusta ja siitä kuinka kantajuus etenee 
taudiksi on välttämätöntä kun pneumokokkitaudeille suunnitellaan pitkällä 
tähtäimellä tehokkaita ennaltaehkäisymenetelmiä. 
Tämä tutkimus kuvaa pneumokokkikantajuuden luontaista kulkua suomalaisilla, 
lapsilla, joita seurattiin 2 kuukauden iästä 2 vuoden ikään asti ennen 
pneumokokkirokotusten aloittamista. Erityistä huomiota kiinnitettiin kantajuuden 
eroihin terveenä ollessa ja hengitystietulehduksen aikana sekä siihen, miten äkillinen 
pneumokokin aiheuttama välikorvatulehdus kehittyy. 
Melkein kaikki lapset kantoivat pneumokokkia vähintään kerran ensimmäisten 
kahden ikävuoden aikana ja keskimääräinen kantajuusprevalenssi oli 27 %. 
Pneumokokkikantajuus lisääntyi selvästi iän myötä ja hengitystietulehduksen 
aikana. Pneumokokkikantajuus ei liittynyt merkittävästi sukupuoleen eikä 
vuodenaikaan, mutta antibioottihoito vähensi kantajuutta lyhytaikaisesti. 
Pneumokokin aiheuttaman äkillisen välikorvatulehduksen aikana pneumokokki, ja 
erityisesti juuri välikorvaeritteestä löytynyt serotyyppi löytyi käytännöllisesti katsoen 
aina nenänielusta, mutta vain puolet välikorvatulehduksen aikana kannetuista 
serotyypeistä todettiin kyseisen korvatulehduksen aiheuttajiksi. Tuoreen 
hengitystietulehduksen alkuvaiheessa lapsilla oli noin kolme kertaa suurempi 
todennäköisyys saada kantajuus kuin terveenä. Äkillisen välikorvatulehduksen 
kehittymisen todennäköisyys oli merkittävästi suurempi silloin, kun kantajuus oli 
alkanut hengitystietulehduksen alkuvaiheen yhteydessä kuin silloin, jos kantajuus oli 
alkanut yli kuukausi ennen hengitystietulehduksen alkua tai yli viikko 
hengitystietulehduksen alun jälkeen. Kaikista äkillisistä välikorvatulehduksista lähes 
80 % oli sellaisen serotyypin aiheuttamia, joka oli saatu kuukauden sisään ennen 
taudin alkua. Aikaisemmat saman serotyypin kantajuusjaksot vähensivät saman 
pneumokokkiserotyypin aiheuttaman äkillisen välikorvatulehduksen 
todennäköisyyttä. Välikorvatulehduksen todennäköisyys ei riippunut lapsen iästä, 
jos pneumokokkikantajuus ja hengitystietulehdus osuivat päällekkäin. 
Pneumokokkikantajuuden luonnollinen kulku oli suomalaisilla lapsilla samanlaista 
kuin muissakin teollisuusmaissa. Viruksen aiheuttama hengitystietulehdus on 
merkittävä tekijä kantajuuden alkamisessa ja sen etenemisessä äkilliseksi 
välikorvatulehdukseksi. Ikä, hengitystietulehdus ja antibioottihoito pitää ottaa 
huomioon kantajuustutkimusten tulosten tulkinnassa. Äkillisen 
välikorvatulehduksen aikaista nenänielukantajuutta voitaisiin käyttää hyväksi 
välikorvatulehdusta aiheuttavien pneumokokkiserotyyppien seurannassa ja 
negatiivisen nielunlöydöksen käyttöä pneumokokin aiheuttaman korvatulehduksen 
poissulkumenetelmänä voitaisiin harkita. Kantajuustutkimukset ovat tärkeitä 
välineitä kun suunnitellaan ja arvioidaan pneumokokin aiheuttaman äkillisen 
välikorvatulehduksen ennaltaehkäisyä. 
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1 INTRODUCTION 
Streptococcus pneumoniae (the pneumococcus) is a bacterium recognised as an 
important pathogen for more than 100 years. Infections caused by pneumococci 
are still important causes of morbidity and mortality. Our knowledge about 
pneumococcal infections has increased rapidly during recent decades and there is 
now a comprehensive body of knowledge on the epidemiology of pneumococcal 
infections from different parts of the world. Complex interactions between 
pneumococci, their host organs, and other microbes in their ecological niche—that 
is the human nasopharynx—have been detected with current methods of 
molecular characterisation. 
Practically all children harbour pneumococci in their nasopharynx at least 
temporarily during the first years of life. Pneumococcal carriage is typically 
asymptomatic and does not cause any harm. At the same time pneumococci cause 
a wide range of diseases, mostly in association with or after a respiratory infection. 
The mildest of pneumococcal diseases develop when the bacteria spread from the 
nasopharynx to the adjacent organs and cause otitis media or sinusitis restricted to 
the mucosa. Pneumonia may follow if bacteria are inhaled or aspirated to the lungs. 
If pneumococci invade the blood vessels through the mucosa, they cause 
bacteraemia and can spread further to other normally sterile organs. Such invasive 
disease forms are serious and can be life-threatening without effective treatment. If 
the bacteria spread through the blood-brain-barrier and cause meningitis, the risks 
of fatality or permanent disability are especially high.  
Pneumococcal diseases are common in all parts of the world. The annual global 
burden of pneumococcal pneumonia and invasive diseases has been estimated 
more than 10 million cases and almost one million deaths in children aged less than 
five years. Young children and the elderly are at the highest risk. Otitis media is 
very common in children and it therefore consumes extensive financial and health 
care resources and affects the quality of life of a large population. Otitis media is 
also the most common cause of antimicrobial treatment in children. Antimicrobial 
use is associated with a new threat, that of increasing antimicrobial resistance of 
pneumococci, which may jeopardise the availability of treatments for 
pneumococcal diseases. The development of effective vaccines for the prevention 
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of pneumococcal infections offers one solution to this problem. The 
pneumococcus has developed more than 90 different types of surrounding capsule, 
i.e. serotypes, which have different disease-causing potentials and induce different 
immune responses in the human host. The current pneumococcal conjugate 
vaccines include 7 to 13 different serotypes and are effective in preventing 
pneumococcal infections caused by the vaccine serotypes. By reducing carriage of 
the vaccine serotypes, however, vaccination increases infections caused by other 
serotypes due to the replacement phenomenon.  
The main reservoir of pneumococcal strains in the population is asymptomatic 
nasopharyngeal carriage, which is most prevalent in children. Vaccinating children 
not only protects them against pneumococcal diseases but also affects 
pneumococcal transmission in the population through indirect effects, both 
through herd immunity and replacement of carriage and disease in unvaccinated 
persons. In addition, the vaccine affects differently the carriage acquisition, carriage 
prevalence, pneumococcal otitis media and invasive pneumococcal disease. Thus, it 
is important to gain new knowledge about the elements associated with 
transmission of pneumococci, acquisition and natural course of pneumococcal 
carriage, and the progression of carriage to disease. This knowledge is essential for 
understanding the components of the long-term effectiveness of pneumococcal 
vaccination, for planning successful vaccination programmes, for specifying the 
optimal timing of vaccination, and for preventing other factors that enhance 
disease development.  
This thesis is based on data from the Finnish otitis media (FinOM) Cohort 
Study, conducted in 1994–1997. In the FinOM Cohort Study, children not 
vaccinated with pneumococcal vaccines were prospectively followed so as to 
collect data on pneumococcal carriage, respiratory infections and otitis media. The 
epidemiological study preceded a trial on the efficacy of two 7-valent 
pneumococcal conjugate vaccines in preventing pneumococcal otitis media and it 
was particularly designed to collect data on pneumococcal otitis media. Therefore, 
the study offered a useful opportunity to study the process of pneumococcal 
carriage and the dynamics of carriage, respiratory infection and otitis media. 
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2 REVIEW OF THE LITTERATURE 
2.1 Streptococcus pneumoniae as a bacterium  
Streptococcus pneumoniae (the pneumococcus) was isolated for the first time by 
George Sternberg in 1880 and Louis Pasteur in 1881 (1). It was formerly known as 
Diplococcus pneumoniae and belongs to the mitis group within the genus 
Streptococcus. The pneumococcus is a lancet-shaped and mostly encapsulated 
gram-positive bacterium that grows in pairs or short chains in broth culture. On 
blood agar, pneumococci form small greyish, mostly mucoid or smooth colonies, 
surrounded by a greenish zone of partial haemolysis (alpha-haemolysis). Non-
capsulated pneumococci produce rough colonies. Pneumococci are easily lysed, 
while the centre of the colony soon becomes depressed because of autolysis. 
2.1.1 Structure of Streptococcus pneumoniae 
The pneumococcal cell surface has three layers: the plasma membrane, the cell wall 
and the capsule composed of polysaccharides. The plasma membrane and the 
peptidoglycan backbone of the cell wall act as anchors for the cell wall 
polysaccharides and surface proteins. Two cell wall polysaccharides, teichoic acid 
and lipoteichoic acid, are common to all pneumococcal strains. Moreover, several 
surface proteins are conserved across most pneumococcal strains. The best known 
of these are the lipoprotein pneumococcal surface adhesin A (PsaA), the enzymes 
immunoglobulin A-protease and neuraminidases and three choline-binding 
proteins, pneumococcal surface protein A, major pneumococcal autolysin and 
pneumococcal surface protein C (PspC, also referred to as CbpA or SpsA) (2,3). 
Several new proteins and other surface components involved in the adherence and 
virulence mechanisms have been recognised recently (4,5). A subpopulation of 
pneumococci produces pilus-like protein structures, able to extend beyond the 
polysaccharide capsule (6). One of the most intensively studied intracellular 
structures is pneumolysin, a toxin common to all clinically relevant pneumococcal 
strains (7). The capsule is the outermost layer of the cell surface and consists of 
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polysaccharides, which show considerable variation in their chemical composition, 
amount and antigenic capacity. 
2.1.2 Identification of Streptococcus pneumoniae 
The standard for the clinical diagnosis of pneumococcal infection is growth of 
viable pneumococci from samples collected from the middle ear fluid (MEF) or 
normally sterile body sites, such as from blood, cerebrospinal fluid, the pleural 
cavity or joints. Similarly, the standard method to identify pneumococcal carriage is 
growth of S. pneumoniae from an upper respiratory tract sample. S. pneumoniae grows 
well on plain blood agar, but the use of selective culture agars that include 
gentamicin or colistin with nalidixic or oxolinic acid suppresses the growth of other 
organisms and thus increases the sensitivity of recovering pneumococci (8,9). The 
use of culture selective medium is especially important when culturing samples 
from the upper respiratory tract, a niche for numerous non-pathogenic and 
potentially pathogenic bacteria (10). Pneumococcal growth requires carbon dioxide 
(CO2). The optimal pH for pneumococcal growth is around 7.2 and the optimal 
temperature is between 35°C and 37°C. To increase the yield of pneumococci, 
specimens are sometimes incubated in an enrichment broth prior to culture. After 
culture, pneumococci are identified by their characteristic colony morphology and 
differentiated from other alpha-haemolytic streptococci by their susceptibility to 
optochin and autolysis in contact with bile salt. The differentiation of atypical 
pneumococci from other alpha-haemolytic streptococci is sometimes difficult (11).  
Pneumococci can be identified directly without culture from clinical samples by 
the immunologic reactions of their antigenic structures with specific antisera or by 
identifying their genetic material with molecular techniques. These tests may not 
only detect live bacteria but also killed pneumococci or even fragments of them. 
These techniques can be used to determine the serotype or to differentiate non-
serotypeable pneumococci from other alpha-haemolytic streptococci (11). 
However, non-cultural identification methods offer limited possibilities for further 
characterisation of pneumococcal properties, since strains cannot be retained for 
later analysis (9,12). 
Counterimmunoelectrophoresis and different latex agglutination methods have 
been used to detect capsular polysaccharide antigens, either directly or after 
enrichment in broth (13). A rapid and easy-to-perform commercial immune-
chromatographic test, Binax NOW®, originally developed to detect cell wall 
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polysaccharide antigens in the urine has recently been adapted to nasopharyngeal 
and MEF samples (14-16). The antigen detection test seems promising for selected 
clinical purposes.  
Polymerase chain reaction (PCR) tests are based on amplification of nucleic 
acids of the pneumococcal genes (17,18). PCR tests are increasingly used for 
research as well as for clinical purposes, although the precise role that they can play 
has not yet been established (9,19). In general, PCR-based methods are highly 
sensitive in detecting bacteria even in low densities (20). PCR methods are also 
valuable in detecting pneumococci in normally sterile body sites during 
antimicrobial treatment. The disadvantage of PCR methods is that they may also 
recognise genetic material that has migrated from the adjacent organs of the host 
or from non-pneumococcal strains that are close relatives to pneumococci, or even 
airborne contaminants (12). For example, PCR-positive but culture-negative MEF 
may yield genetic material from nasopharyngeal carriage or previous pneumococcal 
otitis media (19). Nevertheless, DNA from non-viable bacteria rapidly clears from 
the MEF, and metabolic activity has been demonstrated even in culture negative 
but PCR positive MEF samples, and (21). Thus, PCR may detect viable bacteria 
that fail to grow in culture, for example, due to small amount or dilution of the 
sample, or biofilm formation (19,22,23). Trzciński et al. detected viable 
pneumococci in a remarkable proportion of samples that were initially negative by 
conventional culturing but positive by PCR when they recultured and carefully 
examined the original samples (24). 
2.1.3 Classification of Streptococcus pneumoniae 
S. pneumoniae are classified into serotypes and serogroups according to the antigenic 
properties of the capsular polysaccharide (25). The formerly used American 
nomenclature named serotypes according to their order of discovery. Currently, the 
Danish nomenclature is used worldwide. It classifies serologically cross-reacting 
serotypes into serogroups. Of the known 46 groups, some comprise a single 
known serotype, while some represent two or more immunologically related 
serotypes. More than 90 serotypes have been distinguished, the exact number 
depending on the definition used. In addition, some strains cannot be serotyped 
because they are non-encapsulated. These strains are also called ‘rough’ strains 
because of their specific colony morphology.  
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For decades, the standard for serotyping pneumococci after their identification 
in a culture has been the Neufeld test, also called the Quellung or capsular swelling 
test. The test was first described already in 1902 (26). It is based on microscopic 
visualisation of the capsular swelling and agglutination of cells in reaction to adding 
specific antisera on a pure pneumococcal culture (25). The method requires time, 
resources and a well-trained staff to interpret the results. Alternative serotyping 
methods such as counterimmunoelectrophoresis and latex agglutination tests 
(13,27) have been developed to reduce the work load. Currently, PCR-based assays 
to identify serotype-specific sequences within pneumococcal capsular genes are 
increasingly used for pneumococcal serotyping. 
The importance of simultaneous carriage of multiple serotypes has become 
obvious in planning the treatment and prevention strategies for pneumococcal 
diseases. Multiple carriage poses a special challenge for serotype detection. Sparse 
growth of the minor strains in a cultured sample may be masked by abundant 
growth of the major strains (28), especially if only one or a few colonies are picked 
for serotyping. Up to about 60 colonies should be picked to reach 95% probability 
in detecting the minority type if it comprises only a small percentage of the total 
growth (29). Since serotyping of multiple colonies is time and resource intensive, 
easier and less expensive methods for detecting multiple pneumococcal serotypes 
have been developed, such as the colony blot assay (30), the immunoblot method 
(31), the latex sweep method (32) and direct demonstration of pneumococcal 
capsular polysaccharides after enrichment culture by the Quellung test or electro-
immuno-assay (33). Novel PCR-based methods seem precise and effective. 
Especially simultaneous amplification of multiple sequences in a single reaction—a 
process referred to as multiplex PCR—is promising in reducing the cost and 
workload in identifying multiple carriage (34). 
The structure of the capsular polysaccharide is only one expression of the S. 
pneumoniae genome. Several advanced molecular typing techniques have been 
developed for detailed characterisation of pneumococcal strains and their clonality. 
Multilocus sequence typing (MLST), in which allelic profiles of pneumococcal 
strains are obtained by sequencing internal fragments of multiple house-keeping 
genes is currently widely used (35). Other methods used for molecular 
characterisation of pneumococcal isolates include multilocus enzyme 
electrophoresis, penicillin-binding protein profile analysis, pneumococcal surface 
protein A typing (36), pulsed-field gel electrophoresis (PFGE) (37), restriction 
fragment end labelling (38) and ribotyping (39). The first whole genome sequences 
of pneumococcal strains were published in 2001 (40,41). The achievement enabled 
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exact identification and comprehensive comparison between different 
pneumococcal strains. The genetic methods have offered substantially increased 
possibilities for understanding the characteristics and functions of pneumococcal 
virulence factors in their interaction with host cells. 
Molecular characterisation has revealed that pneumococcal strains expressing 
the same serotype relatively often belong to otherwise diverse clones (42). 
Although rare, it is also possible that pneumococci of a single clonal type express 
different serotypes (42), a phenomenon known as capsular switching. 
2.2 Establishment of carriage and the pathogenesis of 
pneumococcal infection 
S. pneumoniae gains entry into the human host by adhering to the mucosal 
epithelium of the respiratory tract. Pneumococci often remain in the nasopharynx 
as commensals without causing symptoms or any apparent harm to the host. The 
condition of harbouring pneumococci in the upper respiratory tract is called 
‘carriage’ or ‘colonisation’. Even asymptomatic carriage can be considered as 
infection if it causes an antigen-antibody response. Occasionally the bacteria spread 
from the nasopharynx to the middle ear cavity through the Eustachian tube or to 
the paranasal sinuses to cause otitis media or sinusitis, respectively. Pneumococci 
can also be inhaled as aerosols or aspirated into the alveoli of the lungs, causing 
pneumonia. Local infection may progress to systemic infection by transfer of 
bacteria into the circulation via pulmonary capillaries through the vascular 
endothelial cells. The pathogenesis of pneumococcal infection depends on the 
virulence of the bacteria, i.e. their capacity to adhere to and invade the host cells 
and escape clearance by the host defence mechanisms. 
2.2.1 Adherence of pneumococci to human cells  
In the human respiratory tract S. pneumoniae first encounters the mucosa covered by 
a mucus layer and epithelial cells. A healthy mucosa inhibits bacterial attachment 
physically by the washing action of the saliva, the cough reflex, and the viscous 
mucus layer which acts as a physical barrier and transfers the bacteria outwards 
from the body by aid of beating movements of cilia attached to the mucosal 
surface. The mucosa also produces antibacterial substances that kill bacteria or 
 24 
inhibit their growth (43). These include lysozyme, lactoferrin and antimicrobial 
surfactant proteins. The ample commensal flora on the respiratory tract protects 
the mucosa by interfering with growth and invasion of pathogenic bacteria. 
If pneumococci survive the host defence mechanisms in the mucus, they may 
adhere to the epithelial cells of the respiratory mucosa. Adherence is mediated by 
binding between the bacterial surface structures and their target cells throughout 
the human respiratory tract. The epithelial cells express glycoconjugate receptors 
bearing specific carbohydrates on their surface, such as sialic acid residues, 
oligosaccharides and glycosaminoglycans, and pneumococci initially bind loosely to 
these receptors (44,45). However, for effective adherence, colonisation and disease 
development, pneumococci need stronger binding to protein receptors like the 
polymeric immunoglobulin receptor or keratin 10 (46,47). On the bacterium side, 
several choline-binding proteins, enzymes and other structures of the cell surface 
are essential in the adhesion of bacterial ligands to their receptors (4,48-51). 
Recent molecular research has remarkably increased our knowledge about the 
versatility of the pneumococcal surface components and adherence molecules as 
well as the host structures involved in the adhesion process (5,44,52). It is now 
known that pneumococci not only directly bind to the host receptors but also have 
a complex dynamic interplay with several host proteins. This interaction facilitates 
adherence and subsequent internalisation of pneumococci into the host cells. 
During the initial contact between pneumococci and the host cells, pneumococcal 
enzymes reduce the viscosity of the mucus, inhibit the ciliary function, provide 
nutrients to the bacteria, destroy immunoglobulin activity and inhibit the 
opsonophagosytosis by human neutrophils. An important mechanism for 
pneumococci to interact with the host cells is to modify the host structures that 
contain sialic acid and sugars and expose the target cell receptors for adherence 
(52). For more effective colonisation, pneumococci need adherence molecules, 
surface proteins and so-called ‘microbial surface components recognising adhesive 
matrix molecules’. Pneumococci either react directly with the target receptors, or 
recruit host proteins in the extracellular matrix and serum to act as molecular 
bridges in attachment of the bacteria to the target cells and in promoting their 
migration through the cell barriers (5,45). 
A special mechanism facilitating pneumococcal attachment to the target cells is 
phase variation, in which bacteria undergo spontaneous and reversible changes in 
their phenotypic expression between transparent and opaque colony morphologies 
(53). The transparent variants, expressing less capsule and increased or altered 
surface proteins and cell-wall carbohydrate-containing structures, show increased 
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adherence to the human epithelial cells (48,53). A reduction in the amount of 
capsule may be a necessary step for efficient colonisation, as a thinner capsule 
allows greater exposure of pneumococcal cell surface molecules important for 
interaction with the host cells and adherence (54). However, experimental research 
in mouse models has shown that some amount of capsule is required for effective 
colonisation (54,55). Furthermore, the pneumococcal polysaccharide capsule is 
important for the initial survival of the bacterium on the mucosal membrane, one 
mechanism being its negative charge (55). 
2.2.2 Invasion by pneumococci and development of pneumococcal 
infection 
To cause disease, pneumococci must be internalised into the epithelial cells, 
migrate across the epithelial barrier and survive in an environment with versatile 
host protective mechanisms. Mucosal diseases, like otitis media and pneumonia, 
develop when pneumococci multiply and cause cell damage in the mucosal sites of 
the human body. For development of invasive disease, e.g. bacteraemia and 
meningitis, pneumococci need to be translocated through the vascular endothelium 
and gain access to the blood stream, the cerebrospinal fluid, the lung parenchyma 
or other normally sterile body sites. 
In general, pneumococcal adherence appears to be benign until the host cells 
are activated by inflammatory cytokines (56,57). The host cell activation increases 
the number of receptors and induces alterations in the cell surface (56-59). Cell 
activation also starts a signalling mechanism needed for translocation of bacteria 
into and through the cells (60). Both pneumococcal and viral structures may be 
involved in the cell activation and the up-regulation of the host cell receptors 
(46,60,61). 
Inflammation has a major role in the virulence of pneumococci (3,57,62). The 
inflammatory process includes an influx of neutrophils and destruction of the 
structure and function of the host cells (59). The pneumococcal cell wall 
components induce activation of a wide array of cytokines, enzymes and the 
complement, which leads to strong inflammation (62). Several pneumococcal 
proteins contribute to the development of inflammation and cell damage, and 
inhibit the host defence mechanisms (4,52,63). Many adhesive surface proteins and 
enzymes are multifunctional and promote bacterial transport across the host 
epithelial and endothelial cells (5,46,52,60). An important pneumococcal virulence 
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factor is pneumolysin, an intracellular toxin, which enhances the host inflammatory 
process and impairs the function and viability of the host cells (7,56). Pneumolysin 
may also cause direct host cell damage (7). Pathogenesis is promoted by 
pneumococcal autolysins, which cause destruction of pneumococci, thus enhancing 
the release of cell wall components and internal toxins from dying bacteria and 
further increasing the inflammation. This process may be facilitated by 
antimicrobial treatment (64). In addition, the pneumococcal pilus-like structures 
augment the inflammatory process. 
Although the versatile pneumococcal structures are known to participate in the 
pathogenesis of pneumococcal disease (65), the polysaccharide capsule is still 
considered the most important virulence factor of S. pneumoniae. The capsular 
polysaccharides do not elicit inflammatory response and they do not appear to be 
toxic (59). The main role of the capsule in the virulence of pneumococci is to 
protect the bacteria from phagocytosis by polymorphonuclear leucocytes and thus 
enhance their survival in the human organism. Pneumococci survive better in the 
blood and exhibit greater systemic virulence in the opaque phase than in the 
transparent phase of their morphology, probably mostly because of the thicker 
capsule (53). Pneumococcal virulence depends on both the amount and the 
chemical composition of the capsule and it varies across different serotypes (66). 
Differences in the pneumococcal capsule type were found to have significant 
effects on pneumococcal growth in a mouse model, both in the nasopharynx and 
in the lungs (67). However, both the capsule type and the genetic background were 
important, and their joint influence varied with the site of infection (67). 
The involvement of the platelet-activating factor receptor in the development of 
pneumococcal invasive disease was recognised in the 1990s (58). The activated 
receptor mediates adherence to and translocation through human cells, either by 
direct binding or by initiating a signalling cascade that leads to host inflammation 
and bacterial invasion (58-60). However, inhibition of platelet-activating factor 
receptors has been shown to reduce pneumococcal infection only partly, indicating 
that other receptors are also needed in pneumococcal invasion (60). A well-known 
receptor capable for the uptake of pneumococci in the respiratory epithelial cells 
and their transport through the epithelial barrier is the polymeric immunoglobulin 
receptor, which binds to the pneumococcal protein PspC (46,68). The laminin 
receptor promotes the initial adhesion of pneumococci to the human 
microvascular brain cells and may thus initiate the passage through the blood-
brain-barrier (69).  
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2.2.3 Interactions between pneumococci and other nasopharyngeal 
bacteria  
The nasopharynx is a common niche for a range of non-pathogenic species as well 
as S. pneumoniae and other potential bacterial pathogens such as Haemophilus 
influenzae, Moraxella catarrhalis and Staphylococcus aureus. Interactions between 
different species in the establishment of carriage and development of disease are 
not known well, and the complex mechanisms of their mutual competition and 
synergism are currently being intensively studied. Understanding these mechanisms 
is important for the prevention and treatment of pneumococcal diseases since 
between-species competition offers an opportunity for other species to replace 
those eliminated by vaccination or antimicrobial treatment. One species may also 
benefit if another produces enzymes that reduce antibiotic activity or if the species 
gains antimicrobial resistance by horizontal gene transfer (70). 
Non-pneumococcal alpha-haemolytic streptococci inhibit pneumococcal 
growth in vitro and negative associations between these commensals and 
pneumococci have been observed in vivo (71,72). A number of studies have shown 
a negative correlation between the growth of pneumococci and S. aureus in the 
nasopharynx (20,73,74).  
In contrast, there are conflicting results regarding bacterial interactions between 
S. pneumoniae and H. influenzae. Both negative (75-77) and positive (20,74,78,79) 
associations have been observed between these bacteria in the nasopharynx of 
children. Experimental and in vitro studies provide evidence for both synergistic 
and competitive interactions between these two species (80,81). Concurrent 
colonisation of epithelial surfaces by these species induces synergistic pro-
inflammatory responses (80). Several mechanisms of the mutual competition 
between S. pneumoniae and H. influenzae over the ecological niche have been 
suggested, including competition for nutrients and receptors (82). In animal 
experiments, H. influenzae has been associated with decreased frequency and density 
of pneumococcal growth (83,84). S. pneumoniae has been shown to inhibit the in 
vitro survival of H. influenzae through the production of hydrogen peroxide and 
neuraminidase (81,85). H. influenzae for its part activates the complement-
dependent killing of pneumococci (83). H. influenzae also enhances carriage-induced 
antibody production against pneumococcal proteins, at least in children vaccinated 
with a pneumococcal conjugate vaccine (86). 
The complexity of between-species interactions was demonstrated in a study in 
which colonisation by H. influenzae was negatively associated with S. pneumoniae 
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during upper respiratory infection, but when H. influenzae and M. catarrhalis 
colonised the host simultaneously, both were positively associated with S. 
pneumoniae (75). Colonisation with M. catarrhalis has also been shown to increase the 
risk of acute otitis media (AOM) in children colonised with either S. pneumoniae or 
H. influenzae (76). H. influenzae out-competed a non-virulent strain of S. pneumoniae 
in experimental co-colonisation in mice, resulting in selection of more virulent 
pneumococcal strains (87). Viral upper respiratory infection may also affect the 
relative occurrence of different nasopharyngeal bacteria (72).  
2.2.4 Biofilm formation 
One possible explanation for the conflicting findings on between-species 
interactions is biofilm formation. Biofilms are complex three-dimensional 
structures, comprising bacteria from one or several species, hyper-adhesively 
attached to the cell surfaces and encased within a self-produced extracellular matrix 
(88). Bacteria organised in biofilms interact with each other using intercellular 
messenger molecules and form special structures for the delivery of nutrients and 
removal of metabolic waste products (23). In biofilms, bacteria elicit weaker 
inflammatory responses and are more resistant to host defences and other 
environmental challenges, including desiccation and antimicrobial treatment, as 
compared to planktonic strains, i.e. strains not organised in a biofilm (89-91). 
Bacteria living in biofilms may be undetectable with conventional culture methods 
but detectable with PCR-based methods (22,23) 
In animal models, pneumococcal biofilm formation has been associated with 
enhanced adhesive capacity, persistent carriage and decreased virulence (89-91). 
Concordantly, pneumococci in biofilms have expressed high proportions of 
transparent phenotypes, fit for colonisation, along with decreased amount of 
capsule, enhanced production of adhesins and decreased production of 
pneumolysin (90). The presence of H. influenzae has been observed to increase 
pneumococcal biofilm formation in vitro and in vivo (92), but this may be strain-
specific and affected by factors associated with the host (93). Although it has been 
suggested that pneumococcal biofilm formation enhances survival of bacteria and 
prolongs colonisation rather than promotes invasive disease, biofilms have been 
observed in association with a variety of infections as well (22,92,94).  
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2.3 Immunity related to pneumococcal carriage and infection  
In addition to the physical and biochemical host defence mechanisms of the 
mucosa, humans have a versatile complex of immunological defence mechanisms 
to protect themselves against pathogenic microbes. The immune system can be 
classified into different overlapping and co-operating subsystems. The innate (un-
specialised) immune system is not pathogen-specific and therefore it is 
independent of previous contacts with pneumococci. The adaptive (specialised) 
system is based on development of protection mechanisms after recognition of 
pneumococcal structures. The innate immunity operates through leucocytes and 
circulating proteins (the latter mechanism occasionally referred to as ‘humoral 
innate immunity’). Adaptive immunity has been divided in two components. First, 
antibody-dependent (humoral) immunity refers to recognition of different 
polysaccharide or protein molecules (antigens) by the host and production of 
antigen specific antibodies. The antibodies bind to their target antigens and start a 
process aiming at destruction of the bacteria and preventing their attachment and 
invasion. Second, the adaptive cell-mediated immunity operates through leucocytes 
and does not involve antibodies. In the case of mucosal infections, the immune 
system first operates at the mucosal level. The systemic immunity operates through 
the circulation in the whole body.  
2.3.1 Immunological responses to pneumococcal carriage and acute otitis 
media 
If pneumococci escape the physical and biochemical host defence mechanisms of 
the upper respiratory tract mucosa, the bacteria invade the tissue beneath the 
epithelium and stimulate the mucosal innate immune reaction. After the 
pneumococcal structures have been recognised by the host receptors, the release of 
cytokines and other chemical mediators recruits leucocytes into the upper 
respiratory mucosa. This leucocyte migration has an important role in the clearance 
of pneumococcal carriage (95). Inflammation and cell damage further accelerate 
the process of the innate immune response.  
In the systemic innate immune reaction, the pneumococcal structures, 
facilitated with host proteins like the C-reactive protein, trigger complement 
activation, which results in a cascade of biochemical reactions producing molecules 
that cover (opsonisate) the bacteria. The opsonisation makes the bacteria easier to 
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be embedded (phagocytised) and killed by polymorphonuclear leucocytes and 
macrophages. The proteins produced by the complement cascade also enhance 
recruitment and activation of additional cells and molecules participating in the 
process. Furthermore, the inflammatory vasodilatation enhances the migration of 
phagocytic leucocytes from vessels into the infected tissue. Although very quick, 
the innate immunologic mechanism is relatively ineffective, as pneumococci have 
many mechanisms to escape clearance by complement activation (96). As a link 
between the innate and adaptive immunity, dendritic cells and macrophages 
process the pneumococcal antigens and present them to leucocytes responsible for 
the development of adaptive immunity. 
The adaptive immune system targets pneumococcal infections specifically and is 
developed after pneumococcal strains have been encountered by the host. The best 
known adaptive immune mechanism is production of antibodies against the 
polysaccharides of the pneumococcal capsule and a number of other 
pneumococcal antigenic structures. The importance of adaptive cell-mediated 
immune mechanisms independent of antibodies has been recognised only recently 
and is less well understood (97,98)  
At the mucosal level, the antibody production takes place in the so-called 
‘mucosa-associated lymphoid tissue’ beneath the epithelium. The pneumococcal 
polysaccharide and protein antigens induce production of mucosal antibodies, 
transported back to the mucosal surfaces and secreted. The majority of these 
secretory antibodies belong to the immunoglobulin A class. Their main function is 
to prevent bacterial attachment and invasion into the mucous membrane by 
binding to the bacterial adhesins and blocking their interaction with the receptors 
in the epithelial cells. 
Systemic antibodies against pneumococcal antigens circulate in the blood. They 
are produced in the lymph nodes and in the spleen and opsonise bacteria for 
phagocytosis and interfere with the function of different pneumococcal structures. 
The capsular polysaccharides induce serotype specific antibody production. The 
production is independent of T-cells, as polysaccharide antigens can bind directly 
to B-cells and activate them to proliferate and differentiate to antibody-producing 
plasma cells. The antibody response to purified polysaccharide antigens is short-
lived and does not induce immunological memory (99). According to a current 
concept, however, T-cells and B-cells interact in the production of antibodies 
against the capsular polysaccharides during natural encounters between 
pneumococci and the host, most likely because the capsular polysaccharides in 
living pneumococci are presented by leucocytes to the immune system together 
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with the protein and lipid components of the cell wall (100,101). The main 
function of anti-capsular antibodies is to participate in opsonisation, which is 
facilitated by complement activation and which results in phagocytosis 
Antibodies induced by conserved pneumococcal antigens common to all 
capsular types, i.e. the cell wall polysaccharides, different surface proteins and 
pneumolysin, are not serotype-specific. The onset of antibody production against 
proteins requires activation of B-cells by T-cells (102) and the process has been 
shown to induce immunologic memory (103). The protein antibodies interfere with 
the function of their target antigens, for example, by preventing adhesin-mediated 
binding of pneumococci to the host cells (49,50) or reducing the cytotoxic effects 
of pneumolysin (104).  
Epidemiological studies have shown that even infants are capable of producing 
antibodies against the pneumococcal polysaccharides and proteins (105-112). The 
antibody concentrations in serum and saliva increase during the first 2 years of life 
but remain mostly below the level measured in adults (106-109). Previous culture-
confirmed pneumococcal contacts, either carriage or AOM, have been associated 
with increased concentrations of antibodies against some pneumococcal capsular 
polysaccharide and protein antigens in children (106-114). In addition, 
polysaccharide antibodies from children who have previous culture-confirmed 
contacts with homologous serotypes have shown higher capacity to opsonise 
pneumococci for phagocytosis as compared to antibodies from children without 
such contacts (115). Increases in antibody concentrations have been measured 
between the acute and convalescent phases of culture-confirmed pneumococcal 
AOM, although this seems to occur only in a minority of events and vary by age, 
antigen and previous pneumococcal contacts (116-120). In adults, significant 
increases in polysaccharide antibody concentrations against some pneumococcal 
serotypes and proteins were observed, if either the individual or a family member 
carried the serotype during a 10-month follow-up (121).The observed kinetics of 
the development of antibodies in children has varied remarkably between different 
serotypes and by different protein antigens (106,107,109,122). It is not easy to 
interpret how much of this variation is due to real biological differences in the 
responses to these antigens and how much could be explained by other reasons, 
such as undetected previous encounters with pneumococci or other unrecognised 
factors affecting the antibody dynamics.  
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2.3.2 The protective effect of naturally acquired immunity against 
pneumococcal carriage and acute otitis media 
The protective role of anti-capsular polysaccharide antibodies against the invasive 
forms of pneumococcal disease is well established (123). The protective role of 
naturally acquired polysaccharide antibodies, i.e. antibodies induced by encounters 
with pneumococci in carriage or disease against subsequent pneumococcal carriage 
and mucosal infections is less well understood. Repeated episodes of carriage and 
AOM due to the same serotype are not unusual (124,125) and pneumococcal 
AOM may occur even in the presence of serotype-specific antibodies (105).  
In experimental colonisation studies among adult humans, susceptibility to 
colonisation could not be predicted by the pre-inoculation level of serum IgG 
against the homologous capsular polysaccharide (126,127). In contrast, an 
observational study among Israeli toddlers found a lower risk of colonisation with 
serotypes 6A, 14, and 23F after previous exposure to the same serotype, and for 
serotypes 14 and 23F the protection was associated with increased serotype-
specific antibody concentration (114). Previous carriage of selected serotypes 
resulted in delayed re-acquisition of the homologous serotypes in a refugee camp in 
Thailand (128) and the same was observed for serotype 14 among Gambian infants 
(129). In a follow-up study among UK adults, a higher level of anticapsular IgG for 
serotype 14 at the beginning of a 10-month follow-up was associated with reduced 
odds of carriage of this serotype during the follow-up (121). In a study in US 
families in the 1970s, pre-existing serotype-specific antibodies did not protect from 
the acquisition of a homotypic strain but seemed to decrease the duration of 
carriage (113). Concerning AOM, lower pre-existing concentrations of antibodies 
to pneumococcal capsular antigens have been associated with later proneness to 
otitis (130) and lower acute phase concentrations have been observed in children 
with pneumococcal AOM than in children with non-pneumococcal AOM (118).  
Development of anti-capsular polysaccharide antibodies have long been 
considered as the basis for immunity increasing with age against invasive 
pneumococcal diseases (123). However, other mechanisms must also be involved 
in the development of protection, as the decline in the incidence of invasive 
pneumococcal diseases by age is similar across different serotypes despite large 
variation in the exposure and carriage of different serotypes and their 
immunogenicity (131). The decline in disease incidence also starts at an earlier age 
than would be expected based solely on the rate of increase in polysaccharide-
specific antibody levels. Thus, antibodies against antigens common to all 
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pneumococcal serotypes or adapted cellular immune mechanisms could be 
alternative mechanisms for protection. 
Antibodies against the cell wall polysaccharides, common to all serotypes, did 
not prevent pneumococcal carriage from proceeding to disease or the worsening of 
disease in a study among young adults (132). Studies of the protective role of pre-
existing antibodies against pneumococcal proteins in preventing pneumococcal 
carriage have resulted in inconclusive findings. Of the two studies in which 
volunteer adults were challenged intranasally with pneumococci, one suggested 
protection against pneumococcal carriage by pre-existing anti-protein antibodies 
(126), whereas the other did not (127). Studies among UK children aged 2–12 years 
and among young infants in The Gambia showed associations between low 
concentrations of antibodies against pneumococcal protein antigens and 
pneumococcal carriage (122,133). In contrast, in studies among Finnish children, 
naturally acquired protein antibodies in serum and saliva were not protective 
against carriage (120,134-137). Instead, Finnish studies have provided suggested 
evidence that naturally acquired serum and salivary antibodies against selected 
pneumococcal proteins correlate with protection against pneumococcal AOM 
during the second year of life (120,134,135,137). A higher antibody concentration 
against pneumococcal surface adhesin A, but not against pneumolysin, during the 
acute phase of AOM has also been associated with a lower risk of pneumococcal 
involvement (118,138). Similarly, a higher antibody concentration against 
pneumococcal surface protein A during the acute phase of invasive disease has 
been associated with a lower risk of pneumococcal involvement (139). After an 
intra-nasal challenge with pneumococcal serotype 6B, adult volunteers who became 
carriers developed higher IgG levels against pneumococcal proteins than non-
carriers (127). When pooled sera from the carriers was inoculated into mice, the 
mice were protected against invasive disease after inoculation of lethal doses of a 
heterologous serotype 2, indicating protection due to antibodies independent of 
serotype (127). Likewise, previous pneumococcal carriage has been associated with 
serotype-independent protection against subsequent acquisition in a follow-up 
study among Bangladeshi infants (140). 
The role of cellular immunity as another mechanism of serotype-independent 
protection against pneumococcal carriage was evidenced by the mouse models of 
Malley et al. (141). The authors found that colonisation with pneumococci induced 
similar protection against re-colonisation by both homologous and heterologous 
serotypes and that protection was independent of both anticapsular and non-
capsular antibodies. Furthermore, protection was completely abrogated in mice 
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that congenitally or experimentally lacked TD4 positive T-cells. The fact that 
protection was long-lived argued for adapted cellular immunity instead of innate 
immune mechanisms (141). The role of T cells, either alone or together with serum 
and mucosal antibodies, is currently undergoing intensive research in animal and 
human studies (97,98,142-146). 
2.4 Transmission and carriage of Streptococcus pneumoniae  
S. pneumoniae is transmitted between human hosts by respiratory secretions, either 
as airborne droplets or through contaminated hands or fomites (147). If 
pneumococcal adherence to the mucosa is not prevented by the host defence 
mechanisms, pneumococci settle on the mucosa of the human nose, nasopharynx 
or oropharynx. Pneumococcal carriage remains usually asymptomatic, the bacteria 
staying on the mucosal surface without causing any harm until the bacteria are 
cleared. Only a few carriage episodes proceed to disease.  
2.4.1 Sampling sites and methods for identification of pneumococcal 
carriers  
Our knowledge of the dynamics of pneumococcal carriage depends on adequate 
identification of the carrier state. Pneumococci can be sampled from the human 
nasal cavity, nasopharynx or oropharynx.  
Nasal or nasopharyngeal specimens have proved superior to those obtained 
from the oropharynx or tonsils in children, if the swab sampling technique has 
been used (148-154).The sensitivity of nasopharyngeal sampling was >90% in 7 of 
9 reviewed studies in which sampling from both nasopharynx and oropharynx was 
used as the diagnostic standard (9). Strains from the nasopharynx have been shown 
to reflect those causing otitis media better than oropharyngeal strains (155). Usually 
the nasopharyngeal sample is obtained through the transnasal route, but sometimes 
the sample from the nasopharynx has been obtained through the transoral route by 
curving a flexible swab upwards into the nasopharynx (154,156). However, 
sampling the nasopharynx via the transnasal route has proved more sensitive in 
children (154).  
Nasal or nasopharyngeal aspirate samples or nasal wash samples are also used in 
identifying children carrying pneumococci. In a study comparing different sampling 
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sites and methods among children with respiratory tract infection, the sensitivities 
of nasopharyngeal swab samples and nasopharyngeal aspirates were very similar, 
both performing significantly better than swab samples obtained from the 
posterior wall of the oropharynx (148). In a Kenyan study, the nasopharyngeal 
swab culture was positive in 85% of children with a positive nasal wash culture 
(157). A disadvantage of the aspiration and wash techniques is that these methods 
may be less tolerated and require more collaboration. Furthermore, aspiration 
without wash can only be used if nasal secretion is present. Similar pneumococcal 
yields have been observed in studies comparing nasal swabs and nasopharyngeal 
aspirates (148,158) or nasal swabs and nasopharyngeal swabs (148,159). However, 
the presence of respiratory infection may have affected the findings in some of 
these studies. Even cultures from paper tissues with visible secretions after blowing 
or wiping the nose have revealed good sensitivity (159,160) 
Nasopharyngeal sampling has been used to identify pneumococcal carriers also 
among older children and adults. During the last decade, however, it has become 
obvious that simultaneous nasopharyngeal and oropharyngeal samples are required 
for optimal detection of carriage in adults (150,161-165). In some studies of adults 
and adolescents, swab samples obtained from the posterior pharyngeal wall or 
nasopharynx through the mouth have yielded pneumococci even more often than 
samples obtained through the nose (24,163,164,166). In a study among Dutch 
adults, pneumococci were initially found more often from nasopharyngeal samples 
obtained via the transnasal route as compared to the transoral route. However, the 
yield was significantly better when using the trans-oral route if initially culture-
negative but PCR-positive samples were carefully re-cultured after enrichment (24). 
A re-examination of initially negative transnasal samples resulted in only very few 
positive results, which means that repeated sampling (157) was not the main reason 
for the additional yield gained from using both sampling routes. 
The optimal composition of the sampling swab is not well known. Cotton 
swabs may include properties inhibitory to pneumococci (9,10). The performance 
of calcium-alginate, Dacron and rayon tipped swabs has varied in studies using 
conventional culture methods and no clear preference has been determined 
(167,168). Calcium alginate may inhibit some PCR-based assays and, like rayon, 
contains nucleic acids that interfere with the interpretation (9). Recently, high 
pneumococcal yields have been obtained with flocked nylon swabs (168). 
A WHO Working Group published recommendations for a standard method 
for the detection of upper respiratory pneumococcal carriage in children initially in 
2003 to advance the comparability across different studies (10). In the majority of 
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carriage studies, samples have been obtained from the nasopharynx as 
recommended, but variable swab types and swab transport media have been used 
(169). The WHO Working Group has updated their recommendations in 2013 (9). 
Deep nasopharyngeal sampling with the one-swab approach is recommended for 
children, whereas both nasopharyngeal and oropharyngeal sampling is 
recommended for adults. The use of any alternative methods and all deviations in 
the procedure should be reported to help with interpreting the results. Calcium 
alginate, rayon, Dacron or nylon materials are suitable for culture-based studies. 
For molecular analyses, synthetic materials such as nylon or Dacron are preferred. 
Skim milk-tryptone-glucose-glycerin is the recommended medium for transport 
and storage of the samples. Culture remains the standard for detection of 
pneumococci and the use of selective plates enriched with gentamicin is 
recommended. As a new recommendation, one of each morphologically distinct 
colony should be stored along with information of its order of prevalence. This 
allows for the possibility to return to all alpha-haemolytic colonies if the first 
colony turns out to be non-pneumococcal or if information about multiple 
colonisation will later be needed. As the optimal method for detection of multiple 
serotypes has not been identified, the recommendation encourages storing the 
original sample for future assessment. Culture may be complemented with non-
culture techniques, of which the current recommendation favours the detection of 
DNA from major pneumococcal autolysin genes by real-time PCR (9). The core 
method for serotyping of pure pneumococcal isolates is the Quellung test. Latex 
agglutination may also be used, but evidence is insufficient to give 
recommendations for other methods.  
If species other than S. pneumoniae should be detected as well, sampling methods 
should be revisited and complemented. For example, current data suggest that 
both naso- and oropharyngeal swabs may be needed for the optimal recovery of H. 
influenzae (148,150,152).  
When interpreting findings of carriage studies, it must be borne in mind that the 
sensitivity of pneumococcal detection by culture is not perfect (24,170). For 
example, antimicrobial treatment may reduce the bacterial load below the detection 
level or bacteria organised in biofilms may be undetectable with conventional 
culture (22,23). 
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2.4.2 Exposure to pneumococci and transmission 
The major reservoir of pneumococcal strains in the population is upper respiratory 
tract carriage. Asymptomatic carriage is the source for the vast majority of 
transmissions. Transmission occurs most likely when individuals are in close 
contact with one another. Since young children have the highest frequency of 
pneumococcal carriage, they form the most important source for pneumococcal 
transmission. For this reason, most transmission studies have been carried out in 
families with young children or in day care facilities. 
The importance of intra-familial spread of pneumococci was first recognised 
already several decades ago (113,149,171). Family studies continue to be crucial in 
learning about the dynamics of pneumococcal transmission and colonisation. In a 
study among Bangladeshi families, exposure within families to selected target 
serotypes signified more than a ten-fold increase in the rate of acquisition in other 
family members (172). Large families, crowded living conditions (171,173,174) and 
respiratory infections (113,175) favour pneumococcal spread within families.  
Young children are particularly susceptible to acquiring S. pneumoniae. The risk 
for acquisition is especially high if the young child is exposed by a carrying family 
member (140,149,173,175-180). In a subgroup of the FinOM Cohort Study, 
simultaneous carriage of the same serogroup by another family member presented 
a clearly higher risk of carriage at age 6 months to 2 years than with day care 
attendance (177). However, adults are less susceptible to acquiring S. pneumoniae, 
even when exposed at home (173,178,181,182). Adults with children in the family 
tend to carry pneumococci more often than adults living without children 
(183,184), but the parents still carry much less often than their children 
(33,128,150,180,181,183-188). 
Even if different family members carry S. pneumoniae simultaneously, the strains 
are not always the same, especially in populations in which the frequency of 
carriage is high and the turnover of strains is rapid (181,184,185,187). In general, 
however, the same serotype seems to be a good indicator for pneumococcal 
transmission. In 17 of 18 pairs of children and their parents with concurrent 
carriage of the same serotype in Japan, the molecular typing by PFGE showed an 
identical or at least a related pattern (189). Similarly, the nasopharyngeal serotype 
and PFGE type were identical between siblings in 12 of 13 clusters of concurrent 
or closely related AOM events experienced in 11 families (190). 
Children acquire S. pneumoniae effectively also from the community, thus 
introducing new strains into the family (173,176,182,191). Day care attendees 
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usually show higher prevalence of pneumococcal carriage than unselected healthy 
children. Thus, day care centres provide an effective environment for transmission 
of pneumococci (181,182). In Israel, carriage in infants and toddlers cared for at 
home was associated with previous carriage of similar strains in the day care centre 
of their older siblings, but not in other day care centres in the area, the strains 
being identified by serotyping, antibiogram, and PFGE (192). In a study of 
pneumococcal transmission among Finnish day care attendees and their family 
members, about 80% of new serotypes detected in the family were estimated to be 
attributable to the day care attendee (182). In this model, 65% of acquisitions in 
day care attendees were estimated to originate from fellow day care attendees, 25% 
from the community, and only 10% from family members.  
There may be considerable differences in carriage prevalence between individual 
day care centres or primary schools even in the same area (193-198). In a 
comparative analysis of pneumococcal transmission in Portuguese and Finnish day-
care centres, the higher prevalence of carriage in the Portuguese setting was 
assigned to the younger age of attendees, to a higher within-room transmission and 
to the larger day care centre size (199).  
Clustering of strains within day care centres and schools has been demonstrated 
in several studies (181,200-204). Although the overall serotype distributions in 
different day care centres are often similar, more detailed pneumococcal typing 
with molecular methods may yield different patterns for different day care centres 
and even for different rooms within a facility (205). When studied longitudinally, 
pneumococcal microepidemics have been identified within facilities (182,206,207). 
Especially strains resistant to antimicrobials are able to circulate for months or 
become endemic in a day care centre (208). Sometimes observed repeated or 
prolonged epidemics of a serotype may actually represent several distinct epidemics 
of different strains expressing the same serotype, if the strain has not been studied 
in detail with molecular methods (206).  
The staff of the day care centres usually have surprisingly low frequency of 
pneumococcal carriage, similar to that of other adults (197,209-212). However, 
exceptions with high carriage in staff have been reported, especially at the time of 
introduction of a new strain in the facility (33). In an Israeli study, pneumococcal 
strains identified by serotype, resistance patterns and PFGE did not spread 
effectively from day care children to adults, despite close contacts in a kibbutz 
community (181). Adults introduce new strains into the family less often than 
children because adults carry pneumococci less frequently. However, once 
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colonised, adults may effectively transmit the bacterium to susceptible family 
members (173,178).  
2.4.3 Acquisition of pneumococcal carriage  
Worldwide, practically all children acquire S. pneumoniae at least once by the age of 2 
years (125,129,175,188,213,214). New-born infants can be colonised by the 
bacterium from the first days of life (125,175,179,185).  
In developing countries and populations with high risk of pneumococcal 
carriage and disease, the first episode of colonisation occurs early in life 
(128,175,179,185,215,216). First pneumococcal carriage was detected in all children 
in studies conducted in Papua New Guinea (185,215) by the age of 3 months 
(mean 17 days) and in all Australian indigenous children by the age of 4–5 months 
(median 58 days) (216). First pneumococcal carriage has been recognised by the 
age of 1-2 months in at least half of the children followed from birth or early 
infancy in studies in The Gambia, Kenya, India, Bangladesh and among Burmese 
refugees (128,129,140,175,217). 
In the industrialised countries, initial colonisation with S. pneumoniae occurs later. 
About 50% of Swedish children, swabbed four times at 2, 6, 10 and 18 months of 
age, had acquired pneumococci at least once (218). In a US birth cohort swabbed 
at 1–2-month intervals, the proportion was 38% at six months and 54% at one year 
of age (219). The mean age at first detected acquisition was about six months. 
These figures are likely to be underestimates, since duration of carriage may be 
short and the recognition of acquisition depends on the frequency of the sampling. 
This was evidenced in a Costa Rican study in which the cumulative acquisition rate 
during the first year of life was 36% if the children were swabbed at 1, 3, 6 and 12 
months of age, but 72% if the children were swabbed weekly (186). As many as 
38% of children followed from birth with biweekly sampling in Oxfordshire, UK, 
had acquired S. pneumoniae already by the age of 12 weeks (220), this proportion 
being still far smaller than in the high risk populations. 
After first acquisition, new strains are acquired and even the same strain may be 
acquired again after a period of absence. In a birth cohort study in the USA, up to 
six different serotypes were sequentially acquired within the two first years of life 
(125). In a Swedish day care centre, children acquired up to seven different 
serotypes during a 2-year follow-up with monthly sampling (209).  
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It is not straightforward to infer whether sequential findings of the same 
serotype represent continuous carriage or whether the serotype has been cleared 
and re-acquired. Re-appearance of a previously carried serotype may occur even 
after several months of negative findings (113,128,206,209,221,222). An 
intervening negative culture may not be absolutely reliable, especially during 
antimicrobial treatment and if the time spacing between the two positive findings is 
short. In longitudinal data sets, variable algorithms have been used to differentiate 
continuous carriage and re-acquisition. Depending on the sampling frequency, re-
acquisition has been defined as the re-appearance of a serotype or strain if more 
than a specified time (30 days to 14 weeks) has elapsed between two positive 
findings, often allowing one or even two negative findings between the positive 
ones, at least during antimicrobial treatment (113,125,185,209,213,222-224). The 
estimation of incidence rates of pneumococcal acquisition requires a longitudinal 
study with frequent sampling, and yet the exact times of acquisition between two 
samples with different status remain unknown, complicating the analysis. Different 
statistical models have been useful in estimating acquisition rates 
(128,172,175,182,191,225-227). Acquisition rates are higher in preschool children 
than in older children or adults (128,172,182,228). An increase in the acquisition 
rate with age during the first months or years of life has been suggested (191,229), 
but this pattern has not been consistent (225,230). Differences in acquisition rates 
across serotypes have been observed in several studies 
(125,172,175,213,225,228,230,231).  
2.4.4 Clearance of pneumococcal carriage 
The times and rates of pneumococcal clearance can be estimated in longitudinal 
studies with repeated sampling, although the exact timing remains largely 
unknown. Of note, the estimates of duration of carriage are not fully comparable 
across studies due to methodological differences, especially different definitions of 
acquisition and clearance of carriage. For example, studies that estimate serotype-
specific durations of carriage by modelling the serotype-specific clearance rates 
often differentiate the overall disappearance of the serotype from its clearance in 
the absence of competition by other serotypes (immune clearance) (225)((228,232). 
The observed duration of carriage has ranged from a few days up to 17 months 
(125). The observed distribution of duration tends to be skewed. Many short 
carriage episodes and a few long carriages are usually observed. 
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(129,183,207,209,222,233). Without frequent sampling, even long carriage episodes 
may be detected in one sample only and short episodes have a lower probability to 
be detected than long ones.  
The clearance rates increase with age, so that the average duration of carriage 
shortens (128,173,176,191,199,229,230,233). In the US study by Gray et al., the 
estimated average duration of pneumococcal carriage decreased steadily from 4–6 
months at the age of three months to 2–4 months at the age of 15 months, and 
remained constant thereafter up to the age of 24 months (229). In a Swedish study, 
the mean duration was about 2.5 months in children aged less than one year, 
whereas it was 1.5 months and one month in children aged 1–2 and 3–4 years, 
respectively (233). In children aged less than two years, the mean duration was 
about two months in Finland and France (191,206,225). Valuable data with 
frequent samplings from The Gambia (129,176) and Kenya (225) confirm the 
decreasing duration with age, the duration being similar or somewhat longer than 
observed in industrialised countries.  
As compared to children aged less than five years, older children and adults 
have been found to carry pneumococci for shorter times, on average for one 
month or less in Finland, Sweden, the UK and in a refugee camp in Thailand, and 
for about two months in The Gambia (128,176,182,228,233). The effect of 
serotype on duration of carriage has been difficult to ascertain, since serotypes 
carried most frequently and for the longest time are also acquired at the youngest 
age (125,234). A number of studies have shown clear differences across serotypes 
in duration of carriage (129,213,230,231), especially in the youngest children 
(225,228,233). In the South Swedish Pneumococcal Intervention Program, it was 
confirmed that children aged less than four years carried serotypes belonging to 
serogroups 6 and 23 for longer time than those belonging to serogroups 9 and 14 
in each of the narrower age groups (233). In Kenyan infants, the point estimates 
for time to immune clearance varied between 28 and 124 days for different 
serotypes (225). In a cohort study among UK families, the average duration of 
carriage for serotype 6B was 4 months as compared to less than two months for 
other serotypes in children aged less than five years (228). However, in older 
individuals, the average duration of carriage for serotype 6B was only 11 days (228).  
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2.4.5 Prevalence of pneumococcal carriage  
The frequency of pneumococcal carriage in a population is usually characterised by 
the point prevalence of carriage, or sometimes as the proportion of positive 
findings out of the total number of samples in studies with repeated samples. The 
prevalence of carriage depends on the acquisition and clearance rates of 
pneumococcal carriage in the population. 
The prevalence of pneumococcal carriage increases during the first months of 
life, as infants become exposed and start acquiring pneumococcal strains after birth 
(129,186,229,235-237).In several populations the prevalence levels off or peaks 
already during the first year of life, (128,129,164,174,214,238-245) whereas in 
others the prevalence continues to increase at least through the second and 
sometimes the third year of life (73,184,236,244,246). After the peak prevalence, 
carriage starts to decrease slowly but usually remains relatively prevalent up to 
about 3 or 7 years of age (73,184,207,214,244,247,248), after which it decreases 
more quickly (73,79,149,164,177,183,187,188,241,249-252).  
In high risk populations with a large burden of pneumococcal disease, the 
turnover and acquisition of new strains is rapid and the prevalence of 
pneumococcal carriage is high. Extremely high prevalence levels (~90%) have been 
reported among African children in The Gambia and Ethiopia and among HIV 
positive children in Tanzania (129,249,253). Similarly, very high pneumococcal 
prevalence has been observed among highland children in Papua New Guinea and 
Australian indigenous children (215,254). High levels of pneumococcal carriage of 
60–80% have also been observed in several other African and Asian countries 
(164,181,217,238,241,243,255,256), among the indigenous peoples in North and 
South America (180,246), among the Bedouin population in Israel (257), in refugee 
camps in Hong Kong and Thailand (128,239) and in an urban slum community in 
Brazil (247).  
The turnover of pneumococcal strains is slower in industrialised countries and 
middle- and high-income populations, and the average carriage prevalence in 
healthy children under school age usually settles at a lower level, at about 20–50% 
(153,186,188,197,198,218,248,258-262). In studies conducted among ill children 
and in day care centres the prevalence tends to be higher and high point 
prevalences (70–90%) have been observed occasionally also in industrialised 
countries in day care centres or orphanages, especially in young children, 
(205,206,224,263). In contrast, low carriage levels (3–20%) have also been 
reported, but in these studies at least some participating children have been older 
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than five years of age, children with even mild respiratory symptoms have been 
excluded, the samples have been obtained via oral route, and/or the samples have 
been cultured on unselected plates (156,193,195,239).  
Adults carry S. pneumoniae less frequently than children. Across a wide range of 
studies, the prevalence of pneumococcal carriage has been 10% or less 
(79,149,174,181,186,188,214,250). Higher levels of about 15–20% have been 
reported in some studies in day care centres and military service (33,162). Among 
high risk populations even adults carry pneumococci frequently, and the prevalence 
has been as high as ~50–60% among Gambian villagers (249) and ~20-40% in 
some other African countries and among Australian and South-American 
indigenous peoples (180,241). Sampling only the nasopharynx is likely to 
underestimate the proportion of adult carriers. The prevalence increased from 19% 
to 35% among parents of young children in the Netherlands after careful 
examination of the oropharyngeal swab samples in addition to the nasopharyngeal 
ones (24) and when nasal aspiration was used as a third detection method in 
hospital employees with common cold in the USA, the prevalence was as high as 
45% (163). Even with both nasopharyngeal and oropharyngeal sampling, the 
carriage prevalence remains clearly lower in adults as compared to children in the 
same population or family (150,164). It is not well known how much of the low 
carriage frequency in adults is attributable to immunological resistance against 
acquisition, or is due to low sensitivity to detect carriage of short duration.  
The prevalence of carriage in older children and adolescents is between those 
found in children and adults (73,79,149,164,177,181,188,214,241,249,250). There is 
only sparse knowledge about pneumococcal carriage among the elderly, the other 
major risk group for invasive pneumococcal disease. However, carriage seems to 
be rare in this age group (184,264,265), except among some institutionalised 
populations (183,266).  
2.4.6 Carriage of different pneumococcal serotypes  
The diversity of carried serotypes is wide. For example, in a cross-sectional survey 
among Gambian children and adults, the 2428 carriage isolates comprised 74 of the 
more than 90 known serotypes (249).  
In unvaccinated children, the most frequently carried serotypes have belonged 
to serogroups 6, 19, 23 and often also 14 with only little temporal and geographical 
variation (73,125,164,214,220,240,261,267,268). These frequently carried 
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serogroups account for the majority of first acquisitions (125,129,207,213) and re-
acquisitions (125). These serogroups tend to have higher acquisition rates and 
lower clearance rates compared to most other serotypes (125,175,213,225,228). 
The diversity of carried serotypes increases with age (175,263). 
Several reasons for the relative fitness of the most frequently carried serotypes 
have been suggested. The serotype has been shown to affect adherence to human 
respiratory epithelial cells in vitro (269). Although a thinner capsule is associated 
with attachment and colonisation, a thicker capsule helps to escape clearance by 
mucus and surface phagocytosis. A novel hypothesis suggests that a simple 
structure of the capsule requires less energy consumption and leads to better 
growth in a nutrient-restricted environment and to better fitness of the serotype 
(270,271). The serotype-specific antibodies seem to have a role in the regulation of 
acquisition and/or clearance of carriage. Immunogenicity seems to vary between 
serotypes (114,121) and it has been suggested that high immunogenicity is 
correlated with lower acquisition rates (231).  
More than one pneumococcal serotype can be carried at the same time. As 
many as one third of nasal samples collected from children in Papua New Guinea 
yielded more than one distinct pneumococcal serotype, and up to four serotypes in 
one sample (215). Altogether 17% of positive samples from Kenyan infants yielded 
multiple serotypes (157). In most studies, the proportion of positive samples that 
have yielded multiple serotypes has been up to 12% 
(29,125,164,181,187,188,205,220,254,272,273). However, these numbers may be 
underestimates since colonies representing a minority serotype may be sparse and 
indistinguishable from the majority of colonies, and in most studies only a few 
pneumococcal colonies have been picked from the culture plate for serotyping. 
Kaltoft et al. performed direct serotyping from an enrichment serum broth culture 
by a capsular reaction test and found multiple serotypes from 8-12% and 38% of 
positive samples obtained from children and staff in study day care centres, 
respectively (33). In a study among Burmese refugee infants, multiple serotypes 
were detected in 11% of samples positive for pneumococci by picking two or more 
morphologically different colonies for serotyping, while the proportion was 43% 
when a sweep of colonies were serotyped by latex agglutination and it was 49% 
with a molecular-serotyping microarray (274). 
Pneumococcal serotypes compete with each other in the nasopharynx. 
Competition may concern limited nutrients and sites for adherence on the host 
cells. Carriage of a resident strain has been shown to inhibit colonisation by a 
challenge strain in a mouse model (275). Pneumococcal strains have been shown to 
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produce small antimicrobial peptides called bacteriocins, which inhibit the growth 
of other pneumococcal strains without causing harm for the producer strain in 
vitro and decrease colonisation by a competing strain in experimental animal 
models (276). Lower acquisition rates for new pneumococcal strains in the 
presence of another strain have been estimated by statistical modelling, based on 
longitudinal carriage data from epidemiological studies, whereas competition 
through enhanced clearance has not been evident (172,225,227,228). The most fit 
and most frequently carried serotypes (belonging to serogroups 6, 19, 23) with the 
highest acquisition and lowest spontaneous clearance rates are also less susceptible 
to competition by other strains than most other serotypes (225,228). However, 
even the most competitive serotypes do not out-compete other serotypes and the 
diversity of carried serotypes is maintained. One suggested theory is that carriage 
induces serotype-specific immunity against the carried serotype itself, and this 
immunity opens niches for the less fit serotypes not carried earlier in life (87,277-
279).  
For the prevention of pneumococcal diseases with serotype-specific vaccines 
the competition between pneumococcal serotypes poses an important challenge. In 
the clinical trials with pneumococcal conjugate vaccines, it was soon observed that 
while vaccination reduces carriage due to the vaccine serotypes, it increases carriage 
due to other serotypes (280-282). It was first speculated that the explanation for 
this phenomenon could be the more sensitive detection of pre-existent minor 
serotypes, detectable after the elimination of the major ones, so-called ‘unmasking’. 
However, it was soon understood that the increase in carriage with the non-vaccine 
serotypes was true and due to the disappearance of the competing vaccine types, a 
phenomenon termed ‘replacement’ (28,283). Accordingly, clear increases have been 
observed in the incidence of pneumococcal diseases due to the non-vaccine-
serotypes, first in the clinical trials and later also in clinical surveys during ongoing 
vaccination programmes (284-286). 
2.5 Clinical manifestations of pneumococcal infection in children  
The pneumococcus causes a wide variety of diseases. These range from relatively 
mild but common mucosal infections, such as otitis media, sinusitis and non-
bacteraemic pneumonia, to rare but serious and even life-threatening invasive 
diseases like bacteraemia and meningitis. The incidence of pneumococcal diseases 
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is highest in both extremes of life and these diseases constitute an enormous 
burden throughout the world.  
2.5.1 Otitis media  
Otitis media is a continuum of inflammatory conditions of the middle ear, 
accompanied by the collection of effused fluid. The healthy middle ear is an air-
filled cavity within the temporal bone, lined with a mucosal membrane and 
separated from the external ear with the tympanic membrane. It is essential for 
hearing as it conducts sound to the inner ear through the ear ossicles. The middle 
ear is connected to the nasopharynx by the Eustachian tube, which balances the 
pressure between the two locations. 
The acute form of otitis media, AOM, is characterised by an acute symptomatic 
inflammation of the middle ear accompanied by MEF (287). AOM is mostly, if not 
always, caused by a microbial infection and with sensitive methods pathogenic 
bacteria and/or viruses are detected in the MEF in a majority of AOM cases 
(288,289). Otitis media with effusion (OME) is an inflammation of the middle ear, 
associated with collection of effusion without symptoms or signs of acute infection 
(287). OME often follows AOM due to the slow resolution of inflammation and 
MEF. OME can also be associated with disturbances in the function of the 
Eustachian tube and, in turn, predispose to acute and recurrent infections (290-
292). In prolonged OME, the MEF becomes viscous because of increased mucus 
production, leading to ‘glue ear’. Chronic forms of otitis media may cause 
perforation of the tympanic membrane with or without chronic discharge, 
adhesion of the tympanic membrane to the bony parts of the tympanic cavity, 
erosion of the bones in the middle ear or development of cholesteatoma. 
The development of AOM occurs in the following pattern: A predisposing 
event, usually a viral upper respiratory infection, causes inflammatory changes and 
congestion of the respiratory mucosa. The impaired function of the Eustachian 
tube leads to negative pressure in the middle ear, accumulation and trapping of 
secretions and ascending of pathogens from the nasopharynx into the middle ear 
cavity (287,290). Inflammation also disrupts the function of the mucociliary 
system, important in preventing bacteria from ascending into the middle ear and in 
clearing them from it (293). Furthermore, inflammation enhances bacterial 
adherence and invasion into the cells (57). As a consequence, viruses and bacteria 
effectively proliferate in the secretions in the middle ear and the infection proceeds 
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to disease (287). It is likely that the host inflammatory response to infection in the 
middle ear is responsible for most clinical symptoms and signs of AOM (294).  
The criteria for the clinical diagnosis of AOM and its differentiation from OME 
have been debated in recent decades and various criteria have been used in both 
clinical practice and clinical studies (295). The diagnosis of AOM has mainly been 
based on signs suggesting inflammation of the tympanic membrane and presence 
of fluid in the middle ear as observed in pneumatic otoscopy, together with recent 
onset of signs or symptoms of local or systemic illness (296,297). Otoscopic signs 
suggesting presence of MEF behind an intact tympanic membrane include its 
opacity, yellow or greyish colour, bulging and impaired mobility (297). Sometimes 
the MEF can be seen directly as a visible air-fluid level behind the tympanic 
membrane, or occasionally in the ear canal after spontaneous perforation of the 
membrane (297,298). Tympanometry or reflectometry can be used as an aid in the 
assessment of ear-drum mobility (299-301). The symptoms of AOM and upper 
respiratory tract infection are essentially the same, and AOM cannot be 
distinguished from viral respiratory infection on the basis of symptoms, especially 
in young children (302-304). Also ear-related symptoms (ear pain, tugging or 
rubbing of the ear), although relatively often associated with AOM (296,303,305) 
can also be due for example to teething or transient alterations of the middle ear 
pressure. The recently updated US recommendation sets more stringent criteria for 
the clinical diagnosis of AOM and the differentiation between AOM and OME. 
This recommendation emphasises bulging as a specific sign of acute inflammation 
of the tympanic membrane (306,307). While increasing the specificity in 
recognising cases with truly acute bacterial infection, with the highest probability to 
benefit from antimicrobial treatment, these criteria may be insufficient in 
recognising the whole spectrum of AOM (306,308).  
The standard method for the etiological diagnosis of AOM is culturing live 
pathogens from the MEF obtained by myringotomy, tympanocentesis or drainage 
through a perforation. S. pneumoniae has long been the most important bacterial 
cause of AOM. The proportion of AOM cases with pneumococcal aetiology has 
ranged from 20 to 50% in studies across different populations (237,288,309-319). 
After the introduction of large scale pneumococcal conjugate vaccination the 
relative proportion of AOM caused by pneumococci, i.e. the serotypes included in 
the vaccine initially decreased and accordingly, the relative proportion of AOM 
caused by other etiologic bacteria increased. The increase was true especially for 
non-typable H. influenzae, which has rivalled pneumococcus as the other major 
otopathogen (312,320). However, several years after vaccine introduction, the 
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pneumococcal serotype replacement has led to an increase in the incidence of 
AOM caused by serotypes not included in the pneumococcal vaccines, and thus 
the relative proportion of pneumococcal AOM has increased again (321). The third 
bacterium commonly causing AOM is M. catarrhalis (316). Streptococcus pyogenes is 
nowadays a rare otitis pathogen (284,288,314). Viruses are detected in a small 
proportion of MEF samples, if only culture methods are used (322). However, with 
culture combined with antigen detection or especially with the sensitive PCR-based 
methods, the proportion of viral presence in MEF samples from children with 
AOM can reach up to more than 70% (288,323). In a majority of these cases, 
viruses are found together with bacteria, but sometimes viruses are the only 
detected pathogens (288,322). S. pneumoniae tends to cause more severe AOM than 
the two other major otopathogens, non-typable H. influenzae and M. catarrhalis. 
Although the aetiology of AOM cannot usually be determined by its clinical picture 
(315), fever and earache, bulging or spontaneously perforated eardrum and 
myringitis have been associated with pneumococcal AOM (324-327). The 
spontaneous recovery rate has been shown to be lower (20%) for pneumococcal 
AOM than for AOM caused by H. influenzae (50%) (328). Higher leucocyte counts 
and higher concentrations of specific interleukins as markers of vigorous 
inflammation have been found in the blood of MEF in children with 
pneumococcal AOM, as compared to those with AOM caused by H. influenzae or 
M. catarrhalis (329-331). In contrast, the relative proportion of H. influenzae tends to 
be higher in recurrent AOM and OME and in older children (332-334). AOM 
caused by mixed bacteria (335) and the presence of viruses in the MEF 
concomitantly with bacteria have been associated with persistence and recurrence 
of otitis media and poor responsiveness to antimicrobial treatment (336). 
Pneumococcal serotypes that most frequently cause AOM are largely the same 
as the most frequently carried ones, at least in unvaccinated children. The most 
frequent pneumococcal serotypes causing AOM serotypes in unvaccinated young 
children have thus belonged to serogroups 6, 14, 19 and 23 (124,125,284,337). The 
prominence of these serogroups decreases with age (124,337). When 
pneumococcal isolates recovered from MEF samples obtained during AOM were 
compared with those from age matched nasopharyngeal samples obtained at visits 
scheduled by age in the FinOM Cohort Study, small differences were found 
between some serotypes but not between genotypes in their relative ability to cause 
AOM, and there was no significant difference in the genotypic diversities of the 
AOM and carriage strains (338). In another Finnish study, likewise no major 
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differences in the clinical presentation of AOM across different serotypes were 
found (339). 
2.5.2 Sinusitis and bronchitis 
Pneumococci may spread from the nasopharynx and nose into the paranasal 
sinuses during upper respiratory infection and cause sinusitis, especially in older 
children and adults (340). Upper respiratory infection often spreads to the 
paranasal sinuses also in young children, but trapping of secretions is rare and the 
disease often resolves without antimicrobial treatment (341).  
Acute bronchitis is considered to have a viral aetiology. However, S. pneumoniae 
and H. influenzae are involved in the chronic forms of bronchitis, chronic 
suppurative lung disease and bronchiectasis (342). In the pre-antibiotic era, these 
disease entities were common also in children as sequelae of respiratory infections, 
and they still remain a problem in developing countries and among disadvantaged 
indigenous groups (343). In industrialised countries these conditions are mostly 
associated with cystic fibrosis, immunodeficiency, tarcheomalacia and 
neuromuscular conditions (344). 
2.5.3 Pneumonia 
Pneumonia is an acute infection of the lung tissue, filling the alveoli with exudation 
and interfering with breathing and gas exchange. Bacterial pneumonia develops 
mostly as a result of aspiration of the bacteria from the nasopharynx or inhalation 
of the bacteria directly in air-borne droplets (345). The clinical diagnosis of 
pneumonia is based on the symptoms (cough, fever, pain or difficulty breathing, or 
gastrointestinal symptoms (346,347) and clinical signs (crackles or decreased breath 
sounds detected by auscultation of the lungs and signs of difficult breathing 
(346,348,349). A WHO working group has published guidelines for standard 
interpretation of chest radiographs in verifying the diagnosis of pneumonia in 
children, especially for purposes of epidemiological studies and vaccine trials (350). 
The etiological diagnosis of pneumonia is difficult. If pneumonia remains 
restricted to the mucosa, there are no reliable tools for its etiologic diagnosis. Good 
quality sputum samples (351) are difficult to obtain without contamination by the 
upper respiratory flora. Classical pneumococcal pneumonia is considered to 
present with lobar or segmental consolidation in chest radiography and to respond 
 50 
promptly to penicillin (352,353), but these characteristics are not reliable (346,347). 
If the bacteria spread to the blood and cause bacteraemic pneumonia, they may be 
detectable with blood culture (347,354).  
S. pneumoniae is recognised as the most common cause of pneumonia in 
unvaccinated children all over the world, together with H. influenzae type b 
(355,356). The proportion of pneumococcal involvement in pneumonia has been 
estimated to be 20% or more, depending on diagnostic methods, severity of disease 
and population studied (347,355,357,358). Viruses are frequently detected in 
association with childhood pneumonia, either as the only causative agents or as 
counterparts in mixed bacterial-viral infections (347,357,359). Especially the 
influenza virus is known to predispose to pneumococcal pneumonia (360) and 
influenza-associated pneumococcal pneumonia tends to be especially severe (61). 
2.5.4 Pneumococcal invasive disease 
Invasive pneumococcal disease is an infection caused by pneumococci in a 
normally sterile body site. The bacteria can spread into the blood during 
pneumonia or locally from the nasopharynx to cause bacteraemia or they may 
spread through the blood-brain barrier to cause meningitis (69,340). Meningitis and 
other intracranial infections can be sequelae of AOM if the infection spreads from 
the middle ear via venous channels, through the inner ear, or through infected 
bone (292). Pneumococci can also gain entrance into the host through lesions 
caused by trauma or surgical procedures. Occasionally pneumococci cause cellulitis, 
osteomyelitis, pericarditis, pleuritis or arthritis. Because of strong inflammation, 
invasive pneumococcal diseases are always potentially life-threatening.  
The standard diagnosis of invasive pneumococcal disease is based on culture of 
pneumococci from normally sterile body sites. This diagnosis is specific but 
insensitive and thus underestimates the incidence of pneumococcal disease, 
especially if preceding antimicrobial treatment has been given. In an Italian study, 
for example, only 34% of patients with clinical suspicion of invasive pneumococcal 
disease with positive pneumococcal PCR-tests from normally sterile body sites 
yielded pneumococci in culture (361). Using data from vaccine trials for 
epidemiological purposes, the difference in the disease incidence between 
vaccinated and unvaccinated individuals can be attributed to serotypes included in 
the vaccine (355,362,363).  
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A relatively small number of serotypes are responsible for the majority of 
invasive pneumococcal disease in children (364). There are differences across age 
groups and geographical areas in the most frequent serotypes causing invasive 
disease (364). In addition to true epidemiological differences, diagnostic practises 
may affect the observed serotype distribution, mild diseases being under-diagnosed 
with strict sampling policies (365). In unvaccinated populations, both the most 
frequently carried serotypes (6, 14, 19 and 23) and some rarely carried serotypes (1, 
4, 5, and 7) with a special invasive capacity often cause invasive diseases 
(213,215,267,366). The capsular type is important to the ability of pneumococci to 
cause invasive disease (366). Nevertheless, distinct genetic clones showing the same 
serotype may have different abilities to cause invasive disease. (267,367). Within 
serotypes, the genetic diversity is lower among clones causing invasive diseases 
than among those carried (367,368). 
2.5.5 Burden of pneumococcal diseases  
The most common pneumococcal disease is otitis media. According to a recent 
review on the global burden of otitis media, the incidence of AOM is highest in 
Sub-Saharan Africa, Oceania and South Asia and lowest in East Asia, Central and 
Eastern Europe and Southern Latin America (369). Early onset, persistence and 
frequent sequelae of ear infections are very common also in many indigenous 
populations, e.g. among the native populations in Australia, North America and 
Greenland (370,371). The incidence is highest in children aged less than five years 
and half of the estimated more than 700 million cases per year occur in this age 
group (369). 
AOM is also the most common cause of children’s visits to outpatient clinics 
and antimicrobial treatment in developed countries (372-374). Up to 70-80% of 
children experience AOM by the age of 2–3 years (375,376). A rising trend of 
AOM occurrence was observed in both countries in the last decades of the 20th 
century (377,378). In Finland, with about 5 million inhabitants, an estimated 500 
000 cases of otitis media occur annually, and in the USA, pneumococci alone are 
responsible for 5 to 7 million AOM cases each year (379,380).  
Apart from causing more severe symptoms, pneumococcal AOM leads to 
serious bacterial complications more often than AOM caused by H. influenzae and 
M. catarrhalis (292,381). Such complications include mastoiditis and related 
infections (periostitis, retroauricular abscess), and intracranial infections like 
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meningitis, brain abscesses and lateral sinus thrombosis, all of which are life 
threatening and may be associated with permanent neurological damage (382). 
Inner ear problems, e.g. sensorineural hearing loss or vestibular dysfunction may 
also occur, although rarely (383). Instead, conductive hearing loss associated with 
long-lasting bilateral MEF is a common consequence of recurrent AOM and OME 
and chronic forms of otitis media often lead to permanent hearing loss. The 
burden of the sequelae and complications of AOM is especially high in the 
developing and low-income countries with limited health care resources (369).  
Studies of the effects of hearing loss on speech, language skills or educational 
achievements have produced contradictory conclusions (382,384-386). In 
industrialised countries with adequate treatment possibilities the impact is mostly 
considered to be relatively minor (382,387-391).relatively minor (382,388-390). 
However, the harm may be considerable for children with co-existing conditions 
associated with delayed development, like Down’s syndrome (389). In children in 
developing countries and among indigenous populations with high prevalence of 
chronic ear problems, hearing loss is common and has been found to lead to 
learning problems and disability (392,393). The unfavourable impact of recurrent 
AOM on the quality of life of the child and its caregivers has been recognised 
(394). 
Since ear infections are very common, they form a considerable economic 
burden. In addition to the direct costs due to physician visits, antimicrobial 
treatment, surgical treatment to prevent recurrent cases and treatment of 
complications and sequelae, considerable indirect costs incur from parental absence 
from work, travel, and care arrangements for the sick child (379,395,396). High 
AOM morbidity and frequent antimicrobial use has led to increased resistance of 
bacterial strains against antibiotics, which poses a serious global problem (397-399).  
The overall average annual incidence of invasive pneumococcal diseases in 
children aged less than two years was 44 per 100 000 before the implementation of 
pneumococcal infant vaccination in Europe (400). The corresponding incidence 
was 188 per 100 000 in the USA (401) and even higher in the developing countries 
and in some high risk populations (402-405). Pneumococcal pneumonia and 
invasive disease are rarer than ear infections, but pneumonia and invasive diseases 
usually require hospitalisation and the severity of these disease entities highlights 
their importance. Although the case fatality ratio for invasive pneumococcal 
diseases is lower for children than for adults (404,406), it has been estimated that 
almost one million children aged less than five years die because of pneumococcal 
infections each year (355). Most deaths occur in developing countries in Africa and 
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Asia, pneumonia being the most common cause (407). In Finland, on average only 
one child dies annually of pneumococcal diseases. Meningitis, although rare, has a 
very high case fatality ratio (355) and causes invalidising sequelae even in 
industrialised countries (408). 
2.5.6 Treatment of acute otitis media  
AOM, pneumonia and invasive diseases are mostly treated with antimicrobial 
agents. Since etiologic diagnosis is rarely available, treatment is usually empirical 
and relies on epidemiological data on the causative bacteria and their antimicrobial 
susceptibility in the population. For decades, pneumococci have been highly 
susceptible to penicillin, but recently the frequent use of wide-spectrum antibiotics 
has led to increasing antimicrobial resistance. Therefore, the need to reduce 
unnecessary antibiotic use, to improve prevention strategies and to find tools for 
monitoring and predicting the epidemiology of pneumococcal diseases has become 
evident.  
A number of studies conducted in the 1980s and 1990s revealed that most 
AOM episodes resolve without antibiotic treatment (409-412). Thereafter, a new 
treatment strategy for AOM, ‘an observation option’ or ‘watchful waiting’ 
(413,414) was introduced for selected uncomplicated cases, which means delaying 
the decision on antibiotic treatment for a few days, with symptomatic treatment 
and appropriate follow-up. The option is included in the guideline 
recommendations to primary care clinicians, published by the American Academy 
of Pediatrics (306,307) and implemented in many other countries including Finland 
(415).  
Surgical drainage of the middle ear by tympanocentesis or myringotomy with or 
without aspiration was an important treatment for AOM before the antibiotic era. 
The role of the procedure as a valuable adjunct to antimicrobial treatment was still 
stressed by otologists in the Finnish consensus conference 1985 (416,417). Later 
studies showed that the procedure does not offer any additional benefit over 
antimicrobial treatment (418-420) and it is currently mostly restricted to children 
with serious disease or an underlying condition, intensive pain or special need of 
etiologic diagnosis. However, the role of tympanocentesis and myringotomy in the 
diagnosis and treatment of AOM has been occasionally revisited (421). Pichicero et 
al. showed that recurrent AOM and tympanostomy could be prevented if 
tympanocentesis was performed in event of failure of the primary treatment and 
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antimicrobial treatment was selected according to the etiologic bacterium and its 
antimicrobial susceptibility (422). 
2.5.7 Prevention strategies for pneumococcal diseases  
Vaccination is the most effective way to prevent pneumococcal invasive diseases 
and efforts have been paid to investigate its potential in reducing the burden of 
pneumococcal otitis media. A 23-valent polysaccharide vaccine has been available 
since 1983. It has some effect against bacteraemic disease in adults, but children 
younger than two years of age show minimal immune responses against most 
polysaccharide antigens. The efficacy of the polysaccharide vaccine against mucosal 
infections like otitis media is poor (423). When the polysaccharide antigens are 
conjugated to carrier proteins, however, these antigens become immunogenic also 
in young children and induce immunologic memory.  
The first conjugate vaccine was licensed in 2000. The vaccine was primarily 
targeted to prevent invasive diseases, and it included antigens against seven 
serotypes (4, 6B, 9V, 14, 18C 19F and 23F). This vaccine covered >80% of 
serotypes causing pneumococcal invasive disease in children in the USA (365,424). 
The corresponding coverage was 60–70% in Europe before the vaccination era, 
with some additional coverage if serotypes cross-reacting with the vaccine 
serotypes are also considered (364,400,424), while coverage was only about 50% or 
less of serotypes causing invasive diseases in children in Asia and Africa, areas with 
the highest burden of pneumococcal diseases (364,424). In studies among children 
in the USA and Finland, the efficacy of the 7-valent conjugate vaccine was 97% 
against invasive pneumococcal diseases (284,425). The next step in the vaccine 
development was to add serotypes 1 and 5, which are common causes of invasive 
disease in many developing countries. In studies in South Africa and The Gambia, 
an experimental, never licensed 9-valent vaccine showed 72-83% efficacy against 
paediatric invasive pneumococcal diseases and 17-37% efficacy against all-cause 
radiologically confirmed pneumonia (426,427). A 10-valent vaccine including an 
additional serotype 7F prevented 100% of vaccine-type invasive disease in Finnish 
children (428).  
In a Finnish vaccine trial, the efficacy of the 7-valent vaccine was 57% against 
AOM attacks caused by the vaccine serotypes (284). In Finland and the USA the 
vaccine prevented only 6-8% of all AOM cases (284,425,429), but protection 
against frequent episodes of otitis media and tympanostomy tube placement was 
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better, at 20–40% (425,429-431). In the 10-valent vaccine, the conjugated carrier 
protein originates from H. influenzae. The vaccine prevented 67% of vaccine-type 
AOM in Panama (432), and supplemented with serotype 3 it prevented 34% of all-
cause clinical episodes of AOM in a trial conducted in the Czech Republic (433). A 
13-valent vaccine with additional antigens against serotypes 6A and 19A, also 
relative common otopathogens, especially in unvaccinated populations, was 
licensed in 2009 on the basis of immunogenicity studies. The use of 10- and 13-
valent vaccines has now practically replaced the use of the 7-valent vaccine. 
In clinical trials of the 7- to 10-valent conjugate vaccines the relative reduction 
in the risk of pneumococcal carriage due to serotypes included in the vaccine has 
been about 50–60% as based either on carriage prevalence ratios or odds ratios 
(282,434-436). The vaccine prevents new acquisitions rather than affecting carriage 
established before vaccination (434,436). Rinta-Kokko et al. presented a method 
for evaluating the vaccine efficacy against acquisition of carriage using prevalence 
data (437). The authors applied their approach to data from five published trials 
and found that the vaccine efficacy against acquisition of vaccine-type carriage 
varied between 44% and 65% and the overall average efficacy against 
pneumococcal carriage acquisition seemed to be about 50% (437). Vaccination has 
been shown to also decrease the density of vaccine-type carriage (434). The 
protection against carriage lasts for several years (280). Most vaccine trials have 
demonstrated almost complete serotype replacement in carriage after vaccination 
(282,434,436,438).  
By the end of 2013, pneumococcal conjugate vaccines had been introduced into 
childhood vaccination programs in 103 countries, and the global coverage of infant 
immunisation was estimated to be 25% (439). Following vaccine introduction, the 
incidence of invasive vaccine-type disease has declined remarkably, not only in the 
vaccine target population but also in other age groups. This indicates herd 
immunity, i.e. indirect protection through reduced carriage and transmission of the 
vaccine serotypes by vaccinated children (400,401). Although the direct effects in 
the target population for vaccination are clearly beneficial in most countries, the 
benefit of the indirect effect has been questioned because the other type of indirect 
effect, i.e. replacement disease in the non-target population has been relatively 
high. There is heterogeneity between countries in the occurrence and timing of 
replacement in disease, (285,440) and in some countries, especially in Europe, the 
net benefit in the non-target population has been questioned. Reasons for the 
variation in patterns of replacement may be the different and changing blood 
culture practices, with only the most severe cases being captured with more 
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stringent policies (440). Secular changes in serotype distributions and vaccination 
coverage may also have an effect (285,440).  
One solution to the problem of replacement is to increase the serotype 
coverage of pneumococcal vaccines. A 15-valent vaccine is already under clinical 
testing (Clinicatrials.gov NCT01215175), but considering the wide variety of 
carried serotypes, the replacement phenomenon may remain troublesome. 
Nurhonen and Auranen introduced a model for predicting the optimal serotype 
composition in a vaccine to gain the best possible net benefit in the population. 
The model is based on assumptions about the good effectiveness of vaccination in 
reducing carriage of the vaccine serotypes and on their replacement with the non-
vaccine serotypes. In addition, knowledge of pre-vaccination age- and serotype-
specific carriage prevalences and probabilities of invasive disease per carriage 
episode (“case-to-carrier ratios”) is needed (441). As another approach for 
overcoming the problem with replacement, several proteins conserved across all 
serotypes have been tested as vaccine antigens, some of which have reached clinical 
trial phase in humans (442,443).  
General strategies for preventing childhood respiratory infections including 
pneumococcal otitis media comprise of favouring small day care groups with 
improved hygiene routines (444,445), avoiding use of a pacifier at the otitis-prone 
age (444,446) and using xylitol chewing gum (447). Anti-adhesive 
oligosaccharides(448), probiotics (449) and alpha-haemolytic streptococci with 
bacteriocin-like activity (71) have proved promising in inhibiting growth of 
otopathogens in vitro and in preclinical studies (528), but their ability to prevent 
ear infections in clinical studies has been controversial or disappointing (450-453). 
Recurrent attacks of otitis media and prolonged OME can be prevented by the 
insertion of ventilation tubes, with or without adenoidectomy (454). According to 
current recommendations the benefits of prophylactic antimicrobial treatment 
should be carefully weighed against potential harms (306). Influenza vaccination is 
an effective way to reduce otitis media and other secondary bacterial infections 
during the epidemic (455), and vaccines against other respiratory viruses are under 
development.  
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2.6 Pneumococcal carriage, viral upper respiratory infection and 
otitis media  
Pneumococcal carriage with frequent turnover of a large number of different 
strains is common in healthy children. At the same time, carriage is a pre-requisite 
for pneumococcal diseases, including AOM. Both pneumococcal carriage and otitis 
media are associated with upper respiratory tract infection, generally considered to 
be a viral disease, and all three share several common predisposing factors. 
Although much is known about the dynamics of pneumococcal carriage, 
respiratory infections and development of otitis media, the interplay between these 
conditions is far from fully understood. 
2.6.1 Pneumococcal carriage and respiratory infection  
Acute upper respiratory tract infection is most often caused by rhinoviruses. Other 
major respiratory viruses are respiratory syncytial virus, influenza virus, 
parainfluenza virus, adenovirus, coronavirus, enterovirus, bocavirus and 
metapneumovirus, most of which can be divided into subtypes. Combining 
different detection methods including PCR to search for a wide panel of viruses, 
the presence of viral particles can be confirmed in virtually all nasopharyngeal 
specimens from young children during symptoms of respiratory infection 
(76,456,457). Accordingly, symptoms of respiratory tract infection are frequently 
considered as markers of a clinically significant viral infection (458). Serial 
respiratory infections are mostly not caused by the same viruses, as detection of the 
same virus strain ≥2 weeks apart was unusual in a prospective follow-up study 
among US infants (459). Upper respiratory tract infection is very common in 
children except during the first few months of life. Preschool children suffer on 
average about five episodes per year (460-462). 
Viral infection of the upper respiratory tract has a substantial impact on 
pneumococcal transmission and acquisition. Symptoms of upper respiratory 
infection, coughing, sneezing and increased nasal secretion offer effective means 
for the spread of bacteria by droplets or through contamination of hands or 
fomites. In a study of intra-familial transmission of pneumococci and its relation to 
respiratory infection, the inferred donors of pneumococci to other family members 
tended to have respiratory symptoms more often in the two weeks before 
transmission events than at other times (113). Viral co-infection has been 
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associated with increased pneumococcal load in the nasal cavity of children (463) as 
well as in the nasopharynx of ferrets and infant mice (464,465). In the mouse and 
ferret models, pneumococcal transmission was more intense if both the donor 
animals, colonised with pneumococci, and the contact animals were experimentally 
infected with an influenza virus (464,465). In ferrets, influenza infection increased 
especially the susceptibility of the contact animals to pneumococcal acquisition and 
these could acquire pneumococci over longer distances than animals not infected 
with influenza (464).  
Viral infection increases bacterial adherence to the epithelial cells and enhances 
translocation of bacteria through the epithelial barrier (61). In several in vitro 
studies, enhanced binding of S. pneumoniae to the human epithelial cells occurred if 
the cells were infected with influenza virus, rhinovirus or a specific adenovirus type 
as compared to uninfected cells (466,467).In a study among adult volunteers 
pneumococci, adhered in increased numbers to cells from individuals 
experimentally infected with influenza virus (468).  
Knowledge on the mechanisms by which viral respiratory infection contributes 
to bacterial adherence has increased considerably during the last two decades. Viral 
infection up-regulates receptor molecules responsible for pneumococcal 
attachment (56,61,469). The neuraminidases of the influenza virus, together with 
the pneumococcal neuraminidases, probably cleave sialic acids from the cell surface 
molecules (467). It has also been suggested that fibrin and fibrinogen deposits 
during the regenerative processes after viral infection or viral glycoproteins act as 
mediators for bacterial binding (61). Viral infection also leads to impairment of the 
ciliary function, thus slowing down the clearing of bacteria from the mucosa 
(61,470), and it impairs the function of the polymorphonuclear leucocytes (471).  
Experimental studies in animals have shown that viral infection predisposes to 
the establishment of pneumococcal carriage in vitro (464,472). When chinchillas 
were challenged intranasally first with an influenza virus and subsequently with 
pneumococci seven days later, the frequency of nasopharyngeal pneumococcal 
carriage was higher when compared to animals inoculated with pneumococci 
without preceding viral infection (472). No difference was seen in chinchillas 
infected with the adenovirus.  
In a large number of epidemiological studies from different parts of the world, 
the prevalence of pneumococcal nasopharyngeal carriage in children has been 1.2 
to almost 3 times more likely during acute respiratory symptoms or AOM than 
during health (79,113,151,153,175,180,242,259,473,474). In a follow-up study 
among US children during the first three years of life, significantly higher 
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nasopharyngeal isolation rates of S. pneumoniae were observed at physician visits due 
to upper respiratory tract infection or otitis media as compared to routine healthy 
visits (473). In an outpatient clinic in Mexico, the frequency of pneumococcal 
carriers in patients with upper respiratory tract infection, 33% of which had otitis 
media, was greater than in patients without upper respiratory tract infection (33% 
vs. 21%)(242). In Uruguay, 42% of children seeking ambulatory medical care for 
acute respiratory infection carried S. pneumoniae in their nasopharynx whereas only 
15% of healthy children were carriers, and the frequency of heavy or moderate 
oropharyngeal carriage was higher in hospitalised children with pneumonia than in 
healthy controls (153). In Pakistan, children fulfilling criteria of acute lower 
respiratory tract infection carried S. pneumoniae significantly more often than healthy 
children attending immunisation clinics (64% vs. 52%, respectively) (474). Also 
preceding respiratory infection within one month has been identified as a risk 
factor for pneumococcal carriage (475). 
There are also clear associations between pneumococcal carriage and clinical 
AOM. In Greenland, children with concurrent AOM carried S. pneumoniae 
significantly more often than their age-matched controls (48% vs. 29%) (476). In 
US children followed up to 3 years of age, otitis-prone children carried 
pneumococci significantly more often than non-otitis-prone children during 
respiratory infection or AOM (473). In another US study, children were at low risk 
for AOM during respiratory infection if they did not harbour pathogenic bacteria 
in their nasopharynx (477). In an Australian study, nasopharyngeal load of S. 
pneumoniae was higher in children with suppurative otitis media than in children 
with healthy ears (478). 
Pneumococcal carriage has been associated with the frequency of AOM also in 
many longitudinal studies (216,219,240,479). In a one-year follow-up of healthy 
children receiving immunisations and medical care in a study clinic in the USA, 
AOM was diagnosed more often during visits at which pneumococci were carried 
than during those at which it was not isolated (240). In Swedish children followed 
with three nasopharyngeal samplings during the first year of life, the occurrence of 
AOM was significantly associated with nasopharyngeal carriage of pneumococci at 
age 8 to 12 months but not earlier (479). Among Australian Indigenous children 
followed from birth at 2 to 4 week intervals for up to 15 months, the early onset 
and frequency of otitis media was better explained by early colonisation with 
pathogenic bacteria, especially S. pneumoniae, H. influenzae or mixed colonisation, 
than by age (216). In an intensive follow up of US children during the first year of 
life the frequency of pneumococcal carriage was correlated with the occurrence of 
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AOM and OME, but in this study early detection of pneumococcal carriage (at <3 
months of age) did not increase the risk of the first otitis media episode (219). 
Pneumococcal carriage during the first year of life also did not affect the risk of 
otitis media during the second year of life in a cohort of children in the 
Netherlands (480). 
There are also studies in which no difference has been observed in the 
frequency of pneumococcal carriage between respiratory infection or AOM and 
health (150,207,215,217,222,237,481,482). In a study in Papua New Guinea, almost 
all children carried pneumococci even during health with little differences 
according to the health status (215). However, children carried serotypes defined as 
‘invasive’ more often during acute lower respiratory tract infection than during 
health. Similarly, in studies in Pakistan and in Uruguay, children with respiratory 
infections carried more frequently serotypes that caused invasive pneumococcal 
disease in the same area, as compared to healthy children (153,474). This 
association may mainly apply to children with severe or lower respiratory infection, 
since children suffering from mild respiratory infections or AOM mostly carry 
similar serotypes than healthy children (242,483,484). 
2.6.2 Respiratory infection and acute otitis media 
Both viral and pneumococcal structures induce production of cytokines and other 
inflammatory mediators (57,62,64,485,486). The development of inflammation has 
an important role when asymptomatic pneumococcal carriage progresses to AOM. 
Inflammatory markers have been found in MEF from children with AOM (487), 
and higher concentrations in the nasopharynx have predicted development of 
AOM during upper respiratory infection (488). In a mouse model, replication of 
the influenza virus and presence of haemagglutinin were associated with middle ear 
inflammation, which in turn induced growth of pneumococci in the middle ear 
cavity (489). 
Viral infection and the subsequent inflammation cause cytotoxic cell damage 
(61). The inflammation induces vasodilatation, increased vascular permeability, 
secretive activity and congestion of the mucosa, which leads to dysfunction of the 
Eustachian tube and accumulation of fluid into the middle ear. This has been 
demonstrated by abnormal tympanometric findings in animals experimentally 
infected with influenza virus (471). In a clinical study among schoolchildren, the 
middle ear pressure decreased transiently during 66% of upper respiratory 
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infections not leading to AOM, mostly within seven days after the onset of 
symptoms (490). In adults, experimental viral infection caused abnormally negative 
middle ear pressure even without development of symptoms of respiratory 
infection (491). Furthermore, viral infection, especially influenza infection, causes 
impairment of the leucocyte function as shown by animal experiments (471) and 
also observed in humans (492). According to mouse models and in vitro studies, 
influenza infection contributes to bacterial growth via the formation of neutrophil 
extracellular traps (493,494) and by inducing release of bacteria from the biofilm 
(88).  
Experimental studies have shown a clear synergistic effect between the 
influenza virus and pneumococci in development of otitis media. In a study of 
Giebink et al., otitis media developed in 67% of chinchillas inoculated intranasally 
concurrently with pneumococci and influenza virus, versus 21% and 4% when the 
animals were inoculated with S. pneumoniae or influenza virus only (495). In another 
experiment, the middle ear pressure in chinchillas declined and reached a nadir on 
the seventh day after intranasal inoculation with influenza virus, while 
polymorphonuclear leucocyte dysfunction was seen 4–6 days after inoculation, 
whereas neither occurred after inoculation with pneumococci alone. In this study, 
the highest incidence of pneumococcal otitis media occurred when pneumococci 
were inoculated just before the time of influenza-induced leucocyte dysfunction 
and negative middle ear pressure (471). In a third study, in which chinchillas were 
inoculated intranasally first with influenza virus and then with pneumococci seven 
days later, the otoscopic signs of tympanic membrane inflammation peaked eight 
days after the pneumococcal inoculation (496). Influenza virus also increased the 
incidence and severity of otitis in an experimental model with sequential 
inoculation first with viruses and S. pneumoniae seven days later (472).  
Epidemiological studies have documented clear temporal associations between 
seasonal laboratory-documented epidemics of respiratory viruses and the 
occurrence of AOM, viral epidemics peaking either shortly before or concurrently 
with the peak occurrence of AOM (223,497-499). The clinical association between 
viral infection and AOM is evident as well: more than 90% of children with AOM 
have symptoms of upper respiratory tract infection at the time of diagnosis 
(296,303,324). Rhinovirus is the virus most frequently found in children during 
upper respiratory infection and AOM and also when asymptomatic 
(288,456,456,457,500,501), but during rhinovirus infection the risk of AOM has 
not been consistently higher than during viral infection in general (461,497,502).  
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About 20-50% of the upper respiratory infection episodes in children lead to 
AOM (458,500,503). In follow-up studies, most AOM cases have been diagnosed 
within two weeks after the onset of symptoms of upper respiratory infection, the 
average and peak occurrence falling between days 2 and 6 after symptom onset 
(458,477,501,504). Upper respiratory infections are associated also with increased 
risk of OME (461), and detection of viruses in the nasopharynx of even 
asymptomatic children has been associated with development of OME (500,505).  
Numerous clinical studies show that children with respiratory syncytial virus 
infection have a special risk for development of AOM (223,461,499,505). Further, 
of influenza infections of children aged less than three years 40% were complicated 
by AOM in a Finnish follow-up study (506). There is more variation in the 
observed propensity of other specific virus infections to lead to AOM 
(76,223,461,497,499,502,505,507,508). However, as the most common virus 
causing respiratory infections, rhinovirus is the most important virus associated 
with AOM. High loads of viruses in the nasopharynx have inconsistently been 
associated with the risk of AOM (502). 
2.6.3 Pneumococcal carriage and pneumococcal acute otitis media 
The frequent occurrence of pneumococci in the nasopharynx during culture-
confirmed pneumococcal AOM in children has been almost a uniform finding 
(125,155,262,509-513). This means that the sensitivity of nasopharyngeal culture in 
predicting pneumococcal aetiology of concurrent AOM is high. The sensitivity was 
90% based on aggregated data of 4791 paired nasopharyngeal and MEF samples 
available in six published studies (514). Generally, if pneumococci have been 
isolated concurrently both from the nasopharynx and from the MEF, the serotypes 
have been homologous in more than 90% of cases (124,125,510,513,515). If 
characterised beyond the serotype level, a vast majority of paired isolates from the 
nasopharynx and the MEF showed the same resistance patterns (513) or 
indistinguishable genetic patterns in a PFGE analysis (516). 
The high sensitivity of nasopharyngeal culture means that the value of a 
negative nasopharyngeal finding in excluding pneumococcal aetiology of 
concurrent AOM (negative predictive value) is high. However, pneumococcal 
carriage is common both in healthy children and in children with non-
pneumococcal AOM, which results in low specificity and a modest value of a 
positive nasopharyngeal finding to predict pneumococcal aetiology of concurrent 
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AOM (positive predictive value) (262,510,512). The positive predictive value based 
on combined data from six published AOM studies was 50% (514).  
Temporal associations between pneumococcal carriage, respiratory infection 
and development of acute otitis media  
Understanding the development of carriage and disease requires approaching 
them as dynamic longitudinal processes in time. Only a few follow-up studies have 
assessed the temporal relationship between acquisition and carriage of S. 
pneumoniae, respiratory infection and the development of otitis media.  
Brimblecombe et al. observed a close temporal relationship between acute 
upper respiratory infection and acquisition of pneumococcal carriage in a follow-up 
study with fortnightly visits to UK families in the 1950s (171). Based on thorough 
monitoring of respiratory symptoms and collection of nasal and throat swab 
samples, carriage was observed to increase 1-2 days after the start of the symptoms 
of acute coryza and children carried S. pneumoniae twice as often when they had 
nasal discharge as compared to when they did not (171).  
Sleeman et al. followed a cohort of UK children from birth up to 24 weeks of 
age collecting nasopharyngeal swab samples 2–4 weeks apart to study the 
relationship between pneumococcal carriage and physician visits for infection 
(220). Pneumococcal acquisition, defined as the first detection of a new serotype, 
was significantly associated with visits for infection potentially caused by 
pneumococci, but not with visits because of other infections, whereas no 
association was found between established pneumococcal carriage (subsequent to 
acquisition) and visits for infection.  
Grijalva et al. conducted a study among Peruvian Andean children aged less 
than three years, during the introduction of pneumococcal conjugate vaccines in 
the population in 2009–2010 (517,518). If acute respiratory infection was present 
during weekly household visits, nasal swabs were collected for identification of 
respiratory viruses. Nasopharyngeal swab samples were obtained at monthly visits 
for detecting acquisitions of new pneumococcal strains by culture and PCR-based 
methods. The risk of pneumococcal acquisition was about two-fold after exposure 
to influenza or parainfluenza virus and increased also after viral co-infections, 
whereas exposure to viruses in general symptoms of respiratory infection 
irrespective of the viral finding did not increase the risk of pneumococcal 
acquisition. The increase in the acquisition risk was only observed in children who 
already carried a pneumococcal strain. The pattern was relatively constant when 
stratified by vaccination status (518). 
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Gray et al. conducted a prospective follow-up among 82 Alabaman children 
aged less than two years (125,229). Nasopharyngeal swab samples were collected at 
1 to 3 month intervals as well as during visits due to respiratory infections, and 
MEF samples were obtained if AOM was diagnosed. The authors observed that 
pneumococcal AOM developed mostly within one month after acquisition of the 
causative serotype (125,229). In contrast, in the study in Papua New Guinea, the 
authors observed an association between the frequency of serotypes detected from 
children admitted to hospital because of pneumonia and frequency of serotypes 
carried in a nearby area, the association being similar for new acquisitions and 
prevalent carriage (231). 
Henderson et al. conducted a longitudinal study among children in a day care 
centre in North Carolina to assess the relative importance of viral respiratory 
infection and nasopharyngeal colonisation with S. pneumoniae in development and 
occurrence of AOM (223). The health status of the children was reviewed by 
nurses five days a week and nasal wash and throat swab samples for bacterial and 
viral detection were collected every two weeks and at onset of respiratory illness. A 
higher incidence of otitis media was associated with concurrent or preceding 
(within 14 days) detection of respiratory syncytial virus, adenovirus and influenza 
viruses, with only a modest increase if S. pneumoniae was also present. The presence 
of S. pneumoniae or H. influenzae had a more pronounced effect on the risk of otitis 
in the presence of such viruses which alone posed a small risk of otitis media, such 
as rhinovirus, enterovirus and parainfluenza virus. If no viruses were detected, the 
incidence of otitis media was only marginally associated with pneumococcal 
carriage during the preceding two weeks and pneumococcal acquisitions measured 
as first detections of individual serotypes did not increase the risk of otitis media as 
compared to established carriage (223). Overall, the frequency of otitis media was 
correlated with early or recurrent infection with respiratory syncytial virus, 
adenovirus and influenza viruses but not with early or frequent colonisation with S. 
pneumoniae. 
2.7 Pneumococcal carriage and pneumococcal invasive 
disease  
Children very often harbour S. pneumoniae in their nasopharynx also during invasive 
culture-confirmed pneumococcal disease. In studies conducted in Pakistan, Papua 
New Guinea and The Gambia, pneumococci were found in 90–96% of nasal or 
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nasopharyngeal samples in children with pneumococcal invasive diseases and in 
77–99% of these cases the serotypes found in the nasopharynx and the normally 
sterile body site were homologous (187,474,519). In the study in Papua New 
Guinea, 94% of the blood serotypes were also found from the nasopharynx if they 
belonged to the frequently carried serogroups 6, 14, 19, 23, or to a large group of 
serotypes that were rarely carried and rarely caused invasive pneumococcal disease 
in the study area (519). By contrast, only 50% of serotypes found in the blood were 
concurrently harboured in the nasopharynx if they were labelled ‘invasive’, i.e. 
belonged to a group of serotypes frequently causing invasive diseases but less 
frequently found in carriage in the study area.  
2.8 Other determinants of pneumococcal carriage, upper 
respiratory infection, acute otitis media and pneumococcal 
disease 
Studies from different parts of the world document an extraordinary wide range of 
pneumococcal carriage prevalence (3.5-90%) in children (156,249,520). This 
variation is likely due to differences across the study populations with respect of 
age, current and underlying health status and treatment, genetic background as well 
as socio-economic living conditions and cultural habits. In addition, different 
sampling and laboratory methods may contribute to the differences. Factors 
affecting the occurrence of upper respiratory infections and otitis media are mostly 
the same as those associated with pneumococcal carriage (521) and also 
pneumococcal invasive diseases share similar risk factors. However, there are also 
differences, and it is not well known whether these differences are due to 
shortcomings in the methodology in investigating the associations, or whether 
there are mechanisms by which some factors specifically affect the progress of 
carriage to disease.  
The incidence of respiratory tract infections, AOM and invasive pneumococcal 
diseases starts to increase after protection by maternal antibodies has waned by 6 
months of age (110,111,462), especially in developed populations (112). 
Pneumococcal carriage often starts to increase already during the first months of 
life. The increase of pneumococcal carriage frequency may continue during the 
second and third years of life, after which it remains at a relatively high level up to 
school age, whereas the incidence of respiratory infections, AOM and invasive 
diseases usually peaks earlier at about one year of age or even earlier 
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(131,164,223,375,376,462,522-524). The maturation of immunological mechanisms, 
increasing acquired immunity to microbes as well as anatomical changes in the 
respiratory tract and Eustachian tube are the likely factors contributing to 
decreasing susceptibility of children to these infections by age.  
Both viral and pneumococcal infections are common in children, and both are 
transmitted in close contacts. Thus, spending time with other children such as day 
care mates or siblings is the most indisputable risk factor for pneumococcal 
carriage (175,197,246,261,479), respiratory tract infections (525,526), AOM 
(444,527-532) and invasive pneumococcal disease (533-535). Only few studies have 
failed to demonstrate the impact of day care (243,480) or siblings (243,536) on 
carriage, AOM and pneumococcal invasive disease. Some authors have been able 
to distinguish differences in the risk by the degree of exposure to other children, 
such as the size of day care group (212,444,537,538), time spent in the day care 
(206,444,539) and the number of siblings (239), while others have not 
(125,205,218,540). Some but not all studies have associated the increased risk 
specifically with young age of siblings (184,195,540), with their day-care attendance 
(192,218,537), with their pneumococcal carriage, respiratory symptoms or AOM 
(177,246,375,529) or with sharing a sleeping room with siblings (375).  
Viral respiratory infections, AOM, pneumonia and invasive pneumococcal 
diseases show clear seasonality with peaks in winter 
(223,497,499,541).Alternatively, a bimodal pattern with peaks in the spring and 
autumn has been observed (376,460,498,523,524,529). Seasonal trends have been 
associated with cold or ambient temperatures, humidity and darkness (529,541) or 
also with dry seasons in Africa (164). Additional explanations may be increased 
transmission associated with people spending more time inside in close contact 
with each other during the cold, dark or rainy seasons (209), or with periodical 
changes in the susceptibility of the population to various infections (541). 
Seasonality in pneumococcal carriage is less clear and several studies have failed to 
show any seasonal trends (183,215,217,237,248,542,543). A trend to more 
prevalent carriage in the winter or in association with cold weather or rainy seasons 
has been reported in a number of studies (153,171,175,179,207,209,222,544), but 
occasionally even higher prevalence of carriage in summer has been reported(250). 
In a follow-up study among US families, clear peaks were observed in carriage but 
the peaks did not occur at the same time during different years and no consistent 
seasonal trend was seen (542). In two other US studies, the pneumococcal carriage 
prevalence fluctuated mildly throughout the year, while the acquisition peaked in 
midwinter (229). In a Finnish study, the seasonal trend was clear for AOM caused 
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by H. influenzae and M. catarrhalis but weaker for pneumococcal AOM, which 
occurred frequently also in the summer (324). The authors of two Swedish studies 
explained the observed seasonality in pneumococcal carriage in day care centres by 
the influence of major holidays (209,212). 
Males are over-represented among patients with many infectious diseases (545). 
In adults, the higher risk has been partly attributed to behavioural patterns like 
smoking and alcohol use (266,546). Nevertheless, male sex has remained a risk 
factor even when adjusting for these habits (266), and sex steroids are hypothesised 
to affect immunity and susceptibility to infections (545). Likewise, invasive 
pneumococcal infections in children tend to be more common in boys than girls 
(405,523,524). Furthermore, many authors have found a significant association 
between the risk of otitis media and male gender (375,377,522,530,532) whereas 
others have not (319,444,547-549). Instead, the frequency of pneumococcal 
carriage has been similar in boys and girls in most studies 
(156,174,180,207,218,235,243,248,249). Only in a few studies has the frequency of 
carriage been higher in either boys or girls, and often in narrow age groups only 
(217,222,246,252). 
Many chronic diseases and conditions impair the host defence mechanisms, 
predisposing to pneumococcal invasive infections, pneumonia and AOM. 
Anatomical or functional defects in the lungs, liver, kidneys, nervous system or 
middle ear and adjacent organs, metabolic and neoplastic diseases or their 
treatment predispose to these infections (287,550). Globally, the most important of 
immunological deficiencies predisposing to pneumococcal infections are those 
caused by human immunodeficiency virus (HIV) infection (551), hereditary sickle-
cell disease (552) and various causes of anatomical or functional splenic 
dysfunction. The effect of these conditions on pneumococcal carriage is not as 
clear, and the treatment often interferes with interpretation (553), but at least 
immunological disorders are suggested to affect the carriage (554). In two Kenyan 
studies, the prevalence of pneumococcal carriage was higher in HIV infected than 
in healthy children (238), especially during respiratory infection (238,555), and in a 
South African study even HIV exposed although uninfected children carried 
pneumococci more often than HIV unexposed children (165). Obvious 
immunodeficiencies are rarely diagnosed in children suffering from frequent 
repeated episodes of respiratory infections and AOM, but minor or transient 
deviations in their immunological system may occur (130,556,557). Severe atopy, 
allergy, asthma and gastrointestinal reflux probably predispose to respiratory 
infections (558) but their impact on prolonged and recurrent middle ear problems 
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or carriage has remained controversial and associations with pneumococcal carriage 
have been found only occasionally (181).  
In developed countries, differences in socio-economic conditions are relatively 
small and the roles of income, education and employment of parents, type of 
housing, living conditions and other markers of socio-economic status on carriage 
of pneumococci, respiratory infections, AOM and invasive pneumococcal diseases 
in children have remained controversial (235,375,529,530,532,534,547). However, 
crowding has been identified as a risk factor for these infections in several studies 
also in developed countries (171,177,209,533,539), although not in all (195,222). 
Furthermore, when investigated in detail, a diet rich in added sugar increased the 
frequency of pneumococcal carriage, whereas a diet rich in fruit and berries and 
low in sugar decreased the risk of AOM in Finnish children (559). It is likely that 
the high occurrence of pneumococcal carriage and infectious diseases in 
developing countries and high risk populations in developed countries is largely 
attributable to socio-economic factors (185,535,560,561), malnutrition, vitamin A 
deficiency (180), poor housing or hygiene, smoky firewood, and crowding 
(175,215,239,562). Poor access to health care may worsen these problems (563).  
Genetic and environmental factors affecting the risk of infection are difficult to 
differentiate from each other. Indigenous populations with high risk of 
pneumococcal infections and otitis media do not share common genetic heritage, 
although according to a recent theory, their non-European background could refer 
to a genetic background for their higher susceptibility to pneumococcal infections 
against which people with a European background could be genetically less 
susceptible (564). However, the socio-economic status and cultural lifestyles of 
indigenous people often differ from those of the non-indigenous populations, and 
this difference complicates the interpretation of epidemiological data. Furthermore, 
the declining rate of invasive pneumococcal diseases in Navajo children aged less 
than 3 years from 1989 to 1996 speaks for environmental factors affecting the risk 
in this population (402). Genetic factors may predispose to infectious diseases 
through inherited anatomical structure (565), specific hereditary diseases (552), or 
immunological aberrations (557). Data from the Netherlands suggest that genetic 
variation of innate immune responses plays a key role both in the defence against 
middle ear disease in childhood and in responsiveness to pneumococcal 
vaccination (566). Studies in the USA have shown no differences in the risk of 
otitis media between black and white Americans (319). However, in twin/triplet 
and adoption studies, a genetic component has been found in susceptibility to otitis 
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media (567) and modern genetic studies are expected to identify genes that 
influence the risk of otitis media (568). 
Tobacco smoke contains chemicals that cause inflammation of the respiratory 
tract mucosa and harm its function. Adherence of bacteria to human cells has been 
shown to be more effective in smokers than non-smokers (569,570). Active 
smoking has been identified as a very strong risk factor for invasive pneumococcal 
disease in adults (266). In children, the real quantity of exposure to smoke is 
difficult to measure and it may be associated with socio-economic factors. Thus, 
the role of passive smoking is clearly recognised in many studies as a risk factor for 
pneumococcal carriage (128,217,239,252), otitis media (530,532,537,547), and 
pneumococcal invasive disease (534,535), but remains undetected in others 
(235,529,571). In Alaska, the presence in the household of at least one person 
chewing tobacco rather than the presence of a smoker was an independent risk 
factor, indicating that the effect of parental smoking may be at least partly due to 
increased susceptibility of the smoking parents to infections and subsequent 
transmission of infection to their children (572). Indoor air pollution due to 
combustion of biofuels is regarded as a risk factor for pneumococcal carriage and 
acute respiratory infections in developing countries. 
There are also factors that decrease the susceptibility of children to 
pneumococcal carriage and infection, including otitis media. Human milk has 
properties that protect against bacterial attachment in the human respiratory 
epithelial cells (573). The milk secretory immunoglobulin A antibodies inhibit 
microbes on the mucosa, while antimicrobial molecules such as lactoferrin and 
oligosaccharides may resemble the receptors for pneumococcal attachment 
(573,574). It has also been suggested that breast milk has a unique capacity to 
stimulate the immune system of the infant after which it might respond better to 
infections (575). Breast-feeding is often associated with other potential factors 
affecting bacterial carriage or disease, e.g. age, nutritional and hygienic quality of 
alternative food, time spent in day care, education of the parents or other socio-
economic factors. Hence, it appears plausible that such confounding could explain 
some of the controversial findings about the protective effect of breast-feeding 
against pneumococcal carriage (156,576), AOM (375,479,480,529,532,537,547,576), 
and invasive pneumococcal diseases (533,534).  
Xylitol inhibits the growth of S. pneumoniae (577). It has been found to reduce 
pneumococcal adherence to human epithelial cells in vitro in a Finnish study (578), 
but not in a Spanish study. (579). Xylitol decreased the occurrence of AOM in 
Finnish day care children when used regularly five times a day (447). In animal 
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studies, xylitol did not decrease nasopharyngeal carriage of pneumococci in rats 
(580) but activated neutrophils and increased the survival time of rats during 
experimental pneumococcal sepsis (581). Also probiotics decrease pneumococcal 
adhesion to human epithelial cells in vitro (449). The ingestion of probiotics 
reduces pneumococcal carriage in adults (582), and a beneficial effect in preventing 
respiratory infections and otitis media in children has been suggested (453), 
although in a randomised, controlled trial no effect was seen against either otitis 
media or pneumococcal carriage (452). Of other child care habits, use of a pacifier 
has been identified as a risk factor for otitis media (547), whereas sucking of the 
thumb or use of nursing bottle have not (583).  
The use of antimicrobial agents to treat pneumococcal diseases and AOM also 
affects pneumococcal carriage. With very few exceptions, lower carriage rates have 
been reported in studies that compare children with recent antimicrobial treatment 
in the last month to children without treatment (184,221,246,484,584,585). In other 
studies, the carriage rate had clearly decreased a few days or 2–3 weeks after the 
end of the antimicrobial treatment, after which it increased again, rebounded to the 
initial level or even surpassed it about one or two months after the treatment (221). 
A trend towards a protective effect of antibiotics for as long as two months has 
occasionally been suggested (586). 
There appears to be an association between clearance of the carried strain and 
its susceptibility to the antimicrobial agent: carriage of susceptible strains is reduced 
whereas carriage of non-susceptible strains remains at the same level (484,584,587), 
resulting in an increase in the proportion of non-susceptible strains. Consequently, 
antimicrobial treatment selects resistant strains, and recent or frequent 
antimicrobial use has proven to be a risk factor for carriage of non-susceptible 
strains both at the individual (193) and population levels (397-399). In an Israeli 
study, a resistant strain in the nasopharynx replaced the initially susceptible strain in 
the middle ear within a few days after the start of antimicrobial treatment of AOM 
(588), which is a good example of the close relationship and dynamics between the 
bacterial flora in the nasopharynx and the middle ear.  
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3 AIMS OF THE STUDY 
The aims of this thesis were to investigate the relationship between respiratory 
infection, pneumococcal carriage and pneumococcal AOM.  
The specific objectives were: 
1. To evaluate the course of nasopharyngeal carriage of S. pneumoniae during health 
and during respiratory infection with and without acute otitis media in children 
from the age of 2 months to 24 months (I). 
2. To evaluate the value of nasopharyngeal culture in predicting the pneumococcal 
aetiology of acute otitis media (II).  
3. To evaluate the dynamic interplay between acquisition of pneumococcal carriage, 
respiratory infection and development of pneumococcal acute otitis media (III and 
IV). 
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4 MATERIALS AND METHODS 
4.1 Finnish Otitis Media (FinOM) Cohort Study 
The material for this thesis was derived from the Finnish Otitis Media (FinOM) 
Cohort Study, in which 329 children were prospectively followed from 2 months 
to 24 months of age. The FinOM Cohort Study was conducted by the National 
Institute for Health and Welfare (THL, the former National Public Health 
Institute, KTL) in collaboration with the Public Health Centre of Tampere City 
and the Tampere University Hospital (TAUH).  
The aims of the FinOM Cohort Study were to assess the natural course of 
nasopharyngeal carriage of S. pneumoniae and to collect data on the epidemiology of 
pneumococcal carriage and pneumococcal AOM prior to The Finnish Otitis Media 
(FinOM) Vaccine Trial, which addressed the efficacy of two 7-valent 
pneumococcal conjugate vaccines in the prevention of culture-confirmed AOM 
(284,589). 
4.1.1 Study population and facilities 
Infants born in the Hervanta area of Tampere, Finland, were invited to participate 
in the FinOM Cohort Study, the enrolment lasting from April 1994 to August 
1995. Families with a newborn baby were informed about the study during their 
first routine visit to the local child health centre. All healthy infants born or 
residing in the area were eligible to participate in the study if they were aged 2 
months +/- 2 weeks, if they had no prior immunisation with a pneumococcal 
vaccine, and if their mothers were able to communicate fluently in Finnish. During 
the study, the participating children were vaccinated following the Finnish national 
immunisation programme at the time. The programme did not include any 
pneumococcal vaccine. 
The follow-up started in April 1994 and continued through July 1997. A special 
study clinic with one or two study physicians, including the author of the thesis, 
and several study nurses was established close to the local child health centre. The 
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study physicians were specially trained to diagnose and treat AOM and obtain 
MEF samples and all of the personnel were trained to interview the parents and 
obtain nasopharyngeal and blood samples. The services at the study clinic were 
available for the study children from 8 am to 3 pm during week days, and from 9 
am to 12 noon at all other times.  
The study data were collected on paper case-report forms by the study staff and 
double-recorded manually into an electronic form by the personnel at THL (KTL) 
in Helsinki.  
4.1.2 Study visits. 
The study design comprised ten visits scheduled by age. In addition, the parents of 
the children were asked to contact the study clinic if the parents suspected AOM 
according to predefined symptoms and signs. After diagnosis of AOM, a control 
visit was arranged to check-up of the healing of the AOM. After a physical 
examination, the type of visit was reassessed according to the health status of the 
child. Sometimes more than one visit types could be carried out concurrently, 
depending on the health status of the child and the time windows of the visits. 
Finally, two types of visits were defined, i.e. age-based visits (n=3026) at which 
the child was healthy or had only mild respiratory symptoms, and sick visits 
(n=2122) with respiratory symptoms needing medical aid, suspected or diagnosed 
AOM, fever, or (occasionally) viral exanthema or gastrointestinal symptoms 
together with respiratory symptoms or AOM. Figure 1 illustrates the flow of the 
data from the clinical study visits to the final visit types. 
Age-based visits 
The children were examined in ten visits at the study clinic scheduled at 2, 3, 4, 5, 
6, 9, 12, 15, 18 and 24 months of age of the child, allowing a time window of +/- 2 
weeks at 2–15 months and +/- 4 weeks at 18 and 24 months of age. At each 
scheduled visit, the study physician performed a physical examination, including 
pneumatic otoscopy. If the child was healthy or had only minor respiratory 
infection, the visit was carried out as an age-based visit (n=2811). If the child was 
diagnosed to have AOM, febrile infection (Trec >38°C), viral exanthema or acute 
gastroenteritis at the scheduled visit, the age-base visit was not carried out but a 
new age-based visit was arranged later within the time window if the child had 
passed the acute phase. Further, if the time window of the age-based visit 
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overlapped with the time-window of a visit scheduled to check up on the healing 
of AOM and the child was healthy or had only minor respiratory infection, the two 
visits were combined and carried out as a second type of an age-based visit (n=215, 
see below). 
The study physician or the study nurse gathered background information 
including family structure and education of the parents at the first age-based visit 
of the child. At each age-based visit, the study staff carried out an extensive 
interview using a structured questionnaire about potential risk factors for 
pneumococcal carriage or AOM, including feeding patterns, day care attendance 
and indoor smoking in the family. Use of antimicrobial agents during the 28 days 
preceding the visit was recorded. The child’s visits to other than the study 
physicians were registered according to a patient diary, and medical records were 
requested and evaluated for confirmation of AOM events diagnosed outside the 
study clinic 
Sick visits 
The parents were asked to bring the child to the study clinic if the child had 
respiratory infection or fever and the parents suspected AOM due to the presence 
of at least one of the following symptoms: earache, tugging or rubbing of the ear, 
ear discharge, irritability, poor sleeping, poor eating, vomiting or diarrhoea. The 
parents were also advised to bring the child to the clinic if respiratory symptoms 
continued for more than five days without improving. These visits due to parental 
request because of suspicion of AOM were recorded as a spontaneous sick visit. 
At these spontaneous sick visits, the study physician recorded the history of 
symptoms and current antimicrobial treatment in a structured way and performed a 
thorough physical examination, including pneumatic otoscopy and tympanometry. 
The spontaneous sick visits (n=1897) were the first of the three types of sick visits. 
If the child was diagnosed as having AOM, febrile infection (>38°C), viral 
exanthema or symptoms of respiratory and gastrointestinal symptoms at a 
scheduled visit, the visit was carried out as a second type of sick visits (n=106). At these 
visits, all study procedures were identical with those carried out at the spontaneous 
sick visits. 
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If the study physician diagnosed AOM at any study visit, a control visit (n=694) 
was scheduled at 4 weeks (+/-7days) after the diagnosis to check up on the healing 
of the AOM. If AOM, febrile infection (Trec >38°C), viral exanthema or 
gastrointestinal symptoms (together with even mild respiratory symptoms) were 
diagnosed at the control visit, the visit was classified as a third type of sick visits 
(n=119; 115+4). At these visits, the interview focused on the healing of the 
previous AOM and not on the current symptoms, while the physical examination 
and other study procedures were identical with those at the spontaneous sick visits.  
If the child was healthy or had only minor respiratory infection at the control 
visit, no clinical samples were obtained, and the visit was not included in the 
material of this thesis (n=360), unless the control visit fell within the time window 
of an age-based visit, in which case these two visits were combined and carried out 
as the second type of an age-based visits (n=215; see above). 
4.1.3 Diagnosis of acute otitis media 
The criteria for diagnosing AOM were based on the statement of the Finnish 
consensus conference on the approach of the treatment of AOM in 1985 (344). 
The criteria included symptoms or signs of acute infection together with a visually 
abnormal tympanic membrane suggesting fluid in the middle ear cavity in 
pneumatic otoscopy. For diagnosis, at least one of the following signs or symptoms 
was required: symptoms of respiratory infection, fever, earache, tugging or rubbing 
of the ear, irritability, restless sleep, loss of appetite or other gastrointestinal 
symptoms. The otoscopic criteria for AOM diagnosis were cloudiness, bulging or 
decreased mobility of the tympanic membrane, visible air-fluid level in the middle 
ear or discharge through a spontaneous perforation or ventilation tube.  
In the pneumatic otoscopy, soft speculums of appropriate size were used 
(Welch Allyn 20200 otoscope, Welch Allyn, Skaneateles falls, NY, USA). 
Tympanometry (GSI 38 Autotymp, Grason Stadler, Milford, NH, USA) was used 
as a diagnostic aid (299). Also an examination microscope (OPMI 99FC, Carl 
Zeiss, Oberkochen, Germany) was available for verification of the diagnosis, 
though it was used routinely only during the first few months of the study.  
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4.1.4 Clinical samples  
Nasopharyngeal swab samples  
At each age-based visit, a nasopharyngeal swab (NPS) sample was obtained using a 
sterile swab with flexible aluminium shaft and a dry calcium alginate tip 
(Galgiswab® Type 1, Spectrum Laboratories, INC., Dallas, Texas). The child’s 
head was tipped backwards and immobilised. The shaft of the swab was first bent 
in the peel pouch to follow the arch of the nasopharynx, and then the swab was 
inserted into the nostril, passed into the nasopharynx to a distance equal to that 
from the child’s nose to the tip of the ear and maintained for five seconds. The 
sample was stroked immediately with the swab on the culture plates.  
Nasopharyngeal aspirates 
At each sick visit, a nasopharyngeal aspirate (NPA) was obtained with a sterile 
paediatric mucus extractor (UNO sterile EtO, UnoPlast A/S, Hundested, 
Denmark). The catheter was guided to a depth of 4–8 cm in the nasopharynx 
through a nostril and drawn back while applying a gentle suction with an electric 
suction device. If the amount of the sample was less than 0.5 ml, the sample was 
diluted with 0.5 ml phosphate-buffered saline (PBS) (from October 9, 1995, 1.0 ml 
PBS). The sample was stroked immediately on the culture plates with a 10 μl 
disposable loop for semi quantitative culture. 
Middle ear fluid samples 
Whenever AOM was diagnosed, myringotomy with aspiration was performed. 
After mechanical cleaning of the ear canal, the tympanic membrane was 
anaesthetised with Bonain’s solution (equal amounts of cocaine hydrochloride, 
menthol, and phenol), maintained for 20 minutes or with a touch with 70% liquid 
phenol. A small incision was made in the anteroinferior part of the tympanic 
membrane. A middle ear fluid (MEF) sample was aspirated with an electric suction 
apparatus into a sterile suction tip. The aspirate was immediately flushed into a 
tube with 1.0 ml of PBS and stroked on the culture plates with a 10 μl disposable 
loop for a semi quantitative culture. 
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4.1.5 Bacteriological methods  
The NPS, NPA and MEF samples were cultured on selective sheep blood agar 
plates containing 5 μg/ml gentamicin and on enriched chocolate agar plates. The 
plates were incubated in 5% CO2 at 36–37°C in the study clinic, generally 
overnight, and transported to the bacteriological laboratory in Oulu. The plates 
inoculated on Fridays and Saturdays were incubated in the study clinic until 
Sunday. In the laboratory, the plates were incubated further if needed to reach a 
total incubation time of at least 48 hours.  
After at least 48 hours of incubation, the numbers of colonies on the one of the 
two plates with more abundant growth were counted in the bacteriological 
laboratory. Colony counts >100 per plate were labelled as abundant growth. To 
identify S. pneumoniae, four different alpha-haemolytic colonies were tested for 
optochin sensitivity. If the optochin test was negative but colony morphology was 
suggestive of S. pneumoniae, the bile solubility test was used. Pneumococcal isolates 
were frozen in skim milk and later serotyped by counterimmunoelectrophoresis 
and, for serogroups 7 and 14, by latex agglutination using antiserum pools and 
serotype/serogroup specific antisera. The Quellung test was used when necessary 
to confirm an uncertain result. The isolates belonging to serogroups 6, 9, 18, 19 
and 23 were further serotyped using pneumococcal factor antisera purchased from 
Statens Serum Institut, Copenhagen, Denmark. No particular methods were used 
to search for multiple serotypes. In this thesis, both the individual serotypes and 
serogroups that were not divided into individual subtypes are referred to as 
serotypes for convenience, unless the serogroup level is specifically considered. 
H. influenzae was identified from the NPA and MEF samples. The colonies 
suggestive of H. influenzae on enriched chocolate agar plates were screened using 
the satellite test. Satellite test positive strains were further identified by their 
requirement for X and V growth factors (A/S Rosco, Taastrup, Denmark) on 
Mueller-Hinton agar plates. The ‘abundant growth’ of H. influenzae was quantified 
as that of S. pneumoniae. Other relevant bacteria, such as S. pyogenes, S. aureus and 
gram negative rods were identified from MEF samples using the standard 
operation procedures of the laboratory.  
4.1.6 Treatment of acute otitis media 
The treatment of AOM was based on the recommendations of the Finnish 
consensus conference, adjusted according to the knowledge of local resistance of 
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bacteria to antimicrobial agents. The first-line drugs used at the study clinic were 
V-penicillin or amoxicillin. Second line drugs included sulfonamides with 
trimethoprim, amoxicillin-clavulanate or second generation cephalosporins. The 
second line drugs were used if the child was suspected to be allergic against the 
first line drugs or if the bacterium in the MEF was not susceptible to the first-line 
drug used. Second-line drug were also used if AOM did not respond to the primary 
drug, if AOM recurred within one month, or if the treatment had failed several 
times. In case of spontaneous perforation or a discharging ventilation tube, topical 
antimicrobial agents were used as an additional treatment, or sometimes alone in 
recurrent cases. Symptomatic treatment was used according to the judgment of the 
study physician. All prescriptions of antimicrobial agents, whether systemic or 
topical, were recorded and the use of prescribed antibiotics was asked at the age-
based as well as the control visits.  
The children were referred to the otologists in Tampere University Hospital for 
assessment of the need of ventilation tubes and/or adenoidectomy if the child had 
had MEF continuously for two months, if the child had had three AOM events 
within six months or if the child had had four to five AOM events within one year. 
4.1.7 Ethical consideration  
Written consent was obtained from the parent or guardian after describing the 
study procedures and discussion before the child was enrolled in the study. The 
study protocol was approved by the Ethics Committees of THL (KTL), 
Department of Social and Health Care of Tampere City and Tampere University 
Hospital, Tampere, Finland.  
4.2 Definitions of pneumococcal carriage, respiratory infection 
and pneumococcal acute otitis media 
In the four studies comprising this thesis, pneumococcal carriage (Pnc 
carriage) means the process of harbouring S. pneumoniae in the nasopharynx, 
irrespective of whether the bacterium is associated with disease or not. Pnc carriage 
starts with the acquisition of a pneumococcal strain in the nasopharynx and ends 
with the clearance of the strain from the nasopharynx. At discrete time points, the 
presence of Pnc carriage is observed as a nasopharyngeal culture positive for S. 
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pneumoniae. The acquisition and clearance of carriage, which cannot be directly 
detected, are defined as changes in the individual’s serotype-specific carriage status. 
The methods applied to set or estimate the change points in the carriage status are 
defined in detail in the descriptions of the data subsets for Studies III and IV. Two 
pneumococcal isolates were considered to represent the same strain if they 
expressed the same serotype and were temporally or spatially associated, e.g. 
cultured sequentially from the nasopharynx, or found concurrently both in the 
nasopharynx and MEF.  
In the studies of this thesis respiratory infection with or without AOM refers 
to the symptoms of an infection in the respiratory tract, likely caused by one or 
several sequential viral infections. At separate time points, the presence of 
respiratory infection was defined as presence of symptoms of respiratory tract 
infection in a child presenting at sick visits in the study clinic. In Studies III and IV, 
respiratory infection is approached as a longitudinal process, observed at one or 
more sequential sick visits. The methods for separating sequential episodes of 
respiratory infections and identifying the start of a new respiratory infection are 
defined in detail in the descriptions of the data subsets for Studies III and IV. 
In this thesis, pneumococcal acute otitis media (Pnc AOM) is defined as a 
clinical AOM event with at least one MEF culture positive for S. pneumoniae. The 
bacterium or pneumococcal serotype in the MEF sample was recorded once if it 
was isolated from both ears.  
4.3 Data subsets and designs of Studies I-IV  
4.3.1 Natural course of nasopharyngeal pneumococcal carriage (Study I) 
To describe the natural course of Pnc carriage during health and respiratory 
infection, the culture results from all available NPS (n=3024), NPA (n=2007) and 
MEF (n=772) samples were included in the analysis. The proportion of samples 
positive for S. pneumoniae was analysed by age, sex, season and treatment with 
antimicrobial agents within the preceding 28 days. For comparisons between 
carriage during health and respiratory infection, the NPS and NPA samples were 
grouped according to the age they were obtained, i.e. at 1–6, 7–12, 13–18 and 19–
24 months of age. Within each age group, the proportion of samples positive for S. 
pneumoniae was then calculated in several clinical categories: age-based visits, sick 
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visits with or without clinical AOM, sick visits with non-pneumococcal AOM, and 
sick visits with a diagnosis of Pnc AOM. In Study I, all age-based and sick visits 
were included.  
Study I presents, in a descriptive way, the natural course of nasopharyngeal 
carriage in a heterogeneous cohort of basically healthy children, who have variable 
proneness to infections, including AOM. The Kaplan-Meier method and the χ2 test 
were used to compare demographic and background factors between children who 
discontinued or completed the study and to compare the cumulative proportions 
of carriers among boys and girls. SPSS for Windows® software, release 8.0.1 (SPSS 
Inc., Chicago, Illinois) was used for computation. 
4.3.2 The value of nasopharyngeal culture in predicting the aetiology of 
acute otitis media (Study II) 
Study II assessed the value of the nasopharyngeal culture of S. pneumoniae in the 
prediction of S. pneumoniae presence in the MEF sample at the time of clinical 
AOM diagnosis. For comparison, the analysis was repeated for H. influenzae. The 
analyses were based on AOM events with the MEF sample and a concurrent 
available NPA sample (n=761). We excluded events at which the child had 
ongoing oral antimicrobial treatment (n=104) or history of preceding AOM 
diagnosis in the 14 days (n=71) prior to the analyses, since antimicrobial treatment 
was found to affect differently the occurrence of S. pneumoniae and H. influenzae in 
the NPA and MEF samples. This left 586 AOM events of 200 children available in 
the analysis. The quantity of colonies was determined for all NPA samples positive 
for S. pneumoniae and for all but one NPA sample positive for H. influenzae.  
A positive culture for S. pneumoniae or H. influenzae from the MEF sample was 
defined as the standard method for the aetiologic diagnosis of AOM. Accordingly, 
the sensitivity of the nasopharyngeal culture was calculated as the probability for S. 
pneumoniae or H. influenzae to be present in the NPA if the bacterium was found in 
the MEF. The specificity was calculated as the probability of the bacterium to be 
absent from the NPA if it was not found in the MEF. The positive predictive value 
(PPV) refers to the probability of the MEF to be positive for the bacterium if it 
was found in the NPA. The negative predictive value (NPV) means the probability 
of the MEF to be negative for the bacterium if it was not found in the NPA. To 
control for a possible intra-child correlation between measurements from the same 
child, 95% confidence intervals for sensitivity, specificity, PPV and NPV were 
 82 
estimated by logistic regression using generalised estimating equations with an 
exchangeable correlation structure. The effects of age, sex, season and the number 
of previous AOM events on sensitivity, specificity and the predictive values were 
assessed by multivariate logistic regression.  
4.3.3 Pneumococcal acute otitis media in relation to preceding 
pneumococcal carriage (Study III) 
To investigate the association between pneumococcal acquisition and the 
development of Pnc AOM, each child’s follow-up was divided into six non-
overlapping observation periods. The periods started at age-based visits with NPS 
sampling at 3, 6, 9, 12, 15 and 18 months of age and ended at the next among these 
age-based NPS samplings or after exactly 3 months if the next NPS sample was 
not obtained but the child was still in clinical follow-up. A total of 1771 such 
observation periods were identified.  
For Study III, only spontaneous sick visits were considered (Figure 1). These 
visits were considered to represent an acute start or worsening of respiratory 
symptoms suggestive for AOM. To avoid repeated measures from a single episode 
of infection, only visits at least 30 days apart were used. Of these visits, the first 
after the start of the observation period was included in the analysis. This visit was 
referred to as a focus sick visit. If the NPA sample or, in the case of AOM, the 
MEF sample was not available at the visit, the whole observation period was 
excluded. This led to the exclusion of a total of 56 observation periods (3% of all), 
thus leaving 1715 observation periods and 774 focus sick visits for 318 children in 
the analysis.  
The occurrence, timing and clinical features of the focus sick visits were 
compared between those children who carried S. pneumoniae at the start of the 
observation period (initial carriers) and those who did not (initial non-carriers). The 
relationship between the serotype-specific carriage status at the start of the period 
and occurrence of Pnc AOM caused by that serotype at the focus sick visit was 
assessed, allowing concurrent carriage of two serotypes and including these as two 
separate observation periods in the serotype specific analysis. 
The analyses of Study III were largely based on focus sick visits with Pnc 
carriage, referred to as NPA positive focus sick visits. Using conditional logistic 
regression, the relative risk of Pnc AOM at the NPA positive focus sick visits was 
estimated for the initial carriers and non-carriers of the homologous serotype. 
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Since the child could have focus sick visits during several observation periods, a 
frailty variable was included to account for any heterogeneity across children in 
their proneness to Pnc AOM. The temporal association between the initial carriage 
status and the timing of the focus sick visit was investigated in a descriptive way, 
comparing the visits with and without Pnc AOM. In addition, the preceding 
carriage status of the serotype harboured at the focus sick visit was assessed 
retrospectively in these two types of visits. A conditional logistic regression 
approach was applied in the R software, version 1.9.0 (Foundation for Statistical 
Computing, Vienna, Austria, 2004). Other computations were performed with 
SPSS for Windows® software, release 8.0.1 (SPSS Inc., Chicago, Illinois). 
4.3.4 Dynamics of pneumococcal carriage acquisition, respiratory infection 
and pneumococcal acute otitis media (Study IV) 
In Study IV, the acquisition of Pnc carriage, respiratory infection and the 
development of Pnc AOM were approached in more detail as longitudinal 
processes. The subset of data in Study IV comprised of all age-based visits and all 
spontaneous sick visits (Figure 1). 
Episodes of carriage and non-carriage were constructed using all NPS 
samples (n=3024) obtained at the age-based visits and all NPA samples obtained at 
spontaneous sick visit (n=1778). After excluding 17 samples (9 NPS, 8 NPA) with 
no serotype information available and 731 samples (685 NPS and 46 NPA 
samples) obtained at least 62 days apart from any other sample, 4064 
nasopharyngeal samples were available. Episodes of carriage (n=585) were defined 
as a series of consecutive samples yielding the same serotype. Episodes of non-
carriage (n=828) were defined as a series of consecutive negative samples. The 
onset and end of each episode were defined as the midpoints between two samples 
with heterologous findings. If no sample was available less than 62 days before the 
first observation of an episode, the onset was considered unknown. A negative 
nasopharyngeal finding was considered falsely negative and therefore imputed with 
a positive finding if the child had antimicrobial treatment and the previous and 
subsequent samples were of the same serotype. In addition, because 
nasopharyngeal carriage is considered a prerequisite for Pnc AOM, a missing or 
negative nasopharyngeal finding for the serotype detected in the MEF sample was 
imputed with a positive finding. The MEF serotype was retained as the carriage 
serotype if more than one serotype was carried simultaneously. In the absence of 
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Pnc AOM, the newer serotype of multiple ones was retained, or a random one if 
more than one new serotype was found concurrently. All children were considered 
non-carriers at birth.  
Sick episodes (n=1146) were defined to start by spontaneous sick visits, if at 
least 30 days had elapsed since the previous spontaneous sick visit of the child. 
Since the respiratory infections may be overlapping and the fluctuations of the 
respiratory symptoms of the child were not carefully monitored, the onset of a new 
sick episode was used to represent the start of a new respiratory infection, although 
in most cases the symptoms had started or worsened earlier. A sick episode was 
defined to end 30 days after the last spontaneous sick visit of the sick episode, or 
30 days before the next sick episode onset, whichever occurred earlier.  
An exploratory analysis of pneumococcal acquisition hazard was first 
performed using data only from children with at least one sick episode. Based on 
this subset of the data, a non-parametric estimate of the (cumulative) hazard was 
used to identify three strata according to sick episode onsets: health (i.e. more than 
30 days before the sick episode onset), pre-sickness (i.e. within 30 days before any 
sick episode onset), and sickness (i.e. during a sick episode).  
 As a sensitivity analysis, the exploratory analysis was repeated after defining the 
carriage and non-carriage episodes using only samples obtained only 45 days apart, 
allowing more precise estimation of carriage acquisition but reducing the amount 
of data in the analysis.  
Unadjusted estimates of the acquisition hazards were calculated as the numbers 
of acquisitions per at-risk time, separately for carriage and non-carriage episodes. 
The hazards of pneumococcal acquisition and clearance were further estimated in 
the three strata using a Markov transition model and all age-based and sick visit 
samples (description in the Appendix of the Original Communication IV). In the 
Markov model, the 31 possible states included ‘non-carrier’ or ‘carrier’ of any of 
the 30 different serotypes in the data, same hazards of acquisition and clearance 
were assumed for each of the serotypes and the hazards were stratified into two 
age classes (<12 and ≥12 months). A 50% reduction in the acquisition hazard was 
assumed if the child already carried pneumococci as compared to a non-carrying 
child of the same age (182).  
Risk episodes (n=411) were defined as overlapping periods of carriage and 
sick episodes, for which both the onset time of the carriage episode and the timing 
of the first Pnc AOM event were known (i.e. the MEF sample was not missing for 
any AOM before the first Pnc AOM, if any, during the risk episode).  
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The hazard of the first Pnc AOM during the risk episodes was estimated. In an 
exploratory analysis, the risk episodes were stratified according to the temporal 
relationship between onset of the episode of carriage and onset of the sick episode 
so that the Pnc AOM hazard within each stratum was as constant as possible. 
Three strata were recognized and the risk episodes were defined according to the 
underlying episode of carriage starting long before sickness, around sickness 
onset and later during sickness. A Poisson regression model was used to 
estimate the Pnc AOM hazards in the three strata of risk episodes, with adjustment 
for age group (1–5, 6–11, 12–17, 18–24 months of age at the risk episode onset), 
previous homologous carriage (yes/no), and previous homologous Pnc AOM 
(yes/no). To remove the potential impact of repeated sick episodes during the 
same carriage episode before the onset of the risk episode, the analysis was 
repeated involving only the first sick episodes during each carriage episode 
(n=335). Another sensitivity analysis included also those overlapping periods of 
episodes of carriage and sick episodes for which the exact acquisition time of 
carriage was not known, but the carriage had been first detected more than 30 days 
before the sick episode onset. This produced 28 additional risk episodes with 
known aetiology of the first potential Pnc AOM and the occurrence of previous 
sick episodes during the carriage.  
30 days
30 days
Risk episodes for Pnc AOM
Episodes of Pnc carriage
Spontaneous sick visits and sick episodes
30 days30 days 30 days
 
Figure 2.  Risk episodes for pneumococcal acute otitis media.  
Overlapping episodes of pneumococcal carriage (Pnc carriage) and sick episodes were defined for 
assessing the hazard of pneumococcal acute otitis media (Pnc AOM). Solid lines, episodes of Pnc 
carriage; stars, spontaneous sick visit; dashed lines, sick episodes; bars, risk episodes for assessing the 
hazard of Pnc AOM. 
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5 RESULTS 
5.1 Characteristics of the study children and the follow-up  
A total of 329 children were enrolled, representing 53% of all children of eligible 
age and registered in the child health centres in the study area during the enrolment 
period. Of the 329 study children, 158 (48%) were boys, 163 (50%) had older 
siblings living in the household and 122 (37%) attended day care during the follow-
up. Of the enrolled 329 children, 167 (51%) were breastfed for at least 24 weeks 
and 135 (41%) were exclusively breastfed for at least 12 weeks. Altogether 225 
children (68%) had a mother or father with higher education, i.e. senior high 
school, college or academic degree. Families of 12 (4%) children reported smoking 
indoors in the home during the follow-up. Of the 329 participating children, 316 
(96%), 309 (94%), 284 (86%) and 281 (85%) were followed until at least 7, 13, 19 
and 24 months of age, respectively. The reasons for discontinuation were moving 
out of the study area (40% of those who discontinued), withdrawal of consent 
(33%), loss to follow-up (23%), and unknown (4%). Girls discontinued more often 
than boys (19% vs. 10%; χ2, p=0.03) and children without older siblings 
discontinued more frequently than children with older siblings (19% vs. 10%; χ2, 
p=0.03). Otherwise there were no significant differences between those who 
discontinued and those who were followed up to 24 months of age. The total 
follow-up time of the 329 children from the first visit to the last visit or 
discontinuation was 565 person-years.  
Figure 1 illustrates the numbers of clinical study visits. At the age-based visits, 
3024 NPS samples were obtained, the total number decreasing from 328 to 260 
from the first to the tenth scheduled visit. All ten scheduled NPS samples were 
obtained from 212 (64%) of the 329 children and at least 8 samples were available 
from 91% of the children.  
Altogether 2122 sick visits were carried out, 1897 (89%) of them were 
spontaneous sick visits and 225 were initially scheduled by age or for check-up of 
the healing of AOM (Figure 1). Of all 329 children, 288 (88%) presented at least 
once at a sick visit during the follow-up (91% of boys and 85% of girls; χ2, 
p=0.12). The maximum number of sick visits per child was 32 (median, 5). Study 
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physicians diagnosed AOM at 871 sick visits (at 41% of all sick visits), and in 772 
(89%) of these, the diagnosis was verified by collection of a MEF sample from one 
or both ears. AOM was diagnosed at least once in 215 (65%) study children, one or 
two times in 88 (27%), 3–5 times in 75 (23%) and more than 5 times in 52 (16%) 
of the 329 children, maximally 17 times in one child (median, three). These 
numbers comprise 86% of all AOM cases recorded to have occurred among the 
study children during the follow-up. 
5.2 Natural course of nasopharyngeal pneumococcal carriage 
(I) 
5.2.1 Cumulative incidence of the first detection of carriage 
A vast majority of the 329 children encountered S. pneumoniae during the follow-up. 
Of the 281 children who remained in the follow-up until 24 months of age, 244 
(87%) were observed to harbour S. pneumoniae in the nasopharynx at least once, 
either at age-based or sick visits (Figure 3). The cumulative proportions of the 
children who were still in follow-up and who were known to have carried S. 
pneumoniae at least once were 34%, 56% and 80% at 6, 12 and 18 months of age, 
respectively. No difference was observed in the cumulative incidence of the first 
detection of carriage between boys and girls followed for 24 months (90% in boys 
and 83% in girls; χ2 p=0.097). 
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Figure 3.  Cumulative proportion of the first detection of nasopharyngeal carriage of S. pneumoniae 
by age and sex. 
Carriers, children with at least one nasopharyngeal sample positive for S. pneumoniae during the 
follow-up. 
5.2.2 Nasopharyngeal carriage during health, respiratory infection and 
acute otitis media 
The total proportion of NPS samples positive for S. pneumoniae obtained at the age-
based visits during the study follow-up was 21% (649/3024). When adjusted for 
age, the average proportion of NPS samples positive for S. pneumoniae was 27% 
(29% in boys and 26% in girls). At sick visits, the proportion of all NPA samples 
positive for S. pneumoniae was 41% (826/2007) and was almost twice as high at the 
sick visits as compared to the age-based visits (42% in boys and 40% in girls). 
In all, 201 Pnc AOM events were diagnosed, S. pneumoniae causing 26% of the 
772 AOM events with at least one MEF sample available. Of the 761 AOM events 
at which both NPA and at least one MEF sample were available, pneumococci 
caused 199 (26%), the percentages being 26%, 25%, 31% and 22% in four age 
groups of 1-6, 7-12, 13-18 and 19-24 months, respectively. 
The percentages of samples positive for pneumococci, obtained at the age-
based visits and different types of sick visits at 1–6, 7–12, 13–18 and 19–24 months 
of age are presented in Table 1. When assessed by each month of age, clear trends 
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in the pneumococcal carriage frequency were observed by age and health status, as 
illustrated in Figure 4. 
Table 1.  Nasopharyngeal samples positive for S. pneumoniae by age group and clinical category.  
Clinical category Age group 
      
 1-6 months 7-12 months 13-18 months 19-24 months 1-24 months 
 % n/N1 % n/N % n/N % n/N % n/N 
           
All visits 17 341/1989 29 369/1276 41 456/1118 48 309/648 29 1475/5031 
Age-based visits 13 215/1594 21 130/617 35 191/553 43 113/260 21 649/3024 
All sick visits 32 126/395 36 239/659 47 265/565 51 196/388 41 826/2007 
No AOM2 22 50/230 29 106/371 45 151/339 46 100/218 35 407/1158 
Any AOM3 46 76/165 46 133/288 50 114/226 56 96/170 49 419/8492 
Non-Pnc AOM4 30 33/109 28 55/195 30 42/138 46 55/120 33 185/562 
Pnc AOM5 100 38/38 100 65/65 97 60/62 100 34/34 99 197/199 
 
The numbers are based on nasopharyngeal samples obtained at all age-based and sick visits, 
aggregated into four age groups. 1Samples positive for S. pneumoniae of all samples; 2samples obtained 
at sick visits at which no clinical acute otitis media (AOM) was diagnosed; 3samples obtained at sick 
visits at which any clinical AOM was diagnosed, irrespective of aetiology; 4samples obtained at sick 
visits at which AOM not caused by S. pneumoniae (non-Pnc AOM) was diagnosed; 5samples obtained 
at sick visits at which pneumococcal AOM (Pnc AOM) was diagnosed. The aetiology was known for 
761 of 849 AOM events. 
The prevalence of Pnc carriage at age-based visits increased slowly and almost 
linearly with age up to 24 months of age (Figure 4A). The samples obtained at sick 
visits (Figure 4B) showed a similar trend. The carriage frequency was higher at sick 
visits than at age-based visits at all ages, especially in the youngest age. There was 
no systematic difference in the carriage frequency by age between boys and girls, 
either at age-based visits or at sick visits  
At sick visits with no AOM, carriage increased in a similar way by age, and the 
proportion of samples positive for pneumococci was not much lower than in those 
obtained at any sick visit (Figure 4C). Of the 1158 NPA samples obtained at sick 
visits without any AOM, 407 (35%) were positive for pneumococci. If any AOM 
irrespective of aetiology was diagnosed at the sick visit, 419 of the 849 samples 
(49%) grew pneumococci (Figure 4D). During AOM there was very little if any 
trend by age, and the carriage frequency was relatively high in all age groups, 
including the youngest one. The higher carriage frequency at sick visits as 
compared to age-based visits was most obvious in the youngest age group during 
AOM. 
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When examining the nasopharyngeal carriage during AOM by AOM aetiology, 
we found that most of the excess carriage frequency during AOM was clearly due 
to Pnc AOM. During non-pneumococcal AOM, the carriage was as low as at sick 
visits without any AOM (Figure 4E), the overall percentage of positive findings 
being 33% (185/565). Instead, during Pnc AOM, 197/199 (99%) of 
nasopharyngeal samples grew pneumococci (Figure 4F). 
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Figure 4.  Nasopharyngeal samples positive for S. pneumoniae by age month and clinical category.  
The bars present the proportions of nasopharyngeal cultures positive for S. pneumoniae (Pnc) in 
samples obtained at the age-based visits and at the sick visits with and without acute otitis media, by 
age month. A, samples obtained at age-based visits; B, samples obtained at all sick visits; C, samples 
obtained at sick visits at which no clinical acute otitis media (AOM) was diagnosed; D, samples 
obtained at sick visits at which any clinical AOM irrespective of aetiology was diagnosed; E, samples 
obtained at sick visits at which AOM not caused by S. pneumoniae (non-Pnc AOM) was diagnosed; E, 
samples obtained at sick visits at which pneumococcal AOM (Pnc AOM) was diagnosed. The 
aetiology was known for 761 of 849 AOM events. 
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5.2.3 Nasopharyngeal carriage by history of previous sick visits with 
respiratory infection 
The increase of Pnc carriage with age observed in all NPS samples obtained during 
the age-based visits was not evident if only those 1344 NPS samples were 
considered which were obtained before any sick visit of the child, including those 
that occurred outside the study clinic (Figure 5). Although there was an increase in 
the carriage prevalence during the first 9 months, prevalence then levelled off and 
remained at 16–23%. 
 
 
Figure 5.  Nasopharyngeal carriage of S. pneumoniae by age and history of respiratory infections.  
The bars show the proportions of cultures positive for S. pneumoniae (Pnc) in nasopharyngeal swab 
samples obtained at age-based visits, by preceding history of respiratory infections needing medical 
consultations. Grey bars, at least one sick visit carried out at the study clinic or any ambulatory visit 
to other physicians because of respiratory infection or AOM before the sampling date. Black bars, 
no sick visits at the study clinic and no ambulatory visits to other physicians because of respiratory 
infection or AOM before the sampling date. The ambulatory visits to other physicians because of 
respiratory infections were recorded according to the diary cards and interviews during the study 
visits and uncertain cases and AOM diagnoses were verified from medical records. For definitions of 
age-based and sick visits, see text. 
5.2.4 Effect of antimicrobial treatment on pneumococcal carriage  
The children had ongoing oral antimicrobial treatment at 6% of the age-based 
visits and 11% of the sick visits. For 0.4% and 3%, of the visits, respectively, it was 
not known whether the child received antimicrobials.  
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Figure 6 illustrates the effect of antimicrobial treatment on Pnc carriage. 
According to information derived from the diaries and interviews collected at the 
study visits, the child had a history of antimicrobial treatment within the previous 
28 days at 18% (532/3024) of the age-based visits (in 6%, the history was not 
known, or only topical antibiotics had been used).  
In children aged seven months or older, antimicrobial treatment was associated 
with lower carriage prevalence, but only temporarily. In children who had received 
antimicrobial treatment within one week prior to the sampling, the proportion of 
samples positive for S. pneumoniae was half that in samples obtained during visits 
with history of no antimicrobial treatment within the previous 28 days. If 1-2 
weeks had elapsed since the end of treatment, the proportion of positive samples 
was higher, and if more than two weeks had elapsed, it reached 80–100% of the 
level in samples obtained in the absence of treatment within 28 days. In the 
youngest children aged less than seven months, previous antimicrobial treatment 
was not at all associated with reduced carriage.  
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Figure 6.  Effect of antimicrobial treatment on nasopharyngeal carriage of S. pneumoniae by age 
group and time since the end of the treatment.  
The bars represent the proportions of cultures positive for S. pneumoniae in nasopharyngeal swab 
samples obtained at the age-based visits (for definition of age-based visits, see text). A, antimicrobial 
treatment ongoing at the day of the sampling; B, antimicrobial treatment ended 1-6 days before the 
sampling; C, antimicrobial treatment ended 7-14 days before the sampling; D, antimicrobial 
treatment ended 15-28 days before the sampling; E, antimicrobial treatment not used within 28 days 
before the sampling. The numbers of samples are indicated above the bars. 
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5.2.5 Seasonality of pneumococcal carriage  
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Figure 7.  Seasonality of pneumococcal carriage of S. pneumoniae.  
The figure presents the proportion of nasopharyngeal samples positive for S. pneumoniae (Pnc) by 
age, health status and calendar month from January to December. Panel A, nasopharyngeal swab 
samples (NPS) obtained at age-based visits; panel B, nasopharyngeal aspirates (NPA) obtained at sick 
visits. Solid lines, proportion of samples positive for pneumococci; bars, numbers of nasopharyngeal 
samples; dashed lines in panel B, proportion of sick visits with AOM diagnosis of all sick visits.  
No obvious seasonal trend was observed in Pnc carriage. The proportion of all 
NPS samples positive for S. pneumoniae fluctuated between 14% and 25% 
throughout the year. After stratifying the samples by age group, no systematic 
seasonality was seen either (Figure 7). The number of sick visits per month was 
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clearly smaller in the summer from June to August than during the rest of the year, 
but only a faint decrease in the proportion of NPA samples positive for S. 
pneumoniae was seen during the summer months. 
5.2.6 Serotypes carried during health and during respiratory infection  
Of the 267 children who carried S. pneumoniae at least once, 37% carried only one 
serotype during the follow-up. Two different serotypes were carried during the 
follow-up by 31% and 3–6 serotypes by 45% of these children. In one child, 7 
different serotypes were found.  
Altogether 1530 pneumococcal isolates were found in the 1475 nasopharyngeal 
samples (649 NPS samples and 826 NPA samples) positive for S. pneumoniae (Table 
2). Of these isolates, 1457 represented 30 different serotypes/groups, 55 were non-
encapsulated (rough), 16 were non-typable and 2 were lost before serotyping. 
Maximally a child carried a single serotype on 19 occasions. Table 2 lists the 
numbers of the most frequently isolated serotypes in three categories, i.e. in all 
NPS samples obtained at age-based visits, in NPA samples obtained during sick 
visits without any AOM and in NPA samples obtained during sick visits with 
AOM, and in irrespective of aetiology. The distribution of serotypes in in the MEF 
samples is shown for comparison. From the MEF samples, 205 pneumococci were 
isolated and all could be serotyped. Serotypes 6A, 6B, 19F and 23F were the most 
frequently isolated serotypes in all clinical categories in varying order, followed by 
11 and 35 in the NPS samples and 14 and 11 in the MEF samples. During Pnc 
AOM (n=201), two NPA samples were not available, two were negative, one could 
not be serotyped and one comprised a serotype not found in the MEF sample. 
During all other Pnc AOM events, the serotype in the MEF was concurrently 
found in the NPA. An additional serotype, not found in the other site was found 
from three MEF samples and from eight NPA samples.  
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Table 2.  Distribution of serotypes of S. pneumoniae in nasopharyngeal and middle ear fluid 
samples 
 
 Isolates by sample type and clinical category 
  
Nasopharyngeal samples1 
 
 
MEF2 samples 
 
 Age-based 
visits3 
Sick visits, 
no AOM4 
Sick visits, 
any AOM5 
 
Sick visits,  
Pnc AOM2 
Serotype 
 
n % n % n % N % 
6B 106 16 60 14 47 11 18 9 
23F 93 14 87 21 88 20 40 20 
19F 93 14 74 17 91 21 51 25 
6A 61 9 36 9 44 10 23 11 
11 57 8 35 8 24 6 11 5 
35 35 5 5 1 9 2 1 <1 
14 28 4 14 3 25 6 15 7 
15 26 4 15 4 15 3 4 2 
9N 18 3 8 2 9 2 3 1 
19A 17 3 12 3 10 2 6 23 
7 17 3 2 <1 2 <1 1 <1 
9V 15 2 12 3 9 2 5 2 
4 13 2 5 1 5 1 2 1 
18C 10 1 1 <1 10 2 6 3 
22 9 1 10 2 7 2 1 <1 
3 8 1 6 1 6 1 3 1 
Others6 30 4 21 5 17 4 9 4 
Nonencapsulated 28 4 14 3 13 3 6 3 
Nontypable 8 1 6 1 2 <1 0 0 
Not typed 1 <1 0 0 1 <1 0 0 
Total 673 100 423 100 434 100 205 100 
         
 
1Nasopharyngeal samples positive for S. pneumoniae (n=1475; 1530 isolates); 2middle ear fluid samples 
obtained during pneumococcal acute otitis media (Pnc AOM; n=201, 205 isolates); 3nasopharyngeal 
swab (NPS) samples obtained at age-based visits (n=649; 673 isolates); 4 nasopharyngeal aspirate 
(NPA) samples obtained at sick visits without any clinical diagnosis of AOM (n=407; 423 isolates); 
5NPA samples obtained at sick visits with any clinical diagnosis of acute otitis media irrespective of 
aetiology (n=419; 434 isolates); 6other serotypes: 8, 10, 16, 18B, 20, 21, 23A, 25, 28, 31, 33, 34, 38 
and 42. In 54 nasopharyngeal samples from 45 children and in 4 MEF samples from 4 children, two 
(and in one NPA sample, three) serotypes were isolated at the same time. The serotype was included 
only once, if isolated in MEF samples from both ears. 
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5.3 The value of nasopharyngeal culture in predicting the 
aetiology of acute otitis media (II)  
5.3.1 Presence of S. pneumoniae and H. influenzae in nasopharyngeal 
culture according to the aetiology of acute otitis media  
The value of nasopharyngeal culture in predicting the presence of these two 
bacteria in the MEF was studied using all available pairs of NPA and MEF samples 
(N 586) obtained during AOM in the absence of concurrent oral antimicrobial 
treatment and more than two weeks after any previous AOM diagnosis. In total, 
200 children provided at least one AOM event (1-11, median, 2).  
S. pneumoniae grew in 27% (160/586) and H. influenzae grew in 22% (126/586) of 
the MEF samples obtained during AOM. Table 3 shows the occurrence of 
pneumococci or H. influenzae concurrently in the nasopharynx and in the MEF 
during AOM.  
 
 
Table 3.  Occurrence of S. pneumoniae and H. influenzae in the nasopharynx and the same 
bacterium in the middle ear fluid during acute otitis media. 
 
 Culture of the 
bacterium 
from the NPA1 sample 
Culture of the bacterium 
from the MEF2 sample 
  
     
  Positive Negative Total 
  n n N 
     
S. pneumoniae Positive 1593 157 316 
 Negative 1 269 270 
 Total 160 426 586 
     
H. influenzae Positive 97 54 151 
 Negative 29 406 435 
 Total 126 460 586 
 
1NPA, nasopharyngeal aspirate; 2MEF, middle ear fluid sample. 3In 158 of these 159 events, the 
pneumococci from both MEF and NPA were serotyped and the same serotype was found in 157 of 
the 158 events. The bacterium isolated from MEF samples from both ears were regarded as one 
finding. 
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5.3.2 Predictive value of nasopharyngeal culture of S. pneumoniae and H. 
influenzae in predicting their presence in the MEF during acute otitis 
media  
Using the results from Table 3, the sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) of nasopharyngeal culture to predict 
the aetiology of AOM were calculated and are presented in Table 4. For S. 
pneumoniae, the sensitivity (i.e. detecting Pnc AOM with positive nasopharyngeal 
culture) was very high, 99% (159/160). Accordingly, the NPV (i.e. ruling out Pnc 
AOM in presence of negative nasopharyngeal culture) was also very high, >99% 
(269/270). Instead, the specificity of pneumococcal nasopharyngeal culture was 
relatively low 63% (269/426), as pneumococci were often carried also during non-
pneumococcal AOM. Moreover, PPV was low (50%), as only half of the 
pneumococcal carriers had Pnc AOM. The sensitivity and NPV remained close to 
100% irrespective of age, sex, season or the number of previous AOM events. The 
PPV seemed to decrease towards two years of age.  
In predicting AOM caused by H. influenzae (Hi AOM) by nasopharyngeal 
culture of H. influenzae, the sensitivity (77%) and NPV (93%) were lower than those 
for S. pneumoniae, whereas the specificity (88%) and PPV (64%) were higher (Table 
4).  
 
Table 4.  Nasopharyngeal culture of S. pneumoniae and H. influenzae as a predictor for isolation of 
the same bacterium from a middle ear fluid sample obtained concurrently during acute 
otitis media. 
 Sensitivity Specificity PPV1 NPV2 
     
S. pneumoniae 99 63 50 >99 
n/N 159/169 269/426 159/316 269/270 
95% CI3 95-100 57-68 43-56 97-100 
     
H. influenzae 77 88 64 93 
n/N 97/126 406/460 97/151 406/435 
95% CI 69-83 85-91 56-71 90-95 
 
1Positive predictive value; 2negative predictive value; 395% confidence interval, estimated by logistic 
regression using generalised estimating equations with an exchangeable correlation structure to 
control for a possible intra-child correlation between measurements from the same child. The same 
bacterium isolated from both ears was regarded as one finding. 
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5.3.3 Quantity of pneumococcal growth in nasopharyngeal culture as a 
predictor of pneumococcal acute otitis media 
The occurrence of both Pnc AOM and Hi AOM was associated with the quantity 
of the bacterial colonies in the NPA. As seen in Table 5, S. pneumoniae grew more 
often from the MEF if the same bacterium grew abundantly from the NPA. 
Similarly, there was a clear association between a high density of H. influenzae in the 
NPA culture and a positive culture in the MEF, although the probability of Hi 
AOM was relatively high even with low numbers of colonies in the NPA sample 
(Table 5). 
 
Table 5.  Quantity of growth of S. pneumoniae and H. influenzae in the nasopharynx and 
occurrence of the same bacterium in the middle ear fluid during acute otitis media.  
 Culture of the bacterium from the NPA1 sample 
Culture of the bacterium 
from the MEF2 sample 
     
  Positive Negative Total 
  n (%) n N 
     
S. pneumoniae Abundant growth3 153 (55) 123 276 
 Sparse growth4 6 (15) 34 40 
 No growth 1 (<1) 269 270 
 Total 160 (27) 426 586 
     
H. influenzae Abundant growth 83 (71) 34 117 
 Sparse growth 14 (42) 19 33 
 No growth 29 (7) 406 435 
 Total 126 (22) 459 5855 
 
1NPA, nasopharyngeal aspirate; 2MEF, middle ear fluid; 3abundant growth, >100 colonies per plate 
after a 10 μl-loopful plated; 4sparse growth, 1-99 colonies per plate after a 10 μl-loopful plated; 5for 
one NPA sample the quantity of growth was not known for H. influenzae. If the same bacterium was 
isolated from both ears, the event was included only once, with the most abundant growth. 
Comparison between Tables 4 and 6 reveals that using abundant growth in the 
NPA as a positive finding and sparse or no growth as a negative finding, the 
specificity and PPV increased whereas the sensitivity and NPV decreased for both 
S. pneumoniae and H. influenzae. 
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Table 6.  Abundant nasopharyngeal growth of S. pneumoniae and H. influenzae as a predictor for 
isolation of the same bacterium from a middle ear fluid sample obtained concurrently 
during acute otitis media.  
 
Sensitivity Specificity PPV1 NPV2 
     
Abundant growth3 of S. pneumoniae 
n/N 
96 
153/160 
71 
303/426 
55 
153/276 
98 
303/310 
     
Abundant growth of H. influenzae 
n/N 
66 
83/126 
93 
425/459 
71 
83/117 
91 
425/468  
1Positive predictive value; 2negative predictive value; 3positive nasopharyngeal finding, >100 bacterial 
colonies per plate after a 10 μl-loopful plated; negative nasopharyngeal finding, no growth or sparse 
growth (1-99 colonies per plate after a 10 μl-loopful plated). If the same bacterium was isolated from 
both ears, the event was included only once, with the most abundant growth. 
5.3.4 Combinations of S. pneumoniae and H. influenzae in the 
nasopharyngeal samples in predicting their presence in middle ear 
fluid 
There was a clearly inverse association between the presence of H. influenzae in the 
NPA and Pnc AOM while the inverse association between the occurrence of S. 
pneumoniae in the NPA and Hi AOM was less obvious. Table 7 shows the frequency 
of S. pneumoniae and H. influenzae findings in the MEF by different combinations of 
S. pneumoniae and H. influenzae in the NPA sample. The PPV for S. pneumoniae was 
58% (140/241) if it grew in the NPA without H. influenzae. If H. influenzae grew 
without S. pneumoniae in the NPA, the probability of Hi AOM was 66% (50/76). 
Both S. pneumoniae and H. influenzae grew in the NPA in 75 (13%) cases. Of these, 
S. pneumoniae alone grew in 12 (16%) of the MEF samples, H. influenzae alone grew 
in 40 (53%) of the MEF samples and both S. pneumoniae and H. influenzae grew in 7 
(9%) of the MEF samples.  
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Table 7.  Occurrence of S. pneumoniae and H. influenzae in the middle ear fluid of children with 
acute otitis media by combinations of S. pneumoniae and H. influenzae in the concurrently 
obtained nasopharyngeal aspirate. 
Combination of S. pneumoniae and 
H. influenzae in the NPA1 
S. pneumoniae 
in the MEF2 
H. influenzae 
in the MEF 
All AOM3 
events 
    
S. pneumoniae H. influenzae n % n % N 
       
Positive Negative 1404 58 174 7 241 
Positive Positive 195 25 475 63 75 
Negative Positive 0 0 50 66 76 
Negative Negative 1 < 1 12 6 194 
Any combination  160 27 126 22 586 
 
1Nasopharyngeal aspirate; 2middle ear fluid; 3acute otitis media. 4Includes five events with both S. 
pneumoniae and H. influenzae; 5includes seven events with both S. pneumoniae and H. influenzae. The 
same bacterium isolated from both ears was regarded as one finding. 
5.4 Pneumococcal acute otitis media in relation to preceding 
pneumococcal carriage (III) 
5.4.1 The observation periods  
Altogether 318 children provided 1715 observation periods (1–6 per child, median, 
6). The overall proportion of carriers of S. pneumoniae was 23% (397/1715) at the 
age-based visits (at 3, 6, 9, 12, 15 and 18 months of age) that started the six 3-
month observation periods (initial carriers). The proportion of initial carriers 
increased from 12% at three months of age to 38% at 18 months of age. 
The duration of individual observation periods varied because a time window of 
+/- 2 or +/- 4 weeks was allowed for the age-based visits, but by definition, the 
periods never overlapped for an individual child. The median duration of the six 
observation periods varied from 89 days to 93 days (mean 88-95 days) without any 
systematic trend by age. The median and mean durations were similar (91-92 days) 
for observation periods starting with and without Pnc carriage, periods with and 
without a focus sick visit (spontaneous sick visit fulfilling the inclusion criteria for this 
study, see definition), periods with and without AOM diagnosed at the focus sick 
visit, periods with and without S. pneumoniae in the NPA at the focus sick visit, and 
periods with and without Pnc AOM at the focus sick visit. This is important for 
assessing the timing of the NPA positive focus sick visits with and without Pnc AOM 
in relation to the age-based visits starting the observation periods.  
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The 318 children came to 774 focus sick visits (1–6 per child, median, 3). The 
children carried S. pneumoniae at 316 (41%) of the 774 focus sick visits. Any AOM 
was diagnosed at 224 (29%) of these 774 visits and of the 224 AOM events, 70 
(31%) were caused by S. pneumoniae. During Pnc AOM, the MEF always yielded 
only one serotype and the same serotype was also always found concurrently in the 
nasopharynx. 
Table 8 describes the observation periods of the initial carriers and initial non-
carriers. There was little difference in the occurrence of the focus sick visits and the 
presence of AOM at the focus sick visits. By contrast, Pnc carriage at the focus sick 
visits was clearly associated with the initial carriage status. The initial carriers 
harboured pneumococci in their nasopharynx at the focus sick visits about three 
times as often as initial non-carriers (87% vs. 26%).  
Table 8.  Observation periods for investigating the association between the development of 
pneumococcal acute otitis media and preceding pneumococcal carriage. 
Focus sick visits Observation periods 
 Initial carriers1 
23% (n=397) 
Initial non-carriers2 
77% (n=1318) 
All observation periods 
      (N=1715) 
 
% n/N % n/N  % n/N 
Occurrence of focus sick visit3 47 185/397 45 589/1318  45 774/1715 
Any AOM at the focus sick visit4 32 60/185 28 164/589  29 224/774 
NPA positive focus sick visit5 87 161/185 26 155/589  41 316/774 
Pnc AOM at the focus sick visit6 12 22/185 8 48/589  9 70/774 
Non-Pnc AOM at the focus sick visit7 21 38/185 20 116/589  20 154/774 
 
1Children who carried and 2children who did not carry S. pneumoniae at the age-based visit starting the 
3-month observation period: 3for definition of a focus sick visit, see text; 4clinical acute otitis media 
(AOM) irrespective of aetiology diagnosed at the focus sick visit; 5nasopharyngeal aspirate positive 
for S. pneumoniae at the focus sick visit; 6Pnc AOM and 7non-pneumococcal AOM diagnosed at the 
focus sick visit. Concurrent carriage of two serotypes at the focus sick visit was included as two 
separate observation periods in this analysis. 
Nevertheless, initial carriers had Pnc AOM at the focus sick visits only 1.5 times as 
often as the initial non-carriers (12% vs. 8%). The median time from the start of the 
observation period to the focus sick visits was 38 days (42 days and 37 days during 
the periods of initial carriers and non-carriers, respectively). The median duration 
of symptoms leading to the sick visit was 4 days in both initial carriers and non-
carriers. 
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5.4.2 Association of pneumococcal acute otitis media with serotype-
specific carriage history 
The analysis of the development of Pnc AOM according to carriage history in 
Study III was based on those 316 sick visits at which the child carried S. pneumoniae. 
At 12 of these sick visits, the child carried two (or once, three) serotypes 
simultaneously, giving a total of 329 pneumococcal serotypes. Of the 329 
serotypes, 197 (60%) were not present at the start of the period and the serotype-
specific carriage was therefore termed ‘newly acquired’. In the remaining 132 (40%) 
cases the serotype carried at the sick visit was present already at the period onset 
and carriage of that serotype was termed ‘established’. Of the 197 newly acquired 
serotypes, 159 (81%) had been acquired after a negative finding (in initial non-
carriers) while in 38 (19%) cases the serotype carried (by initial carriers) had 
changed.  
Of the events of newly acquired and established carriage at the sick visit, 28% 
(55/197) and 11% (15/132) were associated with concurrent Pnc AOM caused by 
that serotype, respectively. According to the logistic regression model, the OR for 
occurrence of Pnc AOM was 3.8 (95% CI 1.4-10.0) if the child had a newly 
acquired carriage as compared to established carriage. Of the newly acquired 
serotypes that were seen after a negative NPS sample at the onset of the 
observation period, 30% (48 of 159) were associated with Pnc AOM, whereas if 
the serotype had been acquired after initial carriage of another serotype (i.e. the 
serotype had changed), the proportion was 18% (7 of 38). Of the 70 Pnc AOM 
events, 55 (79%) were caused by a serotype not present at the start of the 
observation period.  
Newly acquired Pnc carriage was not associated with the risk of development of 
AOM per se, e.g. as a marker for a high infection pressure, since acquisition of Pnc 
carriage was not associated with non-pneumococcal AOM at a focus sick visit with 
Pnc carriage. Of those children who at the focus sick visit carried at least one newly 
acquired pneumococcal serotype, 13% had non-pneumococcal AOM, whereas the 
proportion was 19% for those who at the focus sick visit carried only established 
serotypes.  
The propensity of newly acquired and established carriage to lead to Pnc AOM 
showed clearly different age trends. The probability of established carriage to cause 
Pnc AOM at the focus visit decreased steadily with age. As seen in Table 9, during 
the first observation period starting at 3 months of age, 33% (3/9) of established 
carriage cases caused Pnc AOM, whereas during the last period starting at 18 
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months of age none of the 25 cases of established carriage did so. Instead, the 
propensity of a newly acquired carriage to lead to Pnc AOM peaked at 9 to 12 
months of age. 
Table 9.  Occurrence of pneumococcal AOM at focus sick visits with pneumococcal carriage, 
according to the presence of the same serotype at start of a 3-month observation period.  
 
Observation periods1 
NPA positive 
focus sick visits2 
From 3 to 6 
months 
From 6 to 9 
months 
From 9 to 12 
months 
From 12 to 15 
months 
From 15 to 18 
months 
From 18 to 21 
months 
 % n/N % n/N % n/N % n/N % n/N % n/N 
Established carriage3 33 3/9 19 5/27 13 3/24 14 3/22 4 1/25 0 0/25 
Newly acquired carriage4 18 4/22 21 5/24 42 15/36 27 10/37 25 10/40 29 11/38 
Any carriage 
 23 7/31 20 10/51 30 18/60 22 13/59 17 11/65 17 11/63  
1Six 3-month observation periods starting at age-based visits; 2focus sick visits (see definition in text) 
with S. pneumoniae cultured from the nasopharyngeal aspirate (NPA); 3the serotype carried at the 
focus sick visit present in the nasopharynx already at the age-based visit starting the observation 
period; 4the serotype carried at the focus sick visit acquired after the start of the observation period. 
A rapid development of Pnc AOM after acquisition of a pneumococcal serotype 
was indirectly suggested by the difference in timing of the NPA positive focus sick 
visit with and without Pnc AOM (Figure 8). The median time elapsed from the 
start of the observation period to the time the parents brought the child to a focus 
sick visit (i.e. because of suspicion of AOM) was shorter if Pnc AOM was 
diagnosed at the visit than if it was not, although in both cases the child carried 
pneumococci at the visit (Figure 6). This difference was especially informative in 
the case of focus visits with newly acquired carriage. The median time of 29 days 
between the period onsets and the focus sick visits with Pnc AOM means, by 
definition, that at least half of these Pnc AOM events had developed 29 days or 
less after acquisition. In the case of established carriage, the corresponding median 
time from period onset to Pnc AOM at the focus sick visit was only 15 days, 
indicating that also a majority of these Pnc AOM events could have developed 
relatively soon after acquisition. The median time from period onsets to the NPA 
positive focus sick visits was shorter in the case of established carriage than in the 
case of newly acquired carriage, probably because, the established carriage had 
been acquired already before the start of the observation period (if not cleared and 
re-acquired). The early timing of focus sick visits with AOM was again specific to 
Pnc AOM.  
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Figure 8.  Temporal association between the age-based visits starting the observation periods and 
the NPA positive focus sick visits with different outcomes.  
Dashed horizontal lines, time before pneumococcal acquisition; A, pneumococcal acquisition event; 
solid horizontal lines, pneumococcal carriage; dashed vertical lines, average (median) time from the 
start of the observation periods to the NPA positive focus sick visits. The question marks indicate 
the unknown time between the start of the observation period and pneumococcal acquisition which 
occurs either before (established carriage) or after (newly acquired carriage) the start of the 
observation period.  
The rapid development of Pnc AOM after pneumococcal acquisition was further 
demonstrated in a retrospective analysis of carriage preceding the sick visit (Figure 
9). The serotypes causing Pnc AOM were found at 21% (15/70) of the age-based 
visits starting the observation periods, and the frequency was only 14% (8/56) at 
visits 2 to 15 weeks before the Pnc AOM. Instead, the preceding carriage of the 
serotypes found at the NPA positive focus sick visits without Pnc AOM was 
constantly high before the sick visit, the average proportion being 45% (117/259). 
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Figure 9.  Preceding carriage of pneumococcal serotypes carried at the focus sick visit with and 
without pneumococcal acute otitis media  
Solid line, pneumococcal acute otitis media (Pnc AOM, n=70); dashed line, no Pnc AOM (n=259); 
Note that during the last week before the focus sick visit the dashed line is hidden behind the solid 
line. The preceding carriage was assessed at the six age-based visits starting the observation periods 
(numbers of samples in the figure). Dots indicate the onset times of symptoms leading to the focus 
sick visit. Figure with permission from PIDJ September 2005–Volume 24–Number 9, pp 801–806). 
Wolters Kluwer Health Lippincott Williams & Wilkins©. 
5.5 Dynamics of pneumococcal acquisition and pneumococcal 
acute otitis media in temporal relationship to respiratory 
infection (IV) 
The proportion of pneumococcal carriers in Study IV was 41% at the 1788 
spontaneous sick visits and 21% at 3024 age-based visits. The difference in the 
frequency of carriage between the spontaneous sick visit and age-based visits was 
clear in children aged less than six months (25% vs. 12%) but only moderate in 
children at least 18 months of age (51% vs. 40%). Figure 10 demonstrates the 
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definition of the 585 episodes of carriage in 228 children (1–9 per child, median, 2). 
The 585 episodes of carriage and the 828 episodes of non-carriage comprised 11% and 33% 
of the total follow-up time (from birth to the last nasopharyngeal sampling) of 607 
years in 327 children. In the episode-based analysis, the time of acquisition could 
be determined for 404 episodes of carriage. The 1146 sick episodes comprised 17% 
of the total follow-up time in the 329 children and 19% of the total follow up in 
those 286 children who had at least one sick episode. 
1897 spontaneous sick visits 
167 PncAOM events
9 NPS samples and 8 NPA samples with no 
serotype information available
3026 age-based visits
46  NPA and 685 NPS  samples obtained    >
62 days apart from any other sample
One PncAOM event
181 carriage episodes 
with unknown  onset time
37 PncAOM events
54 carriage episodes not overlapping with any of 
the 1146 sick episodes
20 periods with unknown aetiology of the first 
potential PncAOM during that periode2
3 PncAOM events
12 homotypic recurrent PncAOM events during 
the risk episodes
1788 NPA samples
1780 serotypable
NPA samples
1734  
NPA samples 
3024 age-based 
NPS samples
3015 serotypable
NPS samples
2330  
NPS samples 
585 carriage episodes 1
166 PncAOM events
404 carriage episodes with known 
onset time
130 PncAOM events
1146 sick episodes 
431 overlapping periods 
of carriage and sick episodes
130 PncAOM events
411 risk episodes for PncAOM
127 PncAOM events
411 risk episodes for PncAOM
115 PncAOM events
828 non- carriage 
episodes 
 
Figure 10.  Defining episodes of carriage and non-carriage, sick episodes and risk episodes for 
pneumococcal acute otitis media.  
NPA, nasopharyngeal aspirate; NPS nasopharyngeal swab; PncAOM, pneumococcal acute otitis 
media. 1Six NPS and seven NPA samples negative for pneumococci were imputed with positive 
carriage because the child was on antibiotic medication and the previous and subsequent samples 
were of the same serotype. In addition, a negative NPA (two), missing NPA (two), or NPA with a 
different serotype from that in the middle ear fluid (MEF; one) were imputed with the serotype 
isolated from the concurrent positive MEF sample. In the 52 cases where two (or in one case, three) 
serotypes were identified concurrently, the serotype not present in the previous sample less than 62 
days apart was chosen 35 times, the serotype in MEF was chosen twice, and in 15 cases the serotype 
was chosen randomly. 2If there were any AOM event with missing MEF sample before the first Pnc 
AOM (if any) during the risk period, the aetiology of the first potential Pnc AOM remained 
unknown. Figure adapted from Original Communication IV, with permission of all authors. 
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5.5.1 Acquisition of carriage in relation to respiratory infection 
Tables 10 and 11 present the 404 observed acquisition events and person-times 
during the 585 episodes of carriage and the 828 episodes of non-carriage stratified 
by age group (0–5, 6–11, 12–17, 18–24 months at the episode onset) and current 
carriage status of the child (Table 10, non-carriers; Table 11, carriers). For this 
episode-based analysis, only episodes with known onset were used. The follow-up 
time was further stratified by the proximity to the sick episode onset, based on an 
exploratory analysis which revealed a clear change point in the overall acquisition 
hazard about one month before the sick episode onset. 
The overall unadjusted acquisition hazard in the episode-based analysis was 
clearly highest in non-carrying children during ‘pre-sickness’ (i.e. during 30 days 
preceding the sick episode onset) and continued to be high during ‘sickness’ (i.e. 
during the sick episode), the acquisition hazards being more than 5-times and 3-
times higher as compared to ‘health’ (i.e. more than 30 days before sick episode 
onset). The acquisition hazards were lower in children who already carried 
pneumococci than in children, who did not, except during sickness. During health, 
the acquisition rate was very low in both carrying and non-carrying children.  
Table 10.  Episode-based crude estimates of hazard of pneumococcal acquisition in non-carriers 
stratified by age group and proximity to sick episode onset. 
 Acquisitions in relation to sick episode onset 
 Health1 Pre-sickness2 Sickness3 
Age4 
(months) 
Aquisition 
hazard5 
Acquisitions/ 
person-time6 
Aquisition 
hazard 
Acquisitions/ 
person-time 
Aquisition 
hazard 
Acquisitions/ 
person-time 
       
0-5 0.05 65/1206.0 0.19 47/248.5 0.08 18/218.3 
6-11 0.02 1/52.2 0.30 39/130.0 0.14 25/180.1 
12-17 0.03 1/39.3 0.45 43/94.6 0.28 33/116.8 
18-24 0.00 0/10.2 0.31 11/35.5 0.24 14/58.6 
Total 0.05 67/1307.5 0.28 140/508.5 0.16 90/573.8 
The at-risk time for pneumococcal acquisition during episodes of non-carriage with known onset 
time is divided into three strata: 1 health, >30 days before any sick episode onset; 2 pre-sickness, within 
30 days before any sick episode onset; and 3sickness, during a sick episode. 4Age group at the 
beginning of the episode of non-carriage. 5A crude estimate of pneumococcal acquisition hazard is 
calculated as acquisitions 6per person-time in months. Table adapted from Original Communication 
IV, with permission of all authors. 
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Table 11.  Episode-based crude estimates of hazard of pneumococcal acquisition in carriers stratified 
by age group and proximity to sick episode onset. 
 Acquisitions in relation to sick episode onset 
 Health1 Pre-sickness2 Sickness3 
Age4 
(months) 
Aquisition 
hazard5 
Acquisitions/ 
person-time6 
Aquisition 
hazard 
Acquisitions/ 
person-time 
Aquisition 
hazard 
Acquisitions/ 
person-time 
       
0-5 0.03 4/145.1 0.13 9/69.3 0.17 9/52.7 
6-11 0.00 0/20.5 0.19 14/71.6 0.16 13/83.3 
12-17 0.04 1/25.3 0.16 14/87.8 0.17 18/106.9 
18-24 0.00 0/8.4 0.27 12/45.9 0.16 13/79.0 
Total 0.03 5/199.3 0.18 49/274.6 0.16 53/321.8 
The at-risk time for pneumococcal acquisition during episodes of carriage with known onset time is 
divided into three strata: 1 health, >30 days before any sick episode onset; 2 pre-sickness, within 30 days 
before any sick episode onset; and 3sickness, during a sick episode. 4Age group at the beginning of the 
episode of carriage. 5A crude estimate of pneumococcal acquisition hazard is calculated as 
acquisitions 6per person-time in months. Table adapted from Original Communication IV, with 
permission of all authors. 
Due to the less frequent age-based sampling in children aged more than 6 months, 
however, most of the episode-based person-time of risk for acquisition during 
health was accrued from children aged less than six months. Using a Markov 
transition model and data from all age-based and sick visit samples, the acquisition 
rate in healthy non-carrying children was significantly higher in the age group >12 
months than in the age group <12 months (0.18 vs. 0.08 per month, respectively). 
Instead, the hazards of clearing carriage were similar in the two age groups, 
corresponding to median carriage durations of 1.9 months with overlapping 90% 
PIs for the medians (1.7–2.2 and 1.7–2.1, respectively).  
The acquisition hazard during the pre-sickness period was 3.5 times higher as 
compared to health (hazard ratio (HR) 90% PI 2.9-4.1). The hazards continued to 
be elevated during sickness (HR 2.2, 90% PI 1.9-2.7). The model predictions about 
the Pnc carriage prevalence at the age-based and sick visits agreed relatively well 
with the prevalence figures observed from the data (Figure 11, panels A and B), 
although there was a slight tendency to overestimation in the age-based samples.  
The model was also used to predict the age-specific prevalence of carriage 
assuming the absence of respiratory infections (i.e. sick episodes) and this was 
compared to the observed prevalence in samples obtained from children who had 
not had sick visits during the follow-up before the sampling. Both predicted and 
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observed age-specific prevalence was lower as compared to that based on all age-
based samples (Figure 11, panel C). 
 
Figure 11.  The prevalence of pneumococcal carriage predicted by Markov transition model, by age 
group. 
The Markov model used data of all nasopharyngeal samples obtained during age-based visits and 
spontaneous sick visits. The frequency of pneumococcal carriage observed directly from the samples 
is shown for comparison. Panel A, nasopharyngeal swab (NPS) samples obtained at age-based visits; 
panel B, nasopharyngeal aspirates (NPA) obtained during spontaneous sick visits; panel C, age-based 
NPS samples collected more than 30 days prior to the first spontaneous sick visit of the child. The 
bar heights indicate the predicted prevalence values, with vertical lines showing the 90% predictive 
intervals. The black dots indicate the actual observed values. Figure from Original Communication 
IV, with permission of all authors. 
5.5.2 Pneumococcal acute otitis media in relation to pneumococcal 
acquisition and respiratory infection 
Of the 585 episodes of carriage, 491 overlapped with 541 of 1146 sick episodes. 
One episode of carriage overlapped with 1-5 sick episodes, and one sick episode 
overlapped with 1-4 episodes of carriage. This produced a total of 603 overlapping 
periods with 166 Pnc AOM events. Figure 10 shows the flow chart for the 
definition of episodes of carriage and risk episodes for Pnc AOM. Considering only 
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the 404 carriage episodes with known onset, 431 overlapping periods with 130 Pnc 
AOM events were available. After excluding 20 overlapping periods with MEF 
samples missing for the first potential Pnc AOM during that period (three Pnc 
AOM events) and 12 repeated homologous Pnc AOM events during the same risk 
episode (always only once and in different children), 411 risk episodes and 115 Pnc 
AOM events remained in the analysis. 
Altogether, 91 (58%) of boys and 73 (46%) of girls had at least one risk episode 
(1-9; median, 2). These 164 children had more often older siblings living in the 
household (59%) as compared to those not providing risk episodes (41%). 
Pnc AOM was diagnosed in 80 children during 28% (115/411) of all risk 
episodes, with little variation by age group (27%, 29%, 30%, and 24% in children 
aged 1-5, 6-11, 12-17, and 18-24 months at the risk episode onset, respectively). Of 
the 115 Pnc AOM events, 79% (91/115) occurred within 30 days after carriage 
acquisition. 
In the explorative analysis, the 411 risk episodes were stratified according to 
temporal proximity of the acquisition of the underlying carriage to the current sick 
episode onset, so that the Pnc AOM hazard appeared constant within each 
stratum. As illustrated in Figure 12, the Pnc AOM hazard during the risk episode 
was considerably higher if carriage had started ‘around sickness onset’, i.e. within 30 
days before or within seven days after the sick episode onset (Figure 12, blue curve, 
marked with a star), as compared to carriage which had started ‘later during sickness’, 
i.e. later than seven days after the sick episode onset (Figure 12, red curve, marked 
with a triangle) or to carriage which had started ‘long before sickness’, i.e. more than 30 
days before the sick episode onset (Figure 12, black curve, marked with a sphere). 
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Figure 12.  Cumulative hazard rate of pneumococcal otitis media by day since acquisition of 
pneumococcal carriage.  
The hazard is presented in three strata, defined by the time of acquisition in relation to the sick 
episode onset. Pnc AOM, pneumococcal acute otitis media; black curve (with sphere), long before 
sickness, i.e. more than 30 days before the sick episode onset; blue curve (with star), around sickness 
onset, i.e. within 30 days before or within seven days after the sick episode onset; red curve (with 
triangle), later during sickness, i.e. during the sick episode more than seven days after its onset. The 
slopes of the curves represent the hazards of Pnc AOM. Note, that if the carriage had started more 
than 30 days before the sick episode onset, the risk episode could only start 30 days or more after 
acquisition. Figure from Original Communication IV, with permission of all authors. 
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Of note, the hazard during carriage that had started around sickness onset 
remained high only for the first 30 days after acquisition. Thereafter, the hazard 
dropped to a very low level, only 3 of 70 Pnc AOM events in this stratum 
occurring more than 30 days after carriage acquisition, as indicated by the change 
in the slope of the blue curve. Therefore, the at-risk time only up to 30 days after 
acquisition with 67 Pnc AOM events was included from this stratum in the further 
analyses, so that 112 Pnc AOM events (instead of 115) were included in the 
Poisson regression model (Table 12).  
During those risk episodes for which the underlying carriage episode had 
started around sickness onset (n=204), 67 Pnc AOM events occurred during 39.1 
months at risk, corresponding to a crude estimate of the Pnc AOM hazard of 1.71 
per month (90% PI 1.40-2.09; Table 12). During risk episodes for which carriage 
started later during the sick episode (n=111), the crude Pnc AOM hazard was 0.50 
per month (26 Pnc AOM events during 52.5 months at risk, 90% PI 0.36-0.68; 
Table 12). During risk episodes for which carriage had started more than 30 days 
before the sick episode onset (n=96), the crude Pnc AOM hazard was 0.49 per 
month (19 Pnc AOM events during 38.7 months at risk, 90% PI 0.34-0.72; Table 
12). 
According to the Poisson regression model with adjustment for age group, 
previous homologous carriage and previous homologous Pnc AOM, the hazard of 
Pnc AOM was significantly higher for carriage acquired around sickness onset as 
compared to carriage acquired later during sickness (HR 3.6, 90% PI 2.4-5.2). The 
relative hazard was even larger when compared to carriage acquired long before 
sickness (HR 4.5, 90% PI 2.5-6.8). The proportion of Pnc AOM events that 
occurred during carriage acquired around sickness onset comprised 60% (67/112) 
of all Pnc AOM events although the total duration of risk episodes in this stratum 
(57 months) comprised only 25% of the total follow-up time of 230 months during 
the risk episodes. There was a non-significant trend towards a lower Pnc AOM 
hazard in the case of previous homologous carriage (HR 0.68, 90% PI 0.42-1.03), 
but previous homologous AOM was not associated with the Pnc AOM hazard. 
Risk episodes for which the underlying carriage had started around the sickness 
onset or later during sickness were necessarily (i.e. by definition) the first risk 
episodes during that carriage episode. In contrast, this was not the case for risk 
episodes for which the underlying carriage had started long before sickness, and in 
76 of 96 of these risk episodes the child had actually had at least one earlier sick 
episode (1-4) during the same carriage episode. The unadjusted Pnc AOM hazard 
during these repeated risk episodes during the same carriage episode was notably 
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low (0.38 per month), although 60 of these risk episodes were observed in children 
at an infection-prone age of 6 to 18 months (median time from the carriage 
acquisition to the risk episode onset, 85 days). Instead, the hazard was higher (1.00 
per month) during the 20 first risk episodes for which the carriage had also started 
long before the risk episode onset but the child had not had any preceding sick 
episodes during the same carriage episode, and which all were observed in children 
less than 12 months of age (median time from the carriage acquisition to the risk 
episode onset, 66 days).  
The Poisson model was next used to compare Pnc AOM hazards only between 
risk episodes without any previous sick episodes during the same carriage episode 
in the three strata (n=335). The relative Pnc AOM hazard during carriage acquired 
around sickness onset was now only about two times higher than the hazard during 
carriage acquired long before sickness, with 90% credible interval for the relative 
hazard including zero (HR 2.1, 90% PI 0.9-4.1). Instead, the hazard remained high 
as compared to the hazard during carriage acquired later during sickness (HR 3.8, 
90% PI 2.5-5.4). Previous homologous carriage now significantly decreased the 
Pnc AOM hazard (HR 0.57, 90% PI 0.30-0.94) but previous homologous Pnc 
AOM was not associated with the Pnc AOM hazard.  
There were 34 additional overlapping periods of carriage and sick episodes, for 
which the episode of carriage had been first detected more than 30 days before the 
sick episode onset although the exact acquisition time could not be defined in the 
episode-based analysis. For 28 of these additional risk episodes, information was 
available on the aetiology of the first potential Pnc AOM event and of the presence 
(n=15) or absence (n=13) of previous sick episodes overlapping with the same 
carriage episode. When the analysis of Pnc AOM during the first risk episodes of 
carriage was repeated while including these 13 additional risk episodes, the Pnc 
AOM hazard was again significantly higher if carriage had been acquired around 
sickness onset than if carriage had been acquired more than one month before 
sickness onset (HR 1.9, 90% CI 1.1-3.4). The augmented data including the 
additional 28 risk episodes are summarised in Table 12. 
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6 DISCUSSION 
All four studies constituting this thesis are based on material collected in the 
Finnish Otitis Media (FinOM) Cohort Study, conducted in 1994–1997 before 
licensure of the pneumococcal conjugate vaccines. In the FinOM Cohort Study, an 
extensive amount of information on nasopharyngeal carriage of S. pneumoniae 
during health and respiratory infection as well as on the occurrence and aetiology 
of AOM was collected. The study thus provided exceptional data for examining 
the dynamics between Pnc carriage and the development of Pnc AOM before the 
era of pneumococcal conjugate vaccines.  
6.1 Study population and follow-up  
Practically all eligible families living in the study area (Hervanta) received 
information about the study at their local child health care centres. These municipal 
health care facilities are frequented by 99% of Finnish families with young children, 
regardless of socio-economic status. Thus about half of the children in the birth 
cohort in the study area participated in the FinOM Cohort Study.  
The study children were fairly representative of the Finnish child population 
aged 2 to 24 months. The mean number of children in the participating families 
was 1.8, corresponding to the average child count in Finland at the time (590). Of 
the study children, 63% never attended day care during the follow-up. This 
proportion is comparative to the proportion (64%) of Finnish children cared at 
home during the second to third years of life (591). Of the study children and the 
Finnish children in general, 51% were breastfed for at least 24 weeks and the 
proportion of those exclusively breastfed for at least 12 weeks was 41% and 45%, 
respectively (592). Of the parents, 56% had an educational attainment of senior 
high school or higher. The corresponding proportion was only 34% in the Finnish 
population >15 years of age in 1997, which, however, includes the elderly with a 
lower average educational attainment (593). Children of immigrant families were 
usually not eligible for the study, as the child’s mother was required to be able to 
 117 
communicate adequately in Finnish. However, in 1995, only 3% of Finnish 
residents had been born outside the country (594).  
The study clinic was established especially to collect data for the FinOM Cohort 
Study. In the clinic, full-time and trained study physicians and nurses were available 
for the study children whenever the children needed medical care for suspicion of 
AOM. The study clinic was located in the centre of the study area and access to the 
clinic was kept easy to enhance the capture of potential AOM cases.  
The compliance of the study participants to follow-up, visits and sampling was 
very good. Only 15% of children discontinued, the main reason being moving out 
of the area. Of the scheduled age-based visits, 92% were carried out, and at only 
two of these visits was the NPS sample not obtained. According to the diaries and 
interviews, 81% of ambulatory visits due to respiratory infection or AOM took 
place at the study clinic, and at 95% of these sick visits, an NPA sample was 
obtained.  
The FinOM Cohort Study was conducted between April 1994 and July 1997. 
No pneumococcal conjugate vaccines were licensed at the time, and none of the 
study participants had received any pneumococcal vaccine. Between December 
1995 and April 1997, about 37% of children living in the Tampere area, including 
Hervanta, were vaccinated at 6 to 13 weeks of age with either of two 7-valent 
pneumococcal conjugate vaccines investigated in the FinOM Vaccine Trial 
(284,589). Therefore, it has been speculated whether there could have been herd 
effects on Pnc carriage among the FinOM Cohort Study children. No significant 
reduction in carriage of the vaccine serotypes, however, was observed at the age of 
12 months in the vaccinated children in the trial (595). A moderate reduction was 
observed in the vaccinated children at the age of 18 months, i.e. starting from 
February 1997, by which time more than 80% of the FinOM Cohort children had 
already finished their follow-up. Thus, it is unlikely that there were significant herd 
effects on Pnc carriage or disease in the FinOM Cohort Study children. 
6.2 Design of FinOM Cohort Study and the sub-studies 
Young children are prone to frequent respiratory infections. The presence of mild 
respiratory symptoms was therefore allowed at the age-based visits for feasibility 
reasons. In contrast, the parents were instructed to bring the child to a sick visit 
specifically when they suspected AOM on the basis of predefined symptoms, 
including symptoms of respiratory infection or fever. This strategy seemed to be 
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successful in distinguishing the conditions of health and respiratory infection, as 
Pnc carriage was clearly more prevalent at the sick visits than at the age-based 
visits. This observation is in concordance with a wide range of previous studies, in 
which the carriage frequency has been higher during respiratory infection as 
compared to health (151,238,240,242,259,473,474). Furthermore, AOM was 
diagnosed in 36% of the spontaneous sick visits, in 15% of the control visits 
scheduled to check-up healing of AOM and in only 3% of the visits initially 
scheduled by age. Since visits with AOM or fever were defined as sick visits, it is 
thus fairly appropriate to consider the child as relatively healthy at the time of the 
age-based visits and ‘having respiratory infection’ at the time of the sick visits, 
especially the spontaneous ones. 
The longitudinal design of the FinOM Cohort Study offered an excellent 
possibility to examine the natural course of Pnc carriage. At the same time, 
however, the design posed many challenges for the analysis. Children with frequent 
sick visits were probably more infection-prone than children with few sick visits, 
either because of a higher infection pressure in the environment or because of an 
individual frailty. This infection-proneness could also affect the frequency of Pnc 
carriage at the sick visits. However, because there is always heterogeneity between 
children in their proneness to infection, this type of selection was not a major 
problem in Study I, in which the aim was to describe the natural course of Pnc 
carriage in an unselected child population. In studies II–IV, different measures 
were taken to diminish the impact of repeated infections and over-representation 
of events from infection-prone children. In Study II, AOM events with a preceding 
AOM event in the two weeks prior were excluded to diminish the proportion of 
recurrent AOM events. Moreover, in calculating the confidence intervals for the 
sensitivity, specificity, PPV and NPV of nasopharyngeal culture in predicting the 
aetiology of AOM, the possibility of correlation between the measurements from 
the same child was controlled. In Study III, only spontaneous sick visits due to 
parental request 30 days apart were included in order to avoid repeated 
measurements of the same infection period, thus diminishing over-representation 
of data from infection-prone children with frequent visits. In Study IV, the onset 
of a new respiratory infection was defined even stricter, by requiring 30 days 
between the last spontaneous sick visit and the start of a new episode. Moreover, 
the assessment of Pnc AOM hazard in Study IV was restricted to episodes during 
immediate risk for Pnc AOM. Comparisons to healthy children were thus not 
relevant.  
 119 
In addition to the above designs, control of statistical uncertainty was required 
because of the possibility of intra-child correlation between measurements from 
the same child. In Studies II and III, the statistical models included a frailty variable 
to account for possible heterogeneity across children in their proneness to Pnc 
AOM. Inclusion of a frailty variable in these analyses did not essentially change the 
results, which indicates that individual proneness is not likely to be a significant 
confounder. In Study IV, previous homologous carriage and AOM of the child 
were included as covariates in the Poisson regression model to estimate the Pnc 
AOM hazard.  
Age-based visits were scheduled at intervals of one month between the ages of 
2 and 6 months, every three months between the ages of 6 and 18 months, and the 
interval between the last two scheduled visits was as long as six months. The 
uneven schedule of age-based visits was another challenge in the design of the 
FinOM Cohort Study. The youngest age group was thus over-represented among 
the NPS samples, whereas the frequency of sick visits peaked at the infection-
prone age between 6 and 18 months. This potential source of confounding had to 
be carefully considered in interpreting the data and in designing the sub-studies. 
Stratification of samples into age groups and including age as a covariate in the 
statistical analyses were used to control for confounding. In Study III, only age-
based visit 3-months apart were allowed to start a new observation period to 
ensure comparability; in estimating the acquisition hazard rates in Study IV, the 
Markov analysis used all data instead of being dependent on the definition of 
episodes of carriage.  
Since the estimated average duration of Pnc carriage is about two months in 
children aged less than two years and even longer in the youngest ones 
(129,185,191,206,228,233), it is likely that the majority of carriage episodes in the 
very young were captured. In contrast, episodes of carriage were more likely missed 
in children aged more than six months, especially if the child had only a few sick 
visits to provide additional samples. The possibility of missing carriage episodes 
was a challenge in Studies III and IV, which addressed temporal associations of 
carriage acquisition and development of Pnc AOM. Without the possibility for 
very frequent sampling, it is impossible to know when Pnc carriage actually starts 
and when it has cleared. In Study III, carriage and subsequent occurrence of Pnc 
AOM were assessed at systematically defined and comparative pairs of age-based 
and sick visits. In the episode-based analysis in Study IV, the less frequent sampling 
resulted in a lack of sufficiently detailed information on episodes of carriage and 
non-carriage in older children during health. However, carriage frequency was 
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similar in samples used to define carriage episodes and in samples obtained at least 
62 days apart from any other sample, when stratified by age and visit type. Thus, 
the detected carriage episodes probably represented relatively well those that 
remained undetected. Furthermore, the Markov transition model used all data, 
including the samples excluded from the episode based analysis in estimating the 
acquisition hazards. Nevertheless, the estimates of individual acquisition and Pnc 
AOM hazards in Study IV should be interpreted with some caution, while the 
relative hazards are likely to be relatively reliable (596).  
Antimicrobial treatment decreases bacterial growth and interferes temporarily 
with its detection, as was evident also in the data comprising this thesis. Data on 
the history of preceding treatment were only available for the age-based visits. Data 
on ongoing treatment were available for almost all age-based and sick visits with 
samples available, the treatment having been ongoing at 6% and 11% of these 
visits, respectively. In Study II, the analysis was based only on samples obtained in 
the absence of antimicrobial treatment and recent AOM events (within 14 days), 
which probably reduced the likelihood of recent antimicrobial treatment. The 
predictive ability of nasopharyngeal culture of S. pneumoniae was similar when AOM 
cases with ongoing antimicrobial treatment or repeated AOM events were also 
included (597), but these cases were excluded from the analysis in Study II to 
improve the comparability between S. pneumoniae and H. influenzae. To avoid data 
reduction, the analysis in Study III was based on all data, after confirming that the 
conclusions were essentially unchanged when the analysis was repeated using only 
samples obtained in the absence of antimicrobial treatment. In defining episodes of 
carriage in Study IV, any one sample negative for pneumococci in the presence of 
antimicrobial treatment was considered positive if the preceding and next samples 
within two months were positive for the same serotype.  
6.3 Detection of events and episodes of acute otitis media 
According to the collected diaries and interviews at the age-based visits and after 
verifying relevant diagnoses from medical records, 81% of all visits due to acute 
infection and 86% of visits at which AOM was diagnosed took place in the study 
clinic. These high percentages indicate that the study quite likely succeeded in 
capturing a vast majority of AOM events occurring in the study children during the 
follow-up. This assertion is further supported by the observed incidence of AOM 
in the FinOM Cohort Study (332), which is comparative to or slightly higher than 
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the AOM incidences observed in three other studies conducted in Finland during 
the period 1978–1995 (376,377,522).  
Diagnosing AOM is not easy, especially in young children who cannot complain 
or locate specific ear-related symptoms verbally. The disease is often misdiagnosed, 
which may be a problem in studies based on routine clinical praxis (295,598). In 
the FinOM Cohort Study special attention was paid to increasing the accuracy of 
the otologic diagnosis. Optimal diagnostic equipment and sufficient time were 
available for cleaning the cerumen from the external auditory canal and for 
examining the appearance and movement of the tympanic membrane. Adequate 
assistance for restraining the child was always available and the study physicians 
were thoroughly trained in diagnostic skills. Routine use of tympanometry reduced 
the subjectivity of the diagnosis. In addition, in 89% of the AOM events the 
presence of MEF was confirmed by myringotomy.  
The design using myringotomy was justified by the statement of the Finnish 
consensus conference on the approach of the treatment of AOM in 1985. The 
otologists emphasised the value of drainage of the middle ear in the prevention of 
prolongation and complications of otitis media (417). However, new studies 
arguing against the effect of the procedure had been published and especially 
paediatricians and general practitioners had started to avoid the procedure in 
primary uncomplicated cases. The design necessitating the routine use of the 
procedure may have decreased the participating in the study, which, however, was 
still very high. Moreover, given the similarity of the background factors of the 
study children and Finnish children in general, it is not likely that any systematic 
selection bias would have arisen. The high compliance and the low percentage of 
those (9% of all children) who discontinued for reasons beyond moving out of the 
study area indicate that the study procedures were tolerated reasonably well. 
The easy access to the study clinic and regular ear examinations at scheduled 
visits may have led to inclusion of relatively mild AOM cases. Moreover, as the 
FinOM criteria for AOM comprised signs of MEF with at least one symptom of 
acute infection, but without specific signs of acute inflammation of the tympanic 
membrane, some cases of residual MEF after previous AOM or OME with 
concurrent symptoms of infection not related to the ear condition may have been 
included. Although differences in the pathogenesis between AOM, recurrent AOM 
and OME are likely (92,292), these conditions form a continuum of diseases that 
are difficult to distinguish also in clinical praxis. Furthermore, pneumococci are 
involved in all three clinical entities and pneumococcal conjugate vaccines seem to 
reduce tympanostomy tube placements due to prolonged or recurrent forms of 
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otitis media even more than the acute form of otitis media (425,429-431). Thus, all 
three disease entities are relevant in the scope of prevention of otitis media with 
pneumococcal vaccines.  
The difference between acute and prolonged otitis media is more important 
when examining the dynamics of AOM development and its relation to Pnc 
carriage and respiratory infection. Therefore, only spontaneous sick visits were 
considered in Studies III and IV, and repeated events during the same infection 
episode were excluded. To increase the likelihood to correctly identify new 
episodes of acute respiratory infection in Study IV, a new sick episode was defined 
to start only if more than 30 days had elapsed without the child showing up at the 
clinic for a spontaneous sick visit. 
6.4 Clinical samples and bacteriological methods 
At the age-based visits, NPS samples were collected from the deep nasopharynx 
with calcium-alginate tipped swabs, as recommended in the standard method for 
detecting upper respiratory carriage of S. pneumoniae by the WHO Working Group 
2003 (10). The only difference to the recommendation was that the shaft of the 
swab was bent in the peel pouch to follow the arch of the child’s nasopharynx 
before entering the swab into the nostril. This method allowed entering the swab 
very deeply into the nasopharynx but may have resulted in less tight contact of the 
swab tip with the mucosa and therefore to less sensitive detection of bacteria. This 
method has not been reported in other carriage studies and its impact is thus 
difficult to assess. 
At the sick visits, nasopharyngeal aspirates (NPA) with a paediatric mucus 
extractor were used, since NPA was considered better for detection of viruses 
(599). The sampling techniques were specifically compared in a preceding study of 
children with acute respiratory infection, and the agreement between NPS and 
NPA sampling in detecting S. pneumoniae was excellent (148). Therefore, it is not 
likely that the higher frequency of pneumococcal recovery during respiratory 
infection as compared to health was due to the different sampling methods. It has 
been a constant finding across many studies worldwide that carriage frequency is 
higher during respiratory infection as compared to health, even when the same 
sampling technique has been used during health and respiratory infection 
(242,473). However, it cannot be ruled out that respiratory infection with increased 
discharge from nasal mucosa may enhance detection of Pnc carriage. Furthermore, 
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in the preceding study, NPA was found to perform significantly better than 
nasopharyngeal swabbing in the detection of H. influenzae (148), so using NPA 
probably improved the comparability of microbial findings in Study II.  
The NPS, NPA and MEF samples were cultured on enriched chocolate agar 
plates and sheep blood agar plates including 5% gentamicin and thus selective for 
S. pneumoniae. The FinOM Cohort Study was primarily designed to examine the 
epidemiology of S. pneumoniae. Culture on selective agars has proven more sensitive 
than standard agars for detecting otitis pathogens, especially in the nasopharynx 
where the pathogens are easily overgrown by other bacteria (8,125). However, 
neither of the plates was selective for H. influenzae, which may have reduced the 
detection sensitivity for this pathogen, thus complicating the comparison between 
the two pathogens in Study II. 
All samples were analysed in the same bacteriological in-house laboratory by a 
small number of trained laboratory technicians, assuring uniform quality of the 
analyses. The serotyping methods used in the study, 
counterimmunoelectrophoresis and latex agglutination have been shown to 
perform as well as the Quellung test (25). Uncertain results were confirmed by 
means of the Quellung test.  
If the child carried the same serotype at two temporally related visits, the 
serotypes were considered to represent the same pneumococcal strain without 
further identification. However, a portion of the NPS and MEF isolates were 
analysed with MLST in a sub-study comparing the ability of serotypes and clones 
to cause AOM or invasive pneumococcal disease (338,367). The vast majority of 
temporally associated isolates with the same serotype in the same child were found 
to have the same sequence type. Therefore, the use of serotype as an indicator for 
continuous or repeated carriage should be relatively reliable. The assumption of the 
equivalence of serotype and strain has also been made in most of carriage and 
transmission studies conducted in the pre-vaccination era. However, the relevance 
of this assumption should be monitored closely during large scale pneumococcal 
vaccinations, which may exert selective immunological pressure on the 
pneumococcal population.  
6.5 Basic features of pneumococcal carriage 
The overall age-adjusted Pnc carriage prevalence based on the age-based visits was 
27%. This figure is comparable to prevalence estimates in studies of unvaccinated 
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children aged less than two years in Sweden, the USA and Costa Rica in the 1990s 
(186,218,248,473). Importantly, these studies were not conducted in day care 
centres or medical settings treating respiratory infections. The prevalence was 
higher than in Chinese children in Hong Kong (239) and Japanese children (666), 
but lower than in more recent reports from the UK, the Netherlands, Israel and 
Sweden (73,181,188,220,235,236,261). As expected, the prevalence of Pnc carriage 
in the FinOM Cohort Study was clearly lower than in populations with special risk 
for pneumococcal infections in low-income circumstances or in tropical 
environment (214-217,238,249,255).  
At 12 months of age, 56% of the children had encountered S. pneumoniae at least 
once, and at 24 months of age the proportion was 87%. This figure suggests that 
most, if not all, children in the FinOM Cohort Study harboured pneumococci at 
some time during the follow-up, considering that some carriage episodes have 
presumably remained unobserved (186). Missed carriage episodes are probable, 
although additional sampling at sick visits completed the relatively infrequent age-
based sampling in children aged more than six months and increased the 
cumulative proportion of carriers at 24 months of age by about 10 percentage 
points. The pattern in the cumulative incidence of first acquisition is concordant 
with previous data about the slow accumulation with age of the first pneumococcal 
encounter in developed countries (10,125,186,218-220), in contrast to populations 
with high risk of Pnc carriage and diseases (129,215,216). However, practically all 
children in any population carry S. pneumoniae at least once during the first two 
years of life (125,128,175,186,213-216,600). 
 The prevalence of carriage at the age-based visits increased up to 24 months of 
age, which is a common pattern in many studies (73,184,229,236,246). In other 
studies, pneumococcal prevalence has peaked or levelled off earlier 
(128,129,164,174,214,238-243). The latter pattern is common especially in 
countries where the strain turnover is fast and carriage prevalence settles at a very 
high level. One could speculate that in these populations pneumococci occupy 
their ecological niche already at very young age and/or an intensive stimulation of 
the immunological system leads to an earlier equilibrium between the infection 
pressure and carriage. Occasionally the prevalence of carriage has been found to 
settle at a low level (about 10% or less) at early age, e.g. in studies among 
exclusively healthy Chinese children in Hong Kong (239). Interestingly, the 
prevalence of carriage in the current study was relatively stable between 9 and 12 
months of age, increasing again thereafter. A similar plateau during the second half 
of the first year of life and a subsequent rise can be perceived from data in a small 
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number of other studies conducted in the USA, Israel and Costa Rica 
(186,229,236). In the US study, the prevalence of serotypes 6 and 23 continued to 
increase during the second year of life, whereas the prevalence of serotypes 14 and 
19 decreased after 18 months of age (229). Furthermore, in the current study, the 
prevalence of carriage increased only a little, if at all, after nine months of age, if 
the child had not had sick visits before the age-based sampling, suggesting some 
kind of change in the dynamics of carriage development between 6 and 12 months 
of age. 
Interestingly, higher concentrations of anti-PsaA antibodies were associated 
with a smaller proportion of pneumococcal aetiology of AOM in the FinOM 
Cohort Study children aged more than nine months if the child concurrently 
harboured pneumococci in the nasopharynx and if the AOM was the child’s first 
clinical AOM (138). This finding suggests that there might be an improvement in 
the immunological competence during the second half of the first year of life. 
However, this pattern remains largely unresolved, since higher concentrations of 
anti-PsaA antibodies did not provide protection against subsequent carriage in 
these children and, although there was a slight trend towards decreasing risk of Pnc 
AOM in the presence of high anti-PsaA antibodies after the age of 12 months, it 
remained statistically non-significant (138).  
There was no systematic difference in Pnc carriage between boys and girls, 
which is consistent with most other studies (156,180,207,218,235,237,243,249,536). 
The lack of a systematic sex difference in Pnc carriage is interesting, since boys are 
known to be at higher risk for invasive pneumococcal diseases in Finland as well as 
elsewhere (405,523,524). Moreover, many studies have shown higher incidences of 
AOM in boys (375,522,530,532). Likewise, the incidence of Pnc AOM in the 
FinOM Cohort Study was higher in boys than in girls, although the difference was 
smaller than for H. influenzae (332). It seems that the higher risk of pneumococcal 
diseases among boys cannot be explained directly with the propensity to Pnc 
carriage, but there must be other mechanisms in the process of development of 
carriage to disease (545).  
Pnc carriage at the age-based visits showed no clear seasonality. A small trend 
towards a bipolar seasonality in carriage frequency was seen in the two oldest age 
groups during respiratory infection, which is in concordance with the increased 
acquisition observed in association with respiratory infection. A similar bipolar 
seasonality was observed also in the incidence of respiratory infections (498) and 
AOM in the FinOM Cohort Study (332), as well as in the occurrence of AOM 
(529) and invasive pneumococcal diseases (601) in Finnish children in general. 
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Concordantly with the weak seasonality in Pnc carriage, the seasonality in the 
incidence of Pnc AOM was less prominent than seasonality in AOM caused by H. 
influenzae or M. catarrhalis (332). It is not clear why different carriage studies present 
conflicting results about the seasonality of Pnc carriage. Certainly, the climate 
varies considerably across different countries, but there may also be other reasons 
for monthly variation than those associated with weather. Although periodical 
trends have usually been associated with changes in weather conditions (541), in 
Kenya, the monthly variation in carriage was not associated with temperature, 
humidity or rainfall (238). The monthly variation in carriage observed in two 
Swedish studies among day care attendees was attributed to main vacations by the 
authors (209,212). In a US study, peaks and lows were observed in Pnc carriage, 
without regular seasonal patterns across different years (542). Gray et al. described 
an interesting detail in the seasonality of Pnc carriage in children: acquisition 
peaked in midwinter, while the prevalence fluctuated mildly throughout the year 
(229). One could speculate that if carriage acquisition is associated with viral 
respiratory infections with bipolar seasonality, the relatively long duration of 
carriage in children levels off the carriage prevalence between the epidemic peaks. 
The observation that acquisition of Pnc carriage and AOM present a similar 
seasonality, while prevalent carriage does not follow a similar pattern supports the 
link between carriage acquisition and development of AOM. This was suggested by 
the findings in Studies III and IV. Strong local seasonal epidemics of other 
nasopharyngeal microbes could also offer an explanation for variable observations 
of seasonality in carriage.  
This thesis focused on the interplay between respiratory infection, Pnc carriage 
and Pnc AOM. Given the limited number of children, this approach did not allow 
for extensive adjustment for their background characteristics. Contacts with other 
children, siblings and day care mates are known to be major risk factors for 
infectious diseases. Furthermore, the importance of Pnc carriage of the family 
members on Pnc carriage among the FinOM Cohort Study children has been 
shown by other authors (177,191). However, since most of the impact of child 
contacts is likely to be due to viral and bacterial transmissions, relatively little effect 
could be expected beyond occurrence of respiratory infections and Pnc carriage. 
Nutritional and socio-economic differences are not likely to have a major impact 
on carriage of otitis morbidity in Finland and the parents rarely reported smoking 
indoors in the vicinity of the child. The Finnish population is relatively 
homogeneous genetically and only a few immigrants were included because of the 
language criterion. Adjusting for repeated measurements from the same child in 
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Studies II and III diminished over-representation of samples from children who 
may have had special risk factors for carriage and infection. 
6.6 Pneumococcal carriage during respiratory infection and 
acute otitis media 
S. pneumoniae detected at the age-based visits was considered to represent Pnc 
carriage during health. Although the study children were not required to be 
completely free of mild respiratory symptoms for feasibility reasons, the children 
underwent a physical examination with otoscopy at each visit, and if fever or AOM 
was recognised, the visit was recorded as a sick visit. In that case, NPA instead of 
NPS was obtained and the healthy visit was carried forward in time. 
The overall proportion of positive sick visit samples was 41%, to be compared to 
the age-weighted average of 27% in the age-based samples. The higher frequency 
of Pnc carriage in association with respiratory infections or AOM has been an 
almost universal pattern (79,151,153,242,252,259,473,474). However, there are a 
number of studies in which no difference has been observed in carriage frequency 
between respiratory infection and health (150,207,215,217,222,237,481,482). A 
possible reason is that the classification of young children as healthy or 
symptomatic is not straightforward because mild respiratory infections are very 
common and minor symptoms may not be easy to recognize. In addition, 
antimicrobial treatment is frequently used in association with respiratory infections, 
and the opposite effects of infection and treatment may interfere with the 
interpretation of results. Some of these studies were also based on oropharyngeal 
rather than nasopharyngeal samples (222,481) and others included children aged up 
to 9–16 years (207,222,481,482), which could have affected the findings. In 
particular, differences in carriage frequency during respiratory infection and health 
may be smaller in the throat than in the nose, as reported in a family study by 
Masters (151). The difference between infection and health also diminished with 
age and was not at all seen in throat swabs from adults (151). However, the 
sampling site or older age do not likely explain entirely the lack of observed effects 
of respiratory infection on carriage, since in a study among Israeli children 
pneumococci were found more often during respiratory infection than during 
health with both nasopharyngeal and oropharyngeal swab samples (150), while in a 
Brazilian study, upper respiratory infection was clearly associated with an increased 
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risk of carriage in adolescents aged 10–19 years (252). In studies in India and Papua 
New Guinea, the level of carriage was very high even during health, which may 
explain the lack of any additional increases during respiratory infection (215,217).  
The increasing prevalence of Pnc carriage with age was evident at both the age-
based and sick visits. When sick visits were stratified by AOM occurrence, the age 
trend remained at visits with no AOM, but was hardly seen at visits with AOM. 
This difference is partly explained by the fact that practically all children carried 
pneumococci during Pnc AOM irrespective of age. In children aged less than 6 
months, however, the carriage frequency tended to be relatively high also during 
non-pneumococcal AOM, although in all age groups combined, the carriage 
frequency during non-pneumococcal AOM was similar to that during sick visits 
with no AOM. This could be due to confounding through over-representation of 
AOM cases in the oldest children within this age group, since respiratory infections 
and AOM are rare during the first months of life and increase towards six months 
of age. However, further stratification by each month of age revealed relatively 
high carriage frequency during non-pneumococcal AOM and also during sick visits 
with no AOM as compared to health at each age band.  
The frequency of Pnc carriage during respiratory infection and AOM as 
compared to health was especially high in the youngest age group. A possible 
explanation for this finding is that children presenting at sick visits already during 
the first months of life had been either more exposed to both viral and bacterial 
infections or were individually more prone to catch infections in general. In other 
words, Pnc carriage could be a marker of proneness to infection, especially in the 
youngest children, while older children with more contacts to other children carry 
pneumococci even without special proneness. Whatever the reason, these results 
highlight the importance of considering both age and the health status of the 
participants when carriage levels in different studies and populations are compared. 
Although Pnc carriage, respiratory infections, and Pnc AOM all generally show 
clear age patterns, there were interesting differences between these entities in the 
FinOM Cohort Study. First, although the prevalence of carriage continued to 
increase throughout the second year of life, the incidence of the respiratory 
infections and Pnc AOM peaked at about 12 months of age and decreased 
thereafter (332,498). Nevertheless, the proportion of Pnc AOM events of all AOM 
events showed little if any variation by age. Interestingly, when examined by risk 
time, i.e. the child both carrying pneumococci and having respiratory infection, the 
age pattern almost disappeared. The age distribution in the occurrence of Pnc 
AOM with the peak at about one year of age thus reflected the incidence of 
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respiratory infections, not the prevalence of carriage. Likewise, the seasonality of 
AOM was similar to that of respiratory infections, whereas there was little if any 
seasonality in Pnc carriage 
In agreement with numerous previous studies, the prevalence of carriage in the 
FinOM Cohort children decreased temporarily during or soon after antimicrobial 
treatment (221,483,484,584,586). When analysed in detail, the effect was largest 
during and one week after the end of the treatment, and became diluted thereafter, 
the carriage frequency reaching the age-group specific level at 15 to 28 days after 
the end of treatment, and even earlier in the age group 7 to 13 months. In children 
aged less than seven months antimicrobial treatment did not lower the carriage 
frequency below the overall level. One reason could be the especially high carriage 
frequency during AOM in the youngest children, as compared to health, 
counteracting the effect of antimicrobial treatment.  
6.7 Nasopharyngeal carriage as a predictor of the aetiology of 
acute otitis media 
The higher prevalence of Pnc carriage during AOM than during respiratory 
infection without AOM was mainly attributable to Pnc AOM. In particular, during 
Pnc AOM the child practically always harboured pneumococci in the nasopharynx, 
whereas during non-pneumococcal AOM, the overall proportion of positive 
samples was almost similar to that at sick visits without AOM. The high 
occurrence of S. pneumoniae in the nasopharynx during Pnc AOM means that the 
sensitivity of nasopharyngeal culture for detecting the pneumococcal aetiology of 
concurrent AOM was almost 100%. Accordingly, the negative predictive value of a 
nasopharyngeal sampling in ruling out Pnc AOM was excellent. By contrast, the 
specificity and the positive predictive value of the nasopharyngeal finding in 
predicting the presence of pneumococci in the MEF were only moderate. The high 
sensitivity and NPV of Pnc carriage in predicting Pnc AOM have been constantly 
documented by numerous studies (155,262). In the current study, however, the 
sensitivity and NPV were extraordinarily high as compared, for example, to the 
sensitivity and NPV derived from six AOM studies in a systematic review of the 
literature (514). One reason for the high sensitivity of nasopharyngeal carriage in 
predicting AOM aetiology may be high sensitivity for detecting Pnc carriage. In the 
FinOM Cohort Study, efforts were paid to obtaining truly deep nasopharyngeal 
samples and selective plates were used to diminish growth of other bacteria so as 
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to increase detection of pneumococci (9). Luotonen et al. used nasal rather than 
nasopharyngeal samples, studied children aged 2 to 6 years and cultured 
pneumococci on unselective plates, reaching a sensitivity of 79% in predicting the 
pneumococcal aetiology of concurrent AOM (510). The older age of the study 
children may explain the lower sensitivity, since although nasal culture has shown a 
good agreement with nasopharyngeal culture, especially in young children (148) it 
might not be as sensitive in older children (602). It is difficult to detect all existing 
potentially pathogenic bacteria in nasopharyngeal samples with ample normal flora, 
whereas the pathogens are more easily found from the normally sterile middle ear. 
Using selective plates to avoid overgrowth of other bacteria, even sparse 
nasopharyngeal growth can be detected, which increases the sensitivity of 
predicting AOM aetiology.  
A higher sensitivity and NPV of carriage of S. pneumoniae than carriage of H. 
influenzae in the prediction of the respective presence of the pathogens in the MEF 
has not been observed consistently in previous studies (262,510,512). In a study 
combining previously published data, the sensitivity was lower (76% vs. 90%) but 
the NPV was higher (80% vs. 70%) for H. influenzae than for S. pneumoniae (514). In 
our study, the use of selective plates for S. pneumoniae but not for H. influenzae could 
have led to better sensitivity to detect pneumococci in the nasopharynx and 
therefore to better sensitivity to predict Pnc AOM by Pnc carriage. Furthermore, 
nasopharyngeal sampling is likely to detect Pnc carriage more sensitively than 
carriage of H. influenzae, since even young children carry H. influenzae often also in 
the oropharynx without nasopharyngeal involvement (148,150,152). Therefore, 
nasopharyngeal sampling and even aspirate may detect H. influenzae less sensitively 
than S. pneumoniae. However, it is not clear whether additional oropharyngeal 
sampling would have been beneficial in predicting Hi AOM, since a Swedish study 
suggested that oropharyngeal culture unlike nasopharyngeal culture has no value in 
assessing the aetiology of otitis media (155), possibly because the Eustachian tube 
is located in the nasopharynx. 
 As S. pneumoniae was a common finding in the nasopharynx even during non-
pneumococcal AOM, the specificity and PPV in predicting Pnc AOM were 
relatively low. The vast majority of positive NPA samples yielded abundant growth 
and there was a clear association between the quantity of pneumococcal growth in 
the NPA and the presence of S. pneumoniae in the MEF. However, using abundant 
growth increased PPV only slightly, since there were only a few samples with non-
abundant pneumococcal growth. The association of high nasopharyngeal bacterial 
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load with bacterial presence in the middle ear and also with otitis media irrespective 
of aetiology has been reported in Australian and US studies (262,478,509) 
The specificity and PPV of nasopharyngeal culture of H. influenzae in predicting 
Hi AOM were higher than those for S. pneumoniae, while the sensitivity and NPV 
were lower. The PPV of Pnc carriage was clearly lower if H. influenzae was also 
present in the nasopharynx. Instead, the presence of pneumococci in the 
nasopharynx hardly affected the PPV for H. influenzae. It is difficult to interpret 
whether this asymmetry is explained with lower sensitivity for detecting H. 
influenzae carriage or whether there were true interactions between the two bacteria 
in causing AOM. Inverse associations between the concurrent presence of S. 
pneumoniae in the nasopharynx and H. influenzae in MEF and vice versa have been 
observed also in other studies but the associations have been of similar magnitude 
for both bacteria (509,510) or prediction of Hi AOM has occasionally been even 
poorer if pneumococci have been carried concurrently with H. influenzae (155). 
However, research in children vaccinated with the 7-valent conjugate vaccine 
suggests that although S. pneumoniae and H. influenzae are relatively frequently 
carried concurrently, they compete in the development of AOM, H. influenzae 
performing better than most serotypes of pneumococci (603).  
In general, evidence on both positive and negative interactions between S. 
pneumoniae and H. influenzae has been presented (20,76-78). Any interaction between 
the two bacteria may be strain-specific (84) and affected by other bacteria (75), 
viruses (72), host defence mechanisms (83,84,86,92) and biofilm formation (93). 
Animal and in vitro observations of decreased density of pneumococci and 
increased density of H. influenzae during concurrent colonisation with the two 
bacteria, as compared to single bacterium colonisation, provide further evidence 
for the hypothesis of the higher propensity of H. influenzae to cause AOM during 
simultaneous colonisation (83,84). Furthermore, H. influenzae stimulates innate and 
pneumococcal-specific immunity, which favours the success of H. influenzae during 
co-colonisation of the two bacteria (83,84). S. pneumoniae in turn is known to inhibit 
survival of H. influenzae by producing hydrogen peroxide and neuraminidase 
(81,85).  
Numerous studies addressing the ability of nasopharyngeal bacterial culture of 
pneumococci and H. influenzae to predict AOM aetiology have been conducted, in 
the hope that it would be helpful in clinical praxis (155,262,509-513). However, 
although the high NPV of nasopharyngeal culture has been acknowledged, the 
overall performance of the procedure has been disappointing, since the PPV 
remains low. The PPV of 50% in our study doubled the overall probability of Pnc 
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AOM (26%), but it cannot be considered optimal for clinical decisions. Schwartz et 
al. suggested reappraising nasopharyngeal culture in predicting AOM aetiology 
(509). They found that a single bacterium comprising at least 25–50% of the total 
number of colonies in the nasopharynx during AOM was the most valuable 
predictor of the aetiology of suppurative otitis caused by that bacterium. Similarly, 
the PPVs in our study were highest for both S. pneumoniae and H. influenzae if 
abundant nasopharyngeal growth of one bacterium was found in the absence of 
the other.  
As a future consideration, adding the clinical picture to the quantified 
multibacterial nasopharyngeal finding could probably further increase the 
specificity and PPV in predicting pneumococcal AOM. Palmu et al. evaluated the 
association between clinical symptoms and signs or their combinations and the 
bacterial aetiology of AOM and constructed an algorithm that doubled the 
probability of pneumococcal aetiology of AOM as compared to the overall 
prevalence (324). The problem with increasing specificity and PPV is that it 
increases the false negative findings, i.e. decreases sensitivity. It has also to be 
considered that PPV and NPV are dependent on the prevalence of the disease in 
the population, in this case Pnc AOM, which is usually not known, since 
aetiological samples are not obtained in uncomplicated cases.  
The usefulness of nasopharyngeal culture in choosing treatment for AOM is 
compromised by the fact that the culture takes 1–2 days to yield a result. Instead, if 
the ‘observation option’ is chosen, the culture result would probably be available at 
a second visit, potentially with antimicrobial susceptibility data. A rapid 
pneumococcal antigen detection test would provide the result during the first 
consultation, but it does not allow quantification of bacteria. Furthermore, there 
are currently no rapid antigen tests adapted to nasopharyngeal samples available for 
other most relevant otopathogens to allow an evaluation of the concurrent 
presence of multiple bacteria. High NPV, due to high sensitivity has clinical value 
even without detection of other pathogens, because exclusion of the potentially 
most severe Pnc AOM could ease choosing the ‘observation option’ and thus 
reduce antimicrobial overuse.  
Despite problems in clinical work, an algorithm for predicting pneumococcal 
aetiology of AOM with high specificity would be useful in defining outcomes for 
research purposes, for example in clinical trials of pneumococcal vaccines. The 
time needed to analyse nasopharyngeal samples is not a problem in a study setting. 
The low sensitivity inevitably associated with high specificity is not a major 
problem in a cohort design, except for the large number of participants needed to 
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detect a sufficient number of outcome events, and thus high cost. The high work 
load and cost could be tolerable if the nasopharyngeal samples could additionally 
be used to answer other study questions. For example, the samples could be used 
for epidemiological surveillance to assess serotype distributions and antimicrobial 
resistance in the population. The distribution of serotypes in the NPA samples 
obtained during clinical AOM resembled slightly more the distribution in the MEF 
samples than did the distribution in isolates from the NPS samples obtained at the 
age-based visits. This difference may be at least partly due to repeated and uneven 
sampling, some serotypes being carried for longer time or at younger age and thus 
more frequently detected by repeated age-based sampling, rather than being real 
differences across serotypes in their biological propensity to cause AOM. 
However, as demonstrated by our Studies III and IV, Pnc AOM is not often 
caused by prolonged carriage. Thus, the distribution of nasopharyngeal serotypes 
detected during AOM may reflect the MEF serotypes better than the distribution 
of serotypes detected during health. The same was also suggested by a study 
conducted in the USA to monitor the distribution of serotypes in the nasopharynx 
and MEF during AOM 8 to 10 years after the introduction of pneumococcal 
conjugate vaccination (321). Indeed, there were some, though slight differences 
across serotypes in their ability to cause AOM when random nasopharyngeal 
samples were compared with random age-matched MEF samples in a study using 
data from the FinOM Cohort Study (412). A difference between carried serotypes 
in their capacity to cause AOM has also been shown in an Israeli study (604). Thus, 
better markers of pneumococcal serotypes causing AOM would be needed to 
evaluate the effects of serotype-specific pneumococcal vaccination against AOM. 
The possibilities to evaluate the distribution of serotypes causing AOM would 
be even better if the specificity of predicting the pneumococcal aetiology of AOM 
could be increased, e.g. by using multibacterial and quantitative detection of 
nasopharyngeal bacteria together with the clinical picture. During Pnc AOM, the 
aetiologic serotype is almost always present in the nasopharynx, as demonstrated 
by our study as well as numerous other studies. This possibility is important 
because MEF samples are not currently used in clinical praxis and thus are seldom 
ethically and practically justifiable for research purposes.  
Frequent scheduled nasopharyngeal sampling could still provide an additional 
possibility to increase the specificity in predicting the pneumococcal aetiology of 
AOM for research purposes. As shown in Studies III and IV, the strain carried 
during AOM has the highest probability to be present in the MEF if it has been 
acquired recently, i.e. the serotype harboured in the nasopharynx during the AOM 
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has not been present in a preceding nasopharyngeal sample. Thus, scheduled 
nasopharyngeal samples obtained frequently enough could provide additional 
information to increase the specificity in predicting the pneumococcal aetiology of 
AOM for research purposes. 
6.8 Dynamics of pneumococcal carriage acquisition, respiratory 
infection and development of acute otitis media  
The longitudinal nature of the FinOM Cohort Study offered a possibility to 
examine the temporal association of Pnc carriage acquisition and development of 
Pnc AOM. We found that Pnc AOM tends to develop soon after acquisition of a 
new serotype. This phenomenon was explained by the distinct increase in the rate 
of carriage acquisition in association with the onset of a new episode of respiratory 
infection, and the fact that carriage acquired around the acute phase of respiratory 
infection was most prone to proceed to otitis media.  
The close association of pneumococcal acquisition with the onset of a new 
respiratory infection appears biologically plausible. Respiratory infections are 
mostly caused by viruses, and there is ample evidence from both in vitro and 
experimental studies that viral infection enhances bacterial adhesion and invasion 
to the host cells (466,467,469), thus contributing to carriage acquisition 
(464,472,605). Viral infection is also a well-known contributor in the development 
of AOM. It is likely that the viral and pneumococcal virulence mechanisms act in a 
synergistic way in the development of inflammation and disease (51,467). It seems 
that the risk of acquiring a new pneumococcal strain is highest at the onset of 
respiratory infection and these newly acquired pneumococci are prone to rapidly 
proceed to AOM. Since only a minority of respiratory infections lead to 
pneumococcal acquisition (477) and only a minority of new pneumococcal 
acquisitions lead to AOM, other factors such as the virulence of the pneumococcal 
strain and host immunity and other host defence mechanisms of the child must be 
involved in the dynamic interplay between pneumococci, viruses and the 
individual.  
A large majority of Pnc AOM events were due to strains acquired recently, 
within the last month. The sensitivity analysis in Study IV showed that the inferred 
timing of increased acquisition before the respiratory infection onset depends on 
the rule used to define the carriage episodes. In the sensitivity analysis, only those 
samples obtained less than 45 days apart were included in defining carriage 
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episodes (as opposed to the 62 days in the base-case model). The period of 
increased acquisition before the sickness was then estimated to be shorter and the 
Pnc AOM hazard during newly acquired carriage was even higher as compared to 
carriage acquired long before sickness or later during sickness. Thus, the time of 
increased acquisition is likely to start later than one month before the respiratory 
infection onset, presumably rather at the time or soon after the beginning of the 
respiratory infection. Indeed, in Study III, the frequency of the preceding carriage 
of the serotype causing Pnc AOM was found to increase most within the two 
weeks before the AOM diagnosis. As symptoms had often lasted for several days 
before the child was brought to the visit and since viral shedding had probably 
started several days before the start of symptoms (606), it is quite possible that 
pneumococcal acquisition had occurred at the time of viral infection onset or even 
later. This assumption is in accordance with an animal study in which influenza 
virus and pneumococci were inoculated sequentially with varying intervals. In that 
study, the highest incidence of Pnc AOM was observed when pneumococci were 
inoculated just before the time of influenza-induced leucocyte dysfunction and 
negative middle ear pressure, both occurring within one week after inoculation of 
the influenza viruses (578). In another animal study, in which the animals were 
inoculated with influenza virus and then with pneumococci seven days later, the 
otoscopic signs of tympanic membrane inflammation peaked eight days after the 
inoculation of pneumococci (496). 
Pnc carriage acquired more than a month before new respiratory infection was 
less prone to lead to Pnc AOM than carriage acquired around the respiratory 
infection onset. The Pnc AOM hazard was not as low if the child had not had 
previous respiratory infection during the same carriage episode as compared to 
purely asymptomatic carriage. Unfortunately, the majority of long asymptomatic 
carriage episodes were captured at less than six months of age when age-based 
sampling was most frequent, whereas long carriage episodes with intervening 
respiratory infections were mostly captured at 6 to 18 months of age. Thus, it was 
not possible to identify whether it was the older age or history of respiratory 
infection during the same episode of carriage that affected the Pnc AOM hazard 
more. It is possible that children who carry pneumococci already at a young age 
may have a special propensity to developing Pnc AOM during respiratory infection 
even after relatively long carriage, either because of more intense exposure to 
infections or because of some individual frailty which could not be recognised in 
these studies. In contrast, children aged more than six months may have host 
defence mechanisms effective enough to prevent development of otitis media after 
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establishment of carriage, even at an infection-prone age. It is also possible that 
continuing carriage itself stimulates immunological response which decreases the 
hazard of Pnc AOM. Based on tis data is impossible to say, whether this protection 
process was accelerated by an intervening viral infection or whether the slightly 
longer average carriage duration before the risk episode onset decreased the Pnc 
AOM hazard in children with repeated respiratory infections during the same 
carriage episode. Interestingly, having at least one previous carriage episode due to 
the same serotype was associated with decreased Pnc AOM hazard after re-
acquisition at all ages. Similarly, when the occurrence of the first Pnc AOM event 
during the whole carriage episode was considered in the FinOM Cohort Study 
children, repeated acquisitions of the same serotype were associated with decreased 
occurrence of Pnc AOM, whereas previous carriage of different serotypes did not 
have any effect on the occurrence (607). This is in accordance with a US study 
among children aged less than two years, in which serotype-specific antibody 
responses to carriage acquisition or Pnc AOM tended to be greatest after repeated 
exposure (105). Thus, our findings may indicate a protective role of preceding 
homologous carriage against Pnc AOM, rarely demonstrated in children despite the 
broad, although fragmentary body of knowledge on the development and function 
of natural immunity against pneumococcal infections.  
The hazard of Pnc AOM was relatively low and the events accumulated slowly 
if pneumococcal acquisition had occurred later than during the first week since the 
first visit due to a new respiratory infection. This lower hazard is concordant with 
findings from an experimental chinchilla study, in which the incidence of 
pneumococcal otitis media was lower if pneumococci were inoculated 12 days after 
inoculation of influenza virus, as compared to the incidence observed if 
pneumococci were inoculated four days after influenza inoculation, i.e. at the time 
when the virus-induced leucocyte dysfunction and a concurrent virus-induced 
decrease in the middle ear pressure were most prominent (471). In our study, the 
yield of the virus may have been short-lived after the symptom onset (495) and it is 
thus possible that there were few, if any, active viruses left to interact with newly 
acquired pneumococci in the development of AOM later during the sick episode.  
Interestingly, although the Pnc AOM hazard was relatively low if the underlying 
carriage had been acquired during the respiratory infection after its acute phase, the 
hazard of pneumococcal acquisition remained high throughout the episode of 
respiratory infection. Thus, after the acute phase of respiratory infection, the 
continuing or healing viral infection still seems to enhance acquisition of Pnc 
carriage, but for some reason, at this phase the viral infection seems to have lost 
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much of its ability to promote progression of Pnc carriage to AOM. This raises the 
question of whether there are mechanisms that prevent AOM without preventing 
carriage acquisition and, if so, whether these mechanisms could have implications 
on planning the prevention of pneumococcal diseases.  
6.9 The role of pneumococcal carriage studies in the prevention 
of pneumococcal diseases with conjugate vaccines 
Pneumococcal conjugate vaccines prevent carriage as well as mucosal infections 
like AOM caused by the serotypes included in the vaccine, unlike a vaccine that 
only includes purified polysaccharides. In two vaccine trials, pneumococcal 
conjugate vaccines reduced the incidence of AOM caused by the vaccine serotypes 
already before the booster dose, whereas the reduction of vaccine-serotype carriage 
was less pronounced and observed only after the booster dose (595,608). In two 
other trials, the reduction in carriage became apparent when the child grew older 
even in the absence of a booster dose (282,609). It has been hypothesised that 
primary vaccine doses could reduce Pnc AOM by reducing the bacterial load in the 
nasopharynx without reducing the frequency of carriage (434,608). The reduction 
in carriage frequency could then follow later, after a booster dose, owing to 
enhanced immunity with increasing age and previous encounters with the 
serotypes.  
The temporal association between pneumococcal acquisition and Pnc AOM 
might offer another explanation for the earlier effect of vaccination on Pnc AOM 
than carriage. Vaccination is believed to affect acquisition of carriage rather than 
established, prevalent carriage (434,436). Thus, if vaccination prevents new 
acquisitions, it prevents also Pnc AOM events which would have promptly 
followed these acquisitions. Instead, if vaccination does not affect established 
carriage, the prevalence in the vaccinated population is maintained until the 
carriage episodes have ended. Thus, the effect of vaccination on carriage may be 
delayed, especially in young children who on average carry pneumococci for a 
longer time than older children. 
Pnc AOM is much milder than pneumococcal invasive infection, but because 
Pnc AOM is very common and usually treated with antimicrobials, its prevention 
has a significant public health impact. Although the effect of the 10-valent 
pneumococcal conjugate vaccine was only 8% in preventing antimicrobial 
purchases in a cluster-randomised trial in Finland, vaccination would lead to more 
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than 12 000 fewer antimicrobial purchases per year for children aged less than two 
years (610).  
The most important goal for pneumococcal vaccination is invasive disease. The 
seriousness of invasive disease highlights the need to investigate the dynamics of 
pneumococcal acquisition, carriage and development of invasive diseases. Invasive 
pneumococcal diseases in children are often caused by serotypes that are frequently 
acquired and carried, but invasive diseases are also relatively often caused by 
serotypes that are rarely found in the nasopharynx, probably due to their rapid 
clearance from the nasopharynx. As a report of the work of a large consortium of 
researchers of pneumococcal epidemiology (PneumoCarr), Simell et al. emphasised 
the important role of vaccine efficacy against carriage acquisition in protecting the 
individual against mucosal pneumococcal diseases (611). Furthermore, the 
differences in the epidemiology and vaccine efficacy by age and differences in the 
case-to–carrier ratios across different serotypes in development of mucosal and 
invasive diseases are important. These facts highlight the need for reliable data on 
the incidence of both Pnc carriage and pneumococcal disease in different 
populations so as to assess the effectiveness of vaccination with conjugate vaccines 
(612). Nevertheless, vaccination also prevents the progress of (breakthrough) 
carriage to invasive disease and its worsening (611), so that other mechanisms than 
those preventing carriage or reducing nasopharyngeal load of pneumococci are also 
likely to be involved.  
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7 SUMMARY AND CONCLUSIONS 
The high global burden of pneumococcal diseases, the emerging resistance of 
pneumococcal strains against antimicrobial treatment and the availability of 
pneumococcal conjugate vaccines emphasise the importance of the investigation of 
pneumococcal infections. Nasopharyngeal carriage of pneumococci is common in 
children and it comprises the main source of transmission of pneumococcal strains in 
the population. Carriage is a prerequisite for development of pneumococcal otitis 
media. The Finnish Otitis Media (FinOM) Cohort Study, a prospective follow-up of 
children during the first two years of life, offered a unique possibility to assess the 
natural course of pneumococcal carriage as well as the dynamic relationship between 
pneumococcal acquisition and carriage, respiratory infection and pneumococcal acute 
otitis media (Pnc AOM).  
The following conclusions were drawn on the basis of the studies in this thesis: 
Young children carry S. pneumoniae more frequently during respiratory infection 
than during health. 
The hazard of pneumococcal acquisition of is higher in association with the onset 
of a respiratory infection than during health and the increased hazard continues 
several weeks after the onset of the respiratory infection. 
A pneumococcal strain acquired around the onset of a respiratory infection is 
especially prone to cause AOM. The majority of Pnc AOM events occur within 
one month after the acquisition of a new strain. 
The prevalence of pneumococcal carriage increases with age during the first two 
years of age. However, in the absence of respiratory infections, pneumococcal 
carriage increases only moderately with age.  
If the child carries pneumococci during respiratory infection, age has little if any 
effect on the occurrence of Pnc AOM. The age-dependency in the incidence of 
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Pnc AOM mainly reflects the age-dependence in the incidence of respiratory 
infections. 
Antimicrobial treatment decreases pneumococcal carriage frequency temporarily, 
but sex and season have little effect.  
If pneumococci are not found from the nasopharynx during AOM, the 
pneumococcal etiology of AOM is very unlikely. A positive nasopharyngeal finding 
increases the possibility of pneumococcal aetiology of AOM but pneumococcal 
carriage is common also during non-pneumococcal AOM.  
Nasopharyngeal carriage during AOM could be used as information in predicting 
the aetiology of AOM for research purposes. The negative nasopharyngeal finding 
could be used for ruling out Pnc AOM in selected cases also in clinical practice. 
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Nasopharyngeal Carriage of Streptococcus pneumoniae in Finnish Children
Younger Than 2 Years Old
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To describe the natural course of nasopharyngeal carriage of Streptococcus pneumoniae and
its relationship to acute otitis media (AOM), 329 Finnish children were followed from ages
2 to 24 months. In total, 3024 nasopharyngeal (NP) swabs (obtained at 10 scheduled healthy
visits) and 2007 NP aspirates (obtained during respiratory infections) were cultured. Carriage
during health increased gradually (9%–43%) with age. Within 4 age intervals, carriage was
lower during health (13%–43%) than during respiratory infection without AOM (22%–45%).
Higher proportions of positive samples were found during AOM (45%–56%), in particular
during pneumococcal AOM (97%–100%). Antimicrobial treatment reduced carriage only tem-
porarily. The most frequent NP serotypes were 6B, 6A, 11, 19F, and 23F. Both age and health
status were important determinants of NP carriage of S. pneumoniae and these features should
be considered carefully during analysis of carriage rates.
Streptococcus pneumoniae causes a wide variety of infections
worldwide, from invasive diseases with considerable mortality
to relatively benign and very common mucosal infections, such
as acute otitis media (AOM). It is also a common component
of the nasopharyngeal (NP) ﬂora in healthy persons. The in-
creasing occurrence of penicillin-resistant strains challenges the
treatment and prevention strategies for pneumococcal diseases
and emphasizes the need for knowledge about factors that af-
fect S. pneumoniae carriage and its progression to disease.
Most children acquire S. pneumoniae in their nasopharynx
during the ﬁrst few years of life [1–6]. Colonization is very rapid
in high-risk populations, such as infants in Papua New Guinea,
who are colonized by the age of 3 months (the pattern is similar
among Australian aboriginal infants) [3, 4]. In industrialized
countries such as Sweden and the United States, about half of
children are colonized with S. pneumoniae at least once by age
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1 year [7, 8]. The reasons for the differences between popula-
tions are not fully understood. The prevalence of NP carriage
increases during the ﬁrst months of life [6, 7, 9, 10] and starts
to decrease after age 3–5 years [2, 11–13]. The wide range of
pneumococcal carriage (5%–89%) in different parts of theworld
[14, 15] reﬂects variations in study populations with respect to
age, ethnicity, socioeconomic living conditions, and differences
in sampling and isolation techniques. The health conditions at
the time of sampling may also vary. The terms “carriage” or
“colonization” apply to both healthy persons and to subjects
with symptoms of acute infection that is possibly or deﬁnitely
caused by S. pneumoniae.
Many studies have shown that recovery of S. pneumoniae
from the nasopharynx or oropharynx is more likely during
respiratory infection than during health [16–20] but others
failed to ﬁnd such a connection [21–23]. Most often, the carried
serotypes are the same as those that cause most cases of AOM
and other pneumococcal diseases in children. As a rule, S.
pneumoniae of the causative serotype is found in the naso-
pharynx or nasal cavity during pneumococcal AOM [1, 24, 25].
Antimicrobial treatment may interfere with isolation rates, and
lower isolation rates have been observed during and soon after
antibiotic treatment, compared with pretreatment rates, but an-
timicrobial treatment does not eradicate the bacteria from the
nasopharynx [23, 26–29]. New strains appear after treatment
[1, 26, 28], but the long-term effect of antimicrobials on carriage
rates is poorly documented. In the Finnish Otitis Media
(FinOM) Cohort Study, we followed an unselected group of
329 infants from ages 2 to 24 months, during health at 10
scheduled visits and during respiratory infection and AOM, to
evaluate the natural course of pneumococcal carriage and its
relationship to respiratory infection with and without AOM.
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Materials and Methods
Study population and facilities. In total, 329 healthy infants
born in the Hervanta area, Tampere, Finland, were consecutively
enrolled in the FinOM cohort study betweenApril 1994 andAugust
1995 and were followed-up prospectively from ages 2 through 24
months. Families with newborns were informed of the study during
their ﬁrst routine visit to their local well-baby clinic. All infants
born or residing in the area were eligible to participate in the study
if they were 2 weeks old and had no prior immuni-months 2
zation with a pneumococcal vaccine and if their mothers could
communicate ﬂuently in Finnish. During the study, the children
were vaccinated in accordance with the Finnish schedule, which
does not include pneumococcal vaccine.
Follow-up began in April 1994 and continued through July 1997.
A study clinic with 1 or 2 doctors and 1–3 nurses was established
near the local well-baby clinic. Study personnel were specially
trained to interview parents, obtain samples, and diagnose and treat
AOM. Study clinic services were available for the study children
from 8 AM to 3 PM on work days and for 3 h on Saturdays, Sundays,
and national holidays.
Scheduled visits and NP swabs (NPS). The children were ex-
amined at age-scheduled healthy visits at ages 2, 3, 4, 5, 6, 9, 12,
and 15 months (2 weeks) and at age 18 months (4 weeks). A
close-out visit was done at age 24 months (4 weeks). The back-
ground information gathered at entry included family structure,
parents’ education, history of family allergies, and history of otitis
media (OM) of siblings. At each scheduled visit, the study staff
questioned parents about potential risk factors for carriage or
AOM, including feeding patterns, allergies, day care attendance of
the study child and siblings, and passive smoking. Responses were
recorded on structured case report forms. Parents were also asked
about antimicrobial drug usage during the 28 days preceding the
visit. A physical examination, including pneumatic otoscopy, was
performed by the study doctor. If the child was diagnosed with
AOM, febrile infection, viral exanthem, or acute gastroenteritis,
the visit was recorded as a “sick visit” and the healthy visit was
carried forward within the time window, if possible.
An NPS specimen was obtained at each healthy visit with a sterile
swab with a ﬂexible aluminum shaft and a dry calcium alginate tip
(Galgiswab; Spectrum Laboratories). The child’s head was tipped
backwards and was immobilized. The bent swab was inserted into
the nostril, was passed into the nasopharynx to a distance equal to
that from the child’s nose to the tip of the ear, and was maintained
for 5 s. The sample was cultured immediately for S. pneumoniae.
Sick visits and NP aspirates (NPAs). If symptoms of acute
infection suggested AOM, the parents were asked to bring the child
to the study clinic. The event was recorded as a sick visit. A patient
history was taken, and the study doctor performed a physical ex-
amination, including pneumatic otoscopy and tympanometry.
Whenever AOM (see deﬁnition below) was suspected, myringo-
tomy was performed to conﬁrm the diagnosis, and a middle ear
ﬂuid sample (MEF) was obtained for etiologic diagnosis. Reso-
lution of each AOM was followed at a check-up visit 4 weeks after
the diagnosis. If AOM, febrile infection (38C), viral exanthem,
or acute gastroenteritis was diagnosed at the check-up visit or at
the close-out visit, the visit was classiﬁed as a sick visit.
An NPA was obtained at each sick visit with a sterile pediatric
mucus extractor (UNO sterile EtO; UnoPlast). The catheter was
guided to a depth of 4–8 cm in the nasopharynx through a nostril
and was drawn back while a gentle suction was applied with an
electric suction device. The sample was diluted with 0.5 mL of PBS,
if needed, and was cultured immediately with a 10-mL loop for S.
pneumoniae. The child’s visits to other than study doctors were
registered if shown in a patient diary, and medical records were
requested to conﬁrm AOM diagnoses.
Bacteriologic methods. NPS, NPA, and MEF samples were
cultured on enriched chocolate agar plates and selective sheep
blood agar plates containing 5 mg/mL gentamicin. The plates were
incubated in 5% CO2 at 36C–37C in the study clinic, usually
overnight, and were transported to the bacteriologic laboratory in
Oulu. The plates inoculated on Fridays and Saturdays were in-
cubated in the study clinic until Sunday. In the laboratory, the
plates were examined for S. pneumoniae and were incubated further
overnight, to reach a total incubation time of 48 h. To identify
S. pneumoniae, 4 different a-hemolytic colonies were tested for
optochin sensitivity. A bile solubility test was used if the optochin
test was negative but colony morphology was suggestive of the
species. The number of colonies was counted from the plate with
more abundant growth. Pneumococcal isolates were serotyped by
counterimmunoelectrophoresis and latex agglutination (for types
7 and 14), using antiserum pools and group- and type-speciﬁc an-
tisera. The isolates of groups 6, 9, 18, 19, and 23 were subtyped
by using pneumococcal factor antisera. All antisera were purchased
from Statens Serum Institut. The susceptibility of pneumococcal
strains to penicillin was tested by the agar dilution method, with
breakpoints 0.06 mg/mL (susceptible), 0.125–1.0 mg/mL (inter-
mediately resistant), and 2 mg/mL (highly resistant).
Deﬁnitions. The carrier state refers to harboring S. pneumoniae
in the nasopharynx either at a healthy visit or during respiratory
infection—even during pneumococcal AOM. AOM was visually
diagnosed as an abnormal tympanic membrane in pneumatic otos-
copy (by color, position, and mobility), suggesting effusion in the
middle ear cavity, concomitantly with 1 of the following signs or
symptoms of acute infection: fever, earache, tugging of the ear,
irritability, acute gastrointestinal symptoms, or other symptoms of
respiratory infection. Tympanometry was used as a diagnostic aid
[30]. We deﬁned pneumococcal AOM as an AOM with 1 MEF
sample with positive culture for S. pneumoniae. Because age proved
to be an important determinant of prevalence rates, the NPS and
NPA samples were grouped according to the child’s age at sampling
in 4 intervals: 6, 7–12, 13–18, and 19 months.
Statistical analysis. The results describe the natural situation
in a heterogeneous cohort where some children are healthy and
some have repeated infections, including AOM. We used the Kap-
lan-Meier method and x2 test to compare the similarity of children
who discontinued and children who completed the study. We used
SPSS for Windows software (release 8.0.1; SPSS) for computation.
Results
Population and samples. In all, 329 children were enrolled
in the study, representing 53% of the children registered in the
well-baby clinics in the study area during the enrollment period.
Table 1 lists the background characteristics of the enrolled chil-
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Table 1. Characteristics of the 329 study children.
Characteristic
No. (%)
of children
Sex
Boys 158 (48)
Girls 171 (52)
Feeding patterns
Any breast-feeding
No 4 (1)
12 Weeks 232 (71)
24 Weeks 167 (51)
Not known 18 (5)
Exclusive breast-feeding
No 28 (9)
12 Weeks 135 (41)
Not known 3 (1)
Day care attendancea
Home care only 207 (63)
Age at entrance
6 Months 4 (1)
12 Months 35 (11)
18 Months 85 (26)
24 Months 122 (37)
Older siblingsb
Yes 163 (50)
No 166 (50)
Education of mother or fatherc
Low 103 (31)
High 225 (68)
Not known 1 (!1)
Smoking indoors in homed
Yes 12 (4)
No 292 (89)
Unknown 25 (8)
a Any type of day care 4 h/week.
b Living in household at the time of enrollment.
c Highest education of either mother or father: low, compre-
hensive school, lower high school, or vocational education; high,
senior high school, college, or academic degree.
d At any time during follow-up.
dren. From 4 families, 2 children (twins from 3 families and
siblings from 1 family) participated in the study. Compliance
of the families was high: 316 (96%), 309 (94%), and 284 (86%)
of the children were followed until ages 7, 13, and 19 months,
respectively, and 281 (85%) completed the entire follow-up. The
main reason for dropping from the study was moving from the
residential area (40% of those who discontinued). The children
who were lost to follow-up were similar to those who were
followed-up for 24 months, in regard to duration of breast-
feeding, age when ﬁrst attending day care, parents’ education,
occurrence of ﬁrst NP S. pneumoniae, and occurrence of ﬁrst
AOM, when compared by the Kaplan-Meier method.However,
girls were lost to follow-up more often than boys (18.7% vs.
10.1%; , x2), and children without older siblings livingPp .027
in the household were lost to follow-up more frequently than
children with older siblings (18.7% vs. 10.4%; , x2).Pp .034
Of the scheduled 3290 healthy visits, 3026 (92%) took place.
During these visits, 3024 NPS samples were obtained. All 10
samples were obtained from 212 (64%) children. The history
of antimicrobial treatment within 28 days before the swabbing
was known for 2993 (99%) of the NPS samples. There was no
treatment in 2322 (77%) cases. Oral treatment was given in 532
(18%) cases. In 168 cases, the treatment was ongoing at the
time of sampling, in 68 it ended 1–7 days before sampling, and
in 296, it ended 7–28 days before the sampling. Only topical
antibiotics were used in 139 cases (5%).
Of all children, 288 (88%) were seen at a sick visit in the
study clinic at least once during the study period. In all, there
were 2122 sick visits during which 2007 (95% of the planned)
NPA samples were obtained. One NPA sample each was ob-
tained from 30 children, 2–10 NPA samples each were obtained
from 196 children, and 11–31 NPA samples each were obtained
from 61 children. In all, 81% of all known visits due to acute
infections took place at the study clinic.
Study doctors diagnosed AOM at 871 sick visits (41% of all
sick visits); in 89% of these, the diagnosis was veriﬁed by col-
lection of a MEF sample from 1 or both ears. During the entire
follow-up period, clinical AOM was diagnosed at least once in
215 (65%) study children, once or twice in 88 (27%) children,
3–5 times in 75 (23%) children, 15 times in 52 (16%) children,
and 17 times in 1 child. These numbers comprise 86% of all
cases of AOM known to have occurred among the study chil-
dren during the follow-up. Only AOMs diagnosed in the study
clinic are considered here.
Children were 6 months old at 395 (20%) sick visits during
which NPA was obtained, 7–12 months old at 659 (33%) such
visits, 13–18months old at 565 (28%) such visits, and19months
old at 388 (19%) such visits. The corresponding percentages of
AOM events were almost the same: 167 (19%), 293 (34%), 234
(27%), and 177 (20%) for the 4 age groups, respectively.
NP carriage at healthy visits, by age and sex. Of the 3024
NPS samples obtained, 649 (21%)were positive forS. pneumoniae
(ﬁgure 1). The prevalence of pneumococcal carriage clearly in-
creased with age; the age-speciﬁc rates were 9% at 2 months,
17% at 6 months, 22% at 12 months, 37% at 18 months, and
43% at 24 months. The age-weighted average proportion of pos-
itive NPS samples for the whole follow-up period was 27%. The
increasing trend was seen in both sexes; the age-weighted average
mean of positive samples was 29% for boys and 26% for girls.
There were no systematic differences in age-speciﬁc prevalence
between boys and girls. The number of colonies was 120 (84%)
in 545 and 1–20 (16%) in 104 positive cultures.
NP carriage of S. pneumoniae during health and respiratory
infection with and without AOM. At sick visits, 2007 NPA
samples were obtained, and 826 (41%) were positive for S.
pneumoniae. At visits without concurrent diagnosis of AOM,
the proportion of positive NPA samples was 35% (407 of 1158);
at visits with concurrent AOM, the proportion was 49% (419
of 849).
The percentages of positive samples obtained within the 4
age intervals were compared among different clinical categories
(ﬁgure 2A). The proportion of positive NPS samples obtained
at healthy visits increased from 13% during the ﬁrst age interval
to 43% during the last age interval. In samples obtained at sick
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Figure 1. Age-speciﬁc prevalence of Streptococcus pneumoniae (Pnc) carriage in 329 children, detected in cultures of 3024 nasopharyngeal swab
(NPS) samples obtained during 10 scheduled healthy visits at ages 2–6, 9, 12, and 15 months and at ages 18 and 24 months *2 Weeks;
**4 weeks.
Figure 2. Proportions of 5031 nasopharyngeal (NP) cultures positive for Streptococcus pneumoniae (Pnc) during health or respiratory infection
with or without acute otitis media (AOM). Samples were obtained during 4 age intervals from children followed from ages 2 to 24 months. A,
NP swab (NPS) samples obtained during scheduled healthy visits ( , gray bars) and NP aspirates (NPA) obtained during respiratorynp 3024
infections without ( , white bars) or with ( , black bars) concurrent AOM. B, NPA samples obtained during concurrent AOMnp 1158 np 849
without ( , black bars) or with ( , gray bars) pneumococcal etiology.np 562 np 199
visits without concurrent AOM, the proportions of positive
NPA samples were somewhat higher (22%–46%) and increased
with age. At sick visits with concurrent AOM, the child’s age
had little, if any, effect on the carriage rate: within the 4 age
categories, S. pneumoniae was found in 46%, 46%, 50%, and
56% of samples, respectively. All percentages were higher than
those observed within the respective age groups at healthy visits
or at sick visits without AOM. This difference was most promi-
nent during the ﬁrst year of life.
We then examined NPA samples obtained at 761 visits during
which AOM was diagnosed and for which 1 MEF sample
was available for culture (ﬁgure 2B). S. pneumoniaewas isolated
from MEF in 26% of the AOM events: 26%, 25%, 31%, and
22%, respectively, by age interval. Throughout the age range,
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Figure 3. Nasopharyngeal (NP) carriage of Streptococcus pneumoniae (Pnc) in relation to oral antimicrobial medication within 28 days before
sampling. NP swab (NPS) samples obtained at 2854 scheduled healthy visits during 4 age intervals: 6 months; 7–12 months; 13–18 months;
and 19 months (4 weeks). Results are shown by antibiotic usage before sampling. Total nos. of samples are shown above the bars.
the NPA samples obtained during pneumococcal AOM usually
were positive for S. pneumoniae (97%–100%), whereas the pro-
portion of positive NPA samples obtained during AOM with
no evidence of pneumococcal etiology was about the same as
in samples obtained at visits without concurrent AOM.
NP carriage at healthy visits in relation to history of antimi-
crobial medication. The effect of antimicrobial treatment was
studied for 2854 (94%) of the 3024 NPS samples for which
there were data of an oral antimicrobial treatment or of no
treatment within 28 days before swabbing. The most frequently
used oral antimicrobials were amoxicillin (40%), trimethoprim-
sulfadiazine or trimethoprim-sulfamethoxazole (27%), amoxi-
cillin-clavulanate (10%), and penicillin V (8%). S. pneumoniae
grew in 499 (21%) of 2322 samples obtained at visits without
and in 112 (21%) of 532 samples obtained at visits with a history
of an oral antibiotic treatment within 28 days. However, dif-
ferences were seen when the data were examined in more detail.
Figure 3 shows the proportions of positive NPS samples ac-
cording to whether oral antibiotics had not been used within
28 days or whether they had been used within 7 days or whether
the use had ended 7–28 days before sampling. Up to age 6
months, the percentages of positive NPS samples were the same
in the ﬁrst 2 groups and were higher if the child had received
antibiotics 7–28 days before sampling. At later ages, the pro-
portion of positive samples was lower (11%–21%) if antibiotic
treatment was recent (within 7 days) but increased (24%–35%)
if 1 week had elapsed since the end of medication.
Season. The percentages of NPS and NPA samples positive
for S. pneumoniae by calendar month are shown in ﬁgure 4.
The occurrence of S. pneumoniae in NPS samples obtained
during healthy visits ﬂuctuated throughout the year (14%–
25%), without any clear seasonal trend, as did the percentages
of positive NPA samples obtained during sick visits, only at a
higher level (33%–52%). However, there was no obvious sea-
sonal trend, in contrast to the numbers of sick visits, which
varied seasonally. The average number of sick visits was 106/
month in the summer months (June to August) and 200/month
the rest of the year.
Cumulative colonization by S. pneumoniae. Of the 329 chil-
dren, 267 (81%) carried S. pneumoniae at least once (NPS or
NPA) during the follow-up period. By the ages of 2, 6, 12, 18,
and 24 months, 37 (11%), 107 (34%), 174 (56%), 228 (80%),
and 244 (87%) of the children still being followed had carried
S. pneumoniae at least once (ﬁgure 5). Of the 281 children with
full follow-up, we detected 219 carriers (78%) during healthy
visits and 207 (74%) during sick visits. For the 212 children
with all 10 NPS samples, the individual number of positive
samples at healthy visits varied from 1 (for 49 children) to 8
(for 3 children; median, 2).
Serotypes. The distribution of serogroups or serotypes of
S. pneumoniae isolated in NPS and NPA samples is shown in
table 2. Of the 1530 isolates, 1456 belonged to 30 different
serotypes, 17 were nontypeable, 55 were rough, and 2 were lost
before typing. In NPS samples, the 6 most frequently isolated
serotypes were 6B, 23F, 19F, 6A, 11, and 35, which accounted
for 66% of all NPS isolates. In NPA samples, 23F, 19F, 6B,
6A, 11, and 14 were the most frequent (73% of all NPA isolates).
Serotypes 19F, 23F, 6B, 6A, 11, and 14 weremost often acquired
ﬁrst (as detected in either NPS or NPA samples) and comprised
62% of the ﬁrst acquisitions. A serotype included in the only
currently available pneumococcal conjugate vaccine (7-valent,
with types 4, 6B, 9V, 14, 18C, 19F, and 23F) was identiﬁed in
58% of the isolates overall (53% of NPS and 62% of NPA
isolates). Together with the cross-reactive types 6A, 9N, 18B,
19A, and 23A, the vaccine-related types comprised 68% of NPS
and 76% of NPA isolates.
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Figure 4. Proportion of nasopharyngeal (NP) samples positive for Streptococcus pneumoniae (Pnc) by calendar month, January–December
(1–12, respectively). A, NP swab (NPS) samples obtained during health. B, NP aspirate (NPA) samples obtained during respiratory infection.
Bars, Total samples; lines, percentage of samples positive for S. pneumoniae.
Figure 5. Cumulative rates of ﬁrst acquisition of Streptococcus pneu-
moniae (Pnc) of children still in follow-up by age. Nasopharyngeal (NP)
swab (NPS) samples were obtained at scheduled healthy visits at 2–6,
9, 12, and 15 months (2 weeks) and at 18 and 24 months (4 weeks);
second NP aspirate (NPA) samples were obtained at sick visits during
respiratory infections with or without acute otitis media.
In all, 168 children (63% of the 267 carriers) acquired 11
identiﬁed serotype during the follow-up. Two, 3, and 4–6 se-
rotypes were carried by 84, 38, and 45 children, respectively,
and 1 child carried his seventh serotype at age 22 months. A
single serotype was found in 6 consecutive NPS samples in 2
children (6B in both cases).
In 24 (3.7%) NPS samples and 29 (3.5%) NPA samples that
were positive for S. pneumoniae, 2 different serotypes were iso-
lated at the same time, and, in 1 NPA sample, 3 different se-
rotypes (3, 6B, and 23F) were found. Multiple serotypes were
recovered from 45 children. In all, 21 different serotypes were
responsible for multiple pneumococcal colonization, but again,
23F, 6B, 19F, 14, 6A, and 11 were the most common, in this
order, accounting for 68% of the multiple isolations.
Susceptibility of NP strains to penicillin. Resistance of the
pneumococcal isolates to penicillin was rare. Eight (1.2%) of
649 NPS isolates and 32 (3.9%) of 826 NPA isolates had reduced
susceptibility to penicillin. Only 2 NPS isolates and 2 NPA
isolates were highly resistant (MIC, 2 mg/mL); others showed
intermediate resistance (MIC, 0.125–1.0 mg/mL). Of the 267
carriers (NPS or NPA), only 12 (4.5%) at least once carried S.
pneumoniae with reduced susceptibility to penicillin.
Discussion
Most children in this closely followed cohort carried S. pneu-
moniae at least once in their nasopharynx during the ﬁrst 2
years of life. The carriage prevalence during health increased
with age. The isolation rates were higher during respiratory
infection without AOM than during health, again with an in-
creasing trend with age. During AOM, the rates were high,
regardless of age, and, during pneumococcal AOM, practically
every child carried S. pneumoniae (also in the nasopharynx).
Antimicrobial treatment reduced the carriage rates only tem-
porarily. The serotypes included in the 7-valent conjugate vac-
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Table 2. Distribution of Streptococcus pneumoniae serogroups or serotypes in 1475 na-
sopharyngeal (NP) samples obtained from 267 children during health (NP swab [NPS]) and
during respiratory infection (NP aspirate [NPA]) with or without acute otitis media.
Serogroup
or serotype
Isolate, by sample type
NPS (n p 673) NPA (n p 857) All (n p 1530)
No. (%)
Cumulative
percentage No. (%)
Cumulative
percentage No. (%)
Cumulative
percentage
6B 106 (15.8) 15.8 107 (12.5) 12.5 213 (13.9) 13.9
23F 93 (13.8) 29.6 175 (20.4) 32.9 268 (17.5) 31.4
19F 93 (13.8) 43.4 165 (19.3) 52.2 258 (16.9) 48.3
6A 61 (9.1) 52.5 79 (9.2) 61.4 140 (9.2) 57.5
11 57 (8.5) 60.9 59 (6.9) 68.3 116 (7.6) 65.0
14 28 (4.2) 65.1 39 (4.6) 72.8 67 (4.4) 69.4
15 26 (3.9) 68.9 30 (3.5) 76.3 56 (3.7) 73.1
35 35 (5.2) 74.1 14 (1.6) 77.9 49 (3.2) 76.3
Others 137 (20.4) 94.5 152 (17.7) 95.7 289 (18.9) 95.2
R 28 (4.2) 98.7 27 (3.2) 98.8 55 (3.6) 98.8
NT 8 (1.2) 99.9 9 (1.1) 99.9 17 (1.1) 99.9
Not typed 1 (.1) 100.0 1 (.1) 100.0 2 (.1) 100.0
Total 673 (100.0) 857 (100.0) 1530 (100.0)
NOTE. In 54 samples from 45 children, 1 serotype was isolated at the same time. NT, nontypeable;
not typed, not typed for another reason; R, rough.
cine used in recent efﬁcacy trials in California [31] and Finland
[32] and licensed in 2000 comprised 53% of the pneumococcal
strains isolated from the nasopharynx during health and 62%
of strains isolated during respiratory infection.
Although 87% of the study children carried S. pneumoniae at
least once during the study, the children acquired their strains
relatively slowly, and the overall carriage rate resembled that in
theUnited States [16] and Sweden [7, 11]. The age-weightedmean
proportion of positive NPS samples was 27%, a value near the
prevalence (21%) among unselected healthy children sampled
once at age 0–2 years in a Swedish study in 1975–1976 [11]. The
cumulative acquisition rates were very near those reported by
Faden et al. [8] (38% at 6 months and 54% at 12 months).
The prevalence of carriage at scheduled healthy visits (NPS)
increased steadily with age from 9% at 2 months to 43% at 24
months. Dagan et al. [9] reported similar gradually increasing
carriage rates from ages 2 to 24 months (from 26% to 62%) in
Israeli children. In some other studies, increasing isolation rates
leveled off at a younger age [5, 7, 10, 20]. In the present study,
the health status of the study children seemed to have an im-
portant association with the carriage rates and also modiﬁed
the association between carriage rates and age. The increase
with age was most clear in the prevalence of carriage in healthy
children, less clear in the NPA samples taken during respiratory
infection without concurrent AOM, and absent inNPA samples
taken during AOM (ﬁgure 2).
The NPA samples obtained during sick visits due to respi-
ratory infection with or without AOM grew S. pneumoniae
almost twice as often (41%) as the NPS samples obtained at
healthy visits (21%). The percentage was even higher (49%) in
the subgroup of NPA samples associated with concurrent
AOM. This result is in agreement with that of Faden et al. [16],
who reported signiﬁcantly higher NP isolation rates during vis-
its with upper respiratory infection or OM than during routine
healthy visits in a follow-up study of US children !3 years old.
Higher isolation rates in samples obtained at visits with signs
of unspeciﬁc respiratory infection also were reported in an ear-
lier study among British families [17] and in studies in Uruguay,
Mexico, and Pakistan [19, 20, 33]. However, several studies
failed to ﬁnd any differences in carriage rates between healthy
and ill children [21–23, 34]. In these studies, the study subjects
were older than those in our study; in 2 studies, throat swabs
rather than NP swabs were used, which could affect the results.
In the present study, the difference in isolation rates between
healthy and ill children depended on age. The difference was
most prominent during the ﬁrst year of life and almost dis-
appeared by age 2 years, when the rates were also high during
health. Furthermore, the excess of carriage strains recovered
during AOM seemed to be related to the concurrent occurrence
of S. pneumoniae in MEF, since nonpneumococcal AOM was
not associated with higher carriage than was respiratory infec-
tion without AOM. This conclusion is also consistent with the
ﬁnding that the seasonal variation was less prominent in pneu-
mococcal AOM than in AOM associated with Haemophilus
inﬂuenzae or Moraxella catarrhalis in this same cohort [35].
One might argue that the difference in pneumococcal recov-
ery observed in our study during health and respiratory infec-
tion was due to the different sampling methods (NPS or NPA).
We consider this to be unlikely because the techniques were
speciﬁcally compared in a previous study of children with acute
respiratory infection, and the agreement between the NPS and
the NPA techniques was excellent [36].
The antimicrobial treatment of the children was assumed to
affect the results, but the overall proportion of samples positive
for S. pneumoniae was similar (21%), whether or not the child
had received oral antimicrobial treatment within 28 days. This
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ﬁnding parallels the observation of Dagan et al. [9] among
children 2–13 months old, which showed no association be-
tween carriage rate and use of antibiotics during the preceding
month. In the present study, the isolation rates were lower if
the therapy was ongoing or had ended within 7 days, but if
1–4 weeks had elapsed since the end of the medication, the
rates increased again or, during the ﬁrst year of life, were even
higher than without antimicrobial treatment (ﬁgure 3). This is
in accordance with ﬁndings of others that a more recent anti-
microbial treatment reduced carriage rates [23, 26–28]. Leach
et al. [28] found lower pneumococcal isolation rates (29%) 2–3
weeks after a single dose of azithromycin administered to Aus-
tralian aboriginal children with trachoma than before treatment
(68%), but, at the 2-month follow-up, the rate had rebounded
to a higher level (78%) than before treatment. Thus, the lower
carriage rates after use of antimicrobials seem to be of very
short duration.
The most frequently isolated NP serogroups or serotypes in
young children in industrialized countries are 6, 14, 19, and 23
[1, 12, 34]. These are related to most OM and invasive infections
caused by S. pneumoniae in children in these areas [24, 29, 35,
37–39]. These serogroups or serotypes were among the most
common in our present study, but group 11 also was common
in both NPS and NPA samples. As expected, serogroups or
serotypes 4, 7, and 18, which cause serious diseases but are less
frequently recovered as carriage strains [37–39], were relatively
rare among our NP isolates. In addition, type 3, a common
cause of AOM in several reports [24, 29, 40], was uncommon
in the present series. Type 3 is found frequently in the naso-
or oropharynx in older children or adults rather than among
infants and young children [15, 21, 37]. The frequency of mul-
tiple serotypes was low (3.7% of positive samples) in this study,
which is in accordance with other studies in which a few colo-
nies (3–5) were serotyped [1, 41]. Higher frequencies of multiple
serotypes were detected by serotyping 50 colonies in PapuaNew
Guinea (29%) [42], but such serotyping is impractical and ex-
pensive [41]. More sensitive methods would be needed to assess
multiple carriage.
In conclusion, we found a high pneumococcal colonization
rate (49%) in the presence of AOM throughout the ﬁrst 2 years
of life, in contrast to the colonization rates during health, which
increased with age from 9% at 2 months to 43% at 2 years.
The ﬁrst practical conclusion from these ﬁndings is that both
age and health status should be considered carefully when car-
riage rates in young children are compared and interpreted.
The reasons for these ﬁndings and the implications for pneu-
mococcal disease will be of interest for further study. Numerous
additional data collected in the FinOM Cohort Study currently
are being analyzed to further characterize the factors that affect
the development of pneumococcal carriage and disease.
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ORIGINAL STUDIES
The Value of Nasopharyngeal Culture in Predicting the
Etiology of Acute Otitis Media in Children Less Than
Two Years of Age
Ritva K. Syrja¨nen, MD,*† Elja E. Herva, MD,‡ P. Helena Ma¨kela¨, MD,* Heikki J. Puhakka, MD,†
Kari J. Auranen, PhD,*§ Aino K. Takala, MD, and Terhi M. Kilpi, MD*
Background: In selecting treatment of acute otitis media (AOM),
knowledge of its etiology would be valuable. We revisited the
possibility to use the nasopharyngeal culture of Streptococcus pneu-
moniae (Pnc) and Haemophilus inﬂuenzae (Hi) for predicting their
presence in the middle ear ﬂuid (MEF) during AOM.
Methods: The sensitivity, speciﬁcity, positive predictive value
(PPV) and negative predictive value (NPV) of bacterial culture of
the nasopharyngeal aspirate (NPA) in predicting the presence of the
same pathogen in the MEF were assessed during AOM events
among children followed from 2 to 24 months of age.
Results: The data comprised 586 AOM events. For Pnc, the sensi-
tivity and NPV were high, 99% (95% conﬁdence interval  95–
100%) and99% (97–100%), respectively. The speciﬁcity and PPV
were relatively low, 63% (57–68%) and 50% (43–56%). For Hi, the
sensitivity and the NPV were lower (77%, 69–83% and 93%,
90–95%) than for Pnc, but the speciﬁcity and the PPV were higher
(88%, 85–91% and 64%, 56–71%). The quantity of Pnc and Hi in
the NPA was clearly related to their presence in the MEF. If both
Pnc and Hi were found in the nasopharynx, Hi was more likely
cultured from MEF.
Conclusion: Together with clinical and epidemiologic features of
AOM, the nasopharyngeal culture can be helpful in selecting spe-
ciﬁc antimicrobial therapy.
Key Words: nasopharyngeal culture, predictive value, etiology,
acute otitis media
(Pediatr Infect Dis J 2006;25: 1032–1036)
Acute otitis media (AOM) forms a considerable diseaseburden for children in developed countries. Streptococcus
pneumoniae (Pnc) and Haemophilus inﬂuenzae (Hi) are the
most important pathogens causing acute otitis media (AOM)
followed by Moraxella catarrhalis (Mc) and, decreasingly,
group A beta-hemolytic streptococci.1–3 Detection of patho-
gens in the middle ear ﬂuid (MEF) by culture is the “gold
standard” for etiologic diagnosis of AOM. Tympanocentesis
and myringotomy are, however, invasive procedures that are
at present rarely considered indicated in uncomplicated cases.
Many studies evaluating the possibility to use nasopharyngeal
culture as a predictor of the bacterial etiology of otitis have
shown that if Pnc or Hi are not found in the nasopharynx
during AOM, it is unlikely that they would be found in the
MEF.4–10 Some of the studies have acknowledged the value
of nasopharyngeal culture in prediction of the etiology of
AOM,4,5 whereas others have considered it too nonspeciﬁc.
The nasopharyngeal sample takes up to 48 hours to
culture and may thus not be practical and cost-effective in the
routine treatment of all AOM cases in the clinical practice,
because antimicrobial agents for empiric treatment of AOM
are available. However, increasing resistance of the otitis
pathogens to the commonly used antimicrobials prompts a
reevaluation of the treatment strategies and stresses the need
to restrict the use of antibiotics in general and of those with
a wide spectrum of activity in particular. Because uncompli-
cated AOM often resolves without antimicrobial treatment,
an option for “watchful waiting” for 48 to 72 hours without
initial antimicrobial treatment has been recommended for
selected uncomplicated cases pending assurance of appropri-
ate follow up.11 Should the child appear for a second visit
because of persistent or aggravating symptoms, the culture
result of the nasopharyngeal sample taken at the ﬁrst visit
would by then be available and provide useful guidance for
selection of treatment or, in borderline cases, further waiting
without an antimicrobial.
For example, there is increasing evidence that Pnc
AOM is likely to have a more severe clinical picture and
more suppurative complications, whereas Hi is associated
with recurrent AOM.3,12–19 Although clearly recognized as a
pathogen, Mc tends to be associated with a milder clinical
picture and is therefore of less importance in this context.12
Recently, studies suggest that the nasopharyngeal culture at
diagnosis may be a valuable predictor for the outcome of the
AOM although the etiology is not known.20,21
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In the current study, based on 586 AOM cases among
329 children followed from 2 to 24 months of age, we
revisited the possibility to use the nasopharyngeal culture of
Pnc and Hi for prediction of their presence in the MEF during
AOM.
MATERIALS AND METHODS
Study Population and Clinical Samples
The study population consisted of 329 healthy children
enrolled in the Finnish Otitis Media (FinOM) Cohort Study and
followed prospectively in 1994–1997 from 2 to 24 months of
age in a special study clinic established for assessing the epide-
miology of AOM.3,22 AOM was diagnosed during visits re-
quested by the parents because of predeﬁned symptoms sug-
gesting AOM, at the follow-up visits scheduled for 3 to 5
weeks after the initial diagnosis of AOM and occasionally at
age-scheduled visits that were part of the study design.
During these visits, AOM was diagnosed by the following
criteria: a visually abnormal tympanic membrane in pneu-
matic otoscopy (in regard to color, position and mobility)
suggesting effusion in the middle ear cavity concomitantly
with at least one of the following signs and/or symptoms of
acute local or general infection: fever, earache, tugging of
the ear, irritability, acute gastrointestinal symptoms or other
symptoms of respiratory infection. Each occasion in which
AOM was diagnosed was deﬁned as an AOM event. Current
use of antimicrobials and any AOM recently diagnosed in
another medical setting than the study clinic were asked from
the parents. AOM events treated outside the clinic were
veriﬁed from medical case records.
Whenever AOM was diagnosed, a sample of MEF and
a nasopharyngeal aspirate (NPA) were obtained. In bilateral
cases, the MEF sample was obtained from both ears. The
MEF sample was aspirated after myringotomy or through
perforation or discharging ventilation tube. If the amount of
the NPA sample was less than 0.5 mL, phosphate-buffered
saline was added to reach an amount of at least 0.5 mL. All
samples were cultured immediately with a 10-L loop on
chocolate agar and on blood agar with 5% gentamicin and
incubated in 5% CO2 at 36° to 37°C in the study clinic
overnight. Thereafter, they were sent to the National Refer-
ence Laboratory for Pneumococcus of the National Public
Health Institute (KTL) in Oulu for identiﬁcation of relevant
pathogens and for serotyping of Pnc with standard methods as
described earlier.3,22 After 48 hours’ incubation, the numbers
of colonies on the plate with more growth were counted. Colony
counts 100/plate were labeled as “abundant growth.”
Calculating Predictive Values and Statistical Analyses. Pos-
itive culture for Pnc or Hi from a MEF sample was deﬁned as
the gold standard for the etiologic diagnosis of the AOM. In this
analysis, 2 MEF samples obtained at the same visit were re-
garded as one sample and any Pnc or Hi found in either or both
of these 2 samples was treated as a single Pnc or Hi ﬁnding in
a single sample. The sensitivity, speciﬁcity and positive and
negative predictive values (PPV, NPV) of the nasopharyngeal
culture of Pnc and Hi in predicting the homologous etiology of
AOM were calculated as conditional probabilities from 2  2
tables with positive and negative ﬁndings in NPA and MEF
samples. To control possible intrachild correlation between the
measurements from the same child, the 95% conﬁdence inter-
vals were determined by logistic regression using generalized
estimating equations with exchangeable correlation structure.
The effects of age, sex, season and the number of previous AOM
on sensitivity, speciﬁcity and the predictive values were assessed
by multivariate logistic regression. There was no signiﬁcant
intrachild correlation between the outcomes. The quantity of
nasopharyngeal growth and occurrence of homologous AOM
were compared with 2 test.
Ethical Review. Written informed consent was obtained from
the parents or guardians. The study protocol was approved by
the Ethics Committees of the Finnish National Public Health
Institute, Department of Social and Health Care of Tampere
City and Tampere University Hospital.
RESULTS
During the study, AOM was diagnosed 871 times at the
study clinic. Both NPA and at least one MEF sample were
available for 761 AOM events. Altogether, 104 events at
which antimicrobial treatment was ongoing (or not known)
were excluded from the analysis as were 71 events that
occurred within 14 days after a previous AOM event (diag-
nosed in the study clinic or in another medical setting and as
a rule treated with antibiotics). This left 586 events in 200
children available for the analysis. Of the 200 children, 60
(30%) had one AOM event that was evaluable in the current
analysis, 70 (35%) had 2 or 3 events and 70 (35%)3 events.
Pnc grew from 316 (54%) of the NPA samples and from 160
(27%) of the MEF samples (Table 1). Hi grew from 151
(26%) of the NPA samples and from 126 (22%) of the MEF
samples. The same pneumococcal serotype grew from both
the NPA sample and the MEF sample in all but one of the 158
events in which Pnc was found in both of these samples and
serotyped.
TABLE 1. Streptococcus pneumoniae (Pnc) and
Haemophilus influenzae (Hi) Findings From 586 Middle
Ear Fluid (MEF) Samples and Nasopharyngeal Aspirates
(NPA) Obtained Concurrently From 200 Children During
Acute Otitis Media
Bacterium
Cultured From NPA
Homologous Bacterium
Cultured From MEF
 
Pnc
 269 1 270
 157 159* 316
426 160 586
Hi
 406 29 435
 54 97 151
460 126 586
Two MEF samples obtained at the same visit were regarded as one sample and Pnc or
Hi found in either or both of these 2 samples was treated as a single Pnc or Hi finding of
a single sample.
*In 158 of these 159 cases, the Pnc from both NPA and MEF samples were serotyped;
the same serotype was found in 157 of these 158.
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Presence of Streptococcus pneumoniae and Haemophilus
inﬂuenzae in Nasopharyngeal Culture as a Predictor of Their
Presence in Middle Ear Fluid. The sensitivity, speciﬁcity, PPV
and NPV of the nasopharyngeal culture of Pnc and Hi in
predicting the homologous etiology of AOM are shown in
Table 2. The sensitivity (99%) and NPV (99%) for Pnc
were very high, but the speciﬁcity (63%) and PPV (50%)
were relatively low. For Hi, the sensitivity (77%) and NPV
(93%) were lower, but the speciﬁcity (88%) and PPV (64%)
were higher than those for Pnc.
The sensitivity and NPV for Pnc remained close to
100% irrespective of age, sex, season or the number of
previous AOM events. Coinciding with a high prevalence of
carriage but low frequency of Pnc AOM, the speciﬁcity and
PPV decreased by age (odds ratio 	OR
  0.94 by each
month of age, 95% conﬁdence interval 	CI
  0.91–0.98),
especially after 18 months of age. The PPV was higher in case
of the second or third AOM event of the child as compared
with the ﬁrst event (OR  1.86, 95% CI  1.01–3.42), but
this trend was not evident for more than 3 AOM events. For
Hi, the PPV increased with age (OR  1.08 by each month
of age, 95% CI  1.01–1.14) and it was higher in boys than
in girls (OR 3.11, 95% CI 1.39–6.95), whereas the NPV
tended to decrease during autumn and winter months and
with increasing number of previous AOM events, all these
categories being associated with a relatively high proportion
of Hi in the MEF samples (data not shown).
Abundance of Bacterial Growth in the Nasopharyngeal Aspi-
rate as a Predictor for Streptococcus pneumoniae and Haemo-
philus inﬂuenzae Acute Otitis Media. The majority of the 316
NPA cultures positive for Pnc (87%) contained 100 colo-
nies in the 10-L loopful plated, and Pnc grew from the MEF
in 55% of these events (Fig. 1). The sensitivity, speciﬁcity,
PPV and NPV for abundant growth of Pnc in predicting Pnc
AOM were 96%, 71%, 55% and 98%, respectively.
For Hi, the association of a positive MEF culture with
high number of bacteria in the NPA culture was also clear,
although less pronounced (Fig. 2). An estimate of the number
of Hi colonies was available for 150 of the 151 Hi-positive
NPA samples. Of these, 78% contained 100 Hi colonies
and Hi was found in the MEF in 71% of these cases. The
sensitivity, speciﬁcity, PPV and NPV for abundant growth of
Hi in predicting Hi AOM were 66%, 93%, 71% and 91%,
respectively.
Effect of Concurrent Presence of the Other Bacterium in
the Nasopharyngeal Aspirate. Pnc was found in the NPA
without Hi in 241 AOM events. Of these, Pnc grew from the
MEF in 140 cases, increasing the PPV of a positive Pnc
ﬁnding to 58%. If both Pnc and Hi were found concurrently
TABLE 2. Nasopharyngeal Culture of Streptococcus pneumoniae (Pnc) and Haemophilus
influenzae (Hi) as a Predictor for Isolation of the Same Bacterium From a Middle Ear Fluid
(MEF) Sample Obtained Concurrently During Acute Otitis Media (AOM)
The Bacterium
Prevalence
Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)MEF NPA
N Percent Percent
Pnc 586 27 54 99 (95–100) 63 (57–68) 50 (43–56) 99 (97–100)
Hi 586 22 26 77 (69–83) 88 (85–91) 64 (56–71) 93 (90–95)
Two MEF samples obtained at the same visit were regarded as one sample and Pnc or Hi found in either or both of these 2 samples was treated
as a single finding of a single sample.
Sensitivity, the probability of presence of the bacterium in NPA, if found from MEF (%); specificity, the probability of absence of the bacterium from
NPA, if not found from MEF (%); PPV, positive predictive value, the probability of presence of the bacterium in MEF, if found from NPA (%); NPV,
negative predictive value, the probability of absence of the bacterium from MEF, if not found from NPA (%); CI, confidence interval (%).
FIGURE 1. Occurrence of Streptococcus pneu-
moniae (Pnc) in the middle ear fluid (MEF)
sample by Pnc colony count (in 10-L sample
plated) in the concurrently obtained nasopha-
ryngeal aspirate (NPA) (N  586). The in-
crease in occurrence of Pnc in the MEF by
increasing nasopharyngeal growth was statis-
tically significant (P  0.001).
Syrja¨nen et al The Pediatric Infectious Disease Journal • Volume 25, Number 11, November 2006
© 2006 Lippincott Williams & Wilkins1034
in the NPA, the probability of ﬁnding Pnc in the MEF was
only 25% (19 of 75) and the probability of ﬁnding Hi was
63% (47 of 75). Hi grew from the MEF in 66% (50 of 76) of
AOM cases in which Hi was found in the NPA without Pnc.
In the 194 AOM cases, in which neither Pnc nor Hi was found
in the NPA, Pnc grew from one MEF sample and Hi grew
from 12 MEF samples.
DISCUSSION
The results of the present study show that nasopharyn-
geal culture can be useful in predicting the bacterial etiology
of AOM. The study comprised a large sample of AOM cases
among children in otitis-prone age, representing a wide range
of clinical pictures in a primary care setting. Because the chil-
dren with previous AOM within 2 weeks and those receiving
antibiotics were excluded, the results are applicable only to
patients with a new episode of AOM.
The study conﬁrmed the previous knowledge that if the
nasopharyngeal culture is negative for Pnc and/or Hi, these
bacteria are unlikely to be present in the MEF.5,7–10,23,24
Unlike in previous studies,7,9 the sensitivity and NPV were
higher for Pnc than for Hi. In the study by Luotonen and
colleagues,6 the sensitivities were lower for both Pnc (79%)
and Hi (74%), which may be the result of their use of nonse-
lective culture media25 and nasal rather than nasopharyngeal
sampling.26 In the present study, the higher sensitivity for Pnc
than for Hi may similarly be the result of the use of highly
selective medium for Pnc but not for Hi. Another explanation
might be that young children carry Pnc mainly in their
nasopharynx, but they may carry Hi also in their oropharynx
without nasopharyngeal involvement.27,28 However, in young
children with respiratory infection, nasopharyngeal aspiration
has performed signiﬁcantly better than nasopharyngeal swab-
bing in detection for Hi, and it has proved to be optimal for
detection of both Pnc and Hi.29
Despite a relatively low speciﬁcity, a positive NPA
culture for Pnc doubled the probability of Pnc AOM and a
positive NPA culture for Hi tripled the probability of Hi
AOM as compared with the prevalences without this knowl-
edge. The colonization density was directly related to AOM:
the more colonies in the NPA, the more likely the presence of
the bacterium in the MEF. The speciﬁcity increased slightly
(from 63% to 71% for Pnc and from 88% to 93% for Hi)
when only abundant growth (100 colonies in the 10-L
sample) was regarded as positive. This classiﬁcation had little
effect on the sensitivity for Pnc but more for Hi. Consistent
with our ﬁndings, Schwartz and colleagues4 found a high
PPV for both Pnc (80%) and Hi (79%) when classifying only
nasopharyngeal growth of any single pathogen covering
25% of total colonies as positive.
Because the proportion of NPA samples with less than
100 colonies was small, PPV increased only slightly (from
50% to 55% for Pnc and from 64% to 71% for Hi) if such
samples were considered to be negative for the respective
bacterium. Although the higher cutoff for positive NPA
culture achieved with quantitation decreases the rate of false-
positive prediction, it correspondingly increases the false-
negative prediction. Furthermore, quantitative culture is not a
routine laboratory procedure and is therefore not likely to
increase the usefulness of nasopharyngeal culture.
Nasopharyngeal culture has not been considered as a
useful predictor of AOM etiology in clinical practice, but in light
of the results of the present study, we encourage a reappraisal of
its usefulness in attempts to implement more judicial antimicro-
bial treatment policy for AOM. Together with clinical and
epidemiologic features of the AOM,3,8,12–15,18,30,31 the result
could be an important aid for reassessment of need of treat-
ment after “observation option” without initial antimicrobial
treatment. Development of sensitive and speciﬁc rapid tests
for recognition of nasopharyngeal otopathogens, eg, based on
antigen detection, would solve the problem of time needed
for bacterial culture.32 Prediction of antimicrobial resistance
is another interesting application of the nasopharyngeal cul-
ture, because Pnc in the NPA and MEF represent almost
always the same serotype as shown in this study and, with
high probability, the same clone.6,10,24,33–35
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ORIGINAL STUDIES
Pneumococcal Acute Otitis Media in Relation to
Pneumococcal Nasopharyngeal Carriage
Ritva K. Syrja¨nen, MD,*† Kari J. Auranen, PhD,*‡ Tuija M. Leino, MD,*
Terhi M. Kilpi, MD,* and P. Helena Ma¨kela¨, MD*
Background: Acute otitis media (AOM) is closely associated with
viral upper respiratory tract infections, but the most common mi-
crobial agent found in the middle ear ﬂuid during AOM is Strepto-
coccus pneumoniae (Pnc). Pnc is also a common colonizer of the
nasopharynx, and its prevalence is further increased during the viral
infection. The aim of this study was to investigate the interplay
between viral infection, pneumococcal acquisition and carriage in
the development of Pnc AOM.
Methods: Pnc carriage was assessed in a longitudinal study of 329
infants at scheduled visits at 3, 6, 9, 12, 15 and 18 months of age
(N  1715). The clinical outcome of the ﬁrst episode of respiratory
infection (“sick visit,” N  774) in the following 3-month period
was recorded. The occurrence and timing of Pnc AOM in relation to
serotype speciﬁc carriage at the start of the observation period were
assessed.
Results: The occurrence, timing and duration of symptoms of the
sick visits or the frequency of overall AOM were not associated with
preceding pneumococcal carriage. Pnc AOM was in each case
associated with concurrent carriage and 3.8 times (95% conﬁdence
interval, 1.4–10.0) more often with carriage acquired after the start
of the observation period than with carriage already present at the
scheduled visit. In all, 79% (55 of 70) of Pnc AOM events were
caused by a serotype acquired after the start of the period.
Conclusion: The majority of Pnc AOM events develop in associa-
tion with newly acquired carriage of pneumococcus.
Key Words: Streptococcus pneumoniae, pneumococcal,
acquisition, carriage, acute otitis media
(Pediatr Infect Dis J 2005;24: 801–806)
Acute otitis media (AOM) is closely associated with upperrespiratory tract infections. More than 90% of children
with AOM have symptoms of upper respiratory tract infec-
tion at the time of diagnosis,1,2 and the occurrence of AOM
episodes peaks 3–4 days after onset of symptoms of respira-
tory infection.3,4 Although viruses are detected in the naso-
pharynx in only 30–50% of AOM cases by viral culture
and/or antigen detection methods, the use of more sensitive,
polymerase chain reaction-based techniques has conﬁrmed
viral infection in as many as 86% of children with AOM.5–8
There are several pathogenic mechanisms by which viral
infection could contribute to AOM. Viral infection causes
dysfunction of the Eustachian tube, which results in impair-
ment of pressure equilibration between the nasopharynx
and the middle ear cavity and access of nasopharyngeal
secretions to the middle ear. Some viruses induce leukocyte
dysfunction9 or cause other changes in the hosts’ immune
defense that could increase the risk of secondary bacterial
infection.7,10 Viral infection of the upper respiratory tract
also has a substantial impact on the nasopharyngeal bacte-
rial ﬂora.11–13
Nasopharyngeal carriage of potential otitis patho-
gens is another contributor to bacterial AOM. The ﬁrst
episode of AOM correlates with onset of carriage in both
U.S. and Australian Aboriginal children.14,15 Carriage of
pneumococci starts during the ﬁrst months of life and is
highest in young children,16–24 largely at the same age at
which AOM is most common.25 The prevalence of pneu-
mococcal carriage is higher during respiratory infection
and AOM than during health,24,26–31 although contradic-
tory data have been reported.32 Furthermore, during pneu-
mococcal AOM, pneumococci are practically always
found in the middle ear and in the nasopharynx,20,33–35 and
the serotypes are usually the same in both sites.20,36–38
The interplay between Streptococcus pneumoniae
(Pnc) carriage, respiratory infection and development of Pnc
AOM is not entirely clear. Does respiratory infection enhance
acquisition of carriage, or does respiratory infection increase
the capacity of preexisting carriage to progress to AOM? In a
prospective study with 82 Alabaman children younger than 2
years of age with carriage sampling at intervals of 1–3
months, Gray et al20 concluded that most Pnc AOMs devel-
oped within 1 month after acquisition of carriage. We have
not been able to ﬁnd other relevant data on the temporal
relationship of Pnc carriage and Pnc AOM. This prompted us
to investigate the relationship between pneumococcal car-
riage, respiratory infection and Pnc AOM in a subset of the
Finnish Otitis Media (FinOM) Cohort Study. We addressed
the question by assessing the carriage status at scheduled
visits in children at 3, 6, 9, 12, 15 and 18 months of age and
examining the occurrence, timing and outcome of the ﬁrst
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respiratory infection in the following 3 months in terms of
Pnc AOM and Pnc carriage.
MATERIALS AND METHODS
The FinOM Cohort Study. The present study comprises a
subset of samples (see “Setting for the Present Analysis”)
from the FinOM Cohort Study, in which 329 children were
enrolled for a prospective follow-up from 2 to 24 months of
age. During the follow-up, the study children made 10 sched-
uled visits and additional ad hoc visits due to acute illness to
the study clinic.24 At the scheduled visits during which the
child was considered healthy, a nasopharyngeal sample (NP)
was obtained with a calcium alginate swab. The parents were
encouraged to bring the child to the study clinic at any time
if predeﬁned symptoms of acute respiratory infection sug-
gesting AOM occurred. At these visits, termed sick visits, a
nasopharyngeal aspirate (NPA) was obtained and the length
of symptoms leading to the visit was assessed by interviewing
the parent(s) using a structured questionnaire. The criteria for
the diagnosis of AOM included a visually abnormal tympanic
membrane in pneumatic otoscopy, suggesting effusion in the
middle ear cavity, concomitantly with signs and/or symptoms
of acute infection. Whenever AOM was diagnosed, a sam-
ple of middle ear ﬂuid (MEF) was aspirated after myringot-
omy or through a discharging ventilation tube or spontaneous
perforation. In bilateral disease, both ears were tapped. Pneu-
mococcal AOM was deﬁned as an AOM with Pnc identiﬁed
by culture from at least 1 ear. The NP, NPA and MEF
samples were cultured for Pnc, and the isolates were sero-
typed as described elsewhere in detail.24,39 Brieﬂy the sam-
ples were cultured immediately on enriched chocolate agar
plates and selective sheep blood agar plates containing 5
g/mL gentamicin. The plates were incubated overnight in
5% CO2 at 36–37°C in the study clinic and transported to the
bacteriologic laboratory in Oulu, where the pneumococci
were identiﬁed by standard methods. Four different colonies
were serotyped by counterimmunoelectrophoresis and latex
agglutination (for types 7 and 14) with the use of antisera
from Statens Serum Institut, Copenhagen, Denmark. Written
informed consent was obtained from the parents or guardians,
and human experimentation guidelines of the National Public
Health Institute were followed in the clinical research. The
study protocol was approved by the Ethics Committees of the
Finnish National Public Health Institute, Department of So-
cial and Health Care of Tampere City and Tampere Univer-
sity Hospital.
Setting for the Present Analysis. To assess the relation of Pnc
AOM to carriage we divided the follow-up time of all study
children into 6 observation periods, each lasting for 3 months.
The periods started by a scheduled visit with NP sampling at
the age of 3, 6, 9, 12, 15 or 18 months and ended at the next
of these scheduled NP samplings, or after exactly 3 months if
the next scheduled visit did not take place. Within each
observation period, we recorded only the ﬁrst sick visit;
however, to avoid repeated measures from a single episode of
infection, these sick visits were excluded if 30 days had
elapsed since the previous one (occurring in the previous
observation period). If the NPA sample or, in case of AOM,
the MEF sample was not obtained at the sick visit, the
observation period was not included.
Statistical Methods. To compare the frequency of Pnc AOM
associated with carriages that were detected already at the
scheduled visit and those that were acquired after the sched-
uled visit, their relative frequency was estimated by using a
conditional logistic regression model. Because a child could
have a sick visit during several observation periods, we
included a frailty variable to account for possible heteroge-
neity across children in their proneness to Pnc AOM. A
conditional logistic regression approach was applied in the R
software, version 1.9.0 (R Foundation for Statistical Comput-
ing, Vienna, Austria, 2004).
RESULTS
Observation Periods. Altogether 1802 NP samples were ob-
tained at the 6 deﬁned ages from 324 of the 329 children
enrolled in the FinOM Cohort Study, but in 31 cases the child
discontinued the follow-up before the end of the observation
period of 3 months. Of the remaining 1771 observation
periods of 319 children, 56 periods were excluded, because
the NPA sample or, in case of AOM, the MEF sample was
not obtained at the sick visit, which left 1715 observation
periods of 318 children available for the analysis.
Sick Visits by Carriage at Start of the Observation Periods.
The point prevalence of Pnc carriage at the scheduled
visits increased from 12% at 3 months to 38% at 18 months
of age (mean, 23% throughout the study). Two serotypes
were carried simultaneously in 15 (4%) of the positive NP
samples. Antimicrobial treatment was ongoing at 109 (6%)
scheduled visits (this information was available for 99%
of visits).
A sick visit was recorded in a total of 774 of the 1715
observation periods. Of carriers and noncarriers at the
scheduled visits, 47% (185 of 397) and 45% (589 of 1318),
respectively, were seen at a sick visit during the subsequent
period (Table 1). The median time from the start of the period
to the sick visit was 42 and 37 days in carriers and noncar-
riers, respectively. Also the duration of symptoms was similar
in both cases (median, 4 days). AOM was diagnosed at 32%
(60 of 185) of the sick visits of carriers and at 28% (164 of
589) of the sick visits of noncarriers. Thus the occurrence, the
timing and the clinical features of the sick visits were not
associated with the preceding Pnc carriage status. This was
true for all observation periods independent of age (data not
shown). In contrast, Pnc carriage during the sick visit (41%,
316 of 774) was strongly associated with carriage at the start
of the period: 87% (161 of 185) of the initial carriers but only
26% (155 of 589) of the noncarriers had Pnc in their naso-
pharynx at the sick visit. Pnc AOM was diagnosed at the sick
visit in 6% (22 of 397) of initial carriers and in 4% (48 of
1318) of noncarriers. In the case of Pnc AOM, the MEF
always contained only 1 serotype, and the same serotype
was without exception also found concurrently in the naso-
pharynx.
Occurrence of Pnc AOM by Established and Newly Acquired
Carriage. Because of the strong association of Pnc AOM with
concurrent Pnc carriage, we next focused on the sick visits, at
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which Pnc were found in the NPA and divided the cases
according to whether or not the serotype was present already
at the start of the period. Pnc were carried at 316 sick visits;
at 12 visits 2 or 3 serotypes were carried simultaneously,
giving a total of 329 Pnc isolates. In 132 of these cases, the
serotype in the nasopharynx was already present at the start of
the period, and the carriage was therefore termed “established
carriage.” In the remaining 197 cases, the serotype in the
nasopharynx at the sick visit was not present at the start of the
period and the carriage was therefore termed “newly acquired
carriage.” A total of 11% (15 of 132) of the established
carriages and 28% (55 of 197) of the newly acquired car-
riages were associated with Pnc AOM. Thus the logistic
regression model showed that Pnc AOM occurred 3.8 times
(95% conﬁdence interval, 1.4–10.0) more often if the child
had a newly acquired carriage than if he or she had an
established one. Altogether 79% (55 of 70) of Pnc AOM
events were caused by a newly acquired serotype.
The occurrence of Pnc AOM associated with estab-
lished carriage declined with age: during the ﬁrst observation
period (age 3–5 months), 3 of 9 established carriages had led
to Pnc AOM, whereas none of the 25 established carriages
had done so during the last period (age 18–20 months) (Fig. 1).
This trend was not seen with newly acquired carriage; instead
the highest proportion of carriages that had led to Pnc AOM
was seen at age 9–12 months. Moreover this pattern was
speciﬁc for Pnc AOM, because the occurrence of nonpneu-
mococcal AOM in children who carried Pnc at the sick visit
showed no trend by history of pneumococcal carriage (data
not shown).
Temporal Association of Pnc AOM and Carriage. The 70
sick visits with Pnc AOM occurred earlier during the obser-
vation period than did the 259 sick visits at which Pnc were
carried in the nasopharynx without diagnosis of Pnc AOM.
This was true both for the visits with newly acquired carriage
(time from start of the period; median, 29 versus 48 days in
cases with or without Pnc AOM) and those with established
carriage (15 versus 32 days, respectively) (Fig. 2). The early
timing of sick visits with Pnc AOM compared with sick visits
with only carriage clearly suggests that Pnc AOM was asso-
ciated with recent acquisition of carriage. This early timing
was speciﬁc for Pnc AOM; no difference in timing of sick
visits with and without Pnc carriage or with and without
overall AOM was observed, and in the Pnc carriers the sick
visits with nonpneumococcal AOM did not time earlier than
visits without any AOM.
We further conducted a retrospective examination of
the serotype-speciﬁc carriage history of the 70 events with
Pnc AOM and the 259 events at which Pnc were carried at
the sick visits without Pnc AOM and found a clear-cut
difference (Fig. 3). By deﬁnition, 100% of the children in
both categories were Pnc carriers at the sick visit. Mark-
edly few of the children in the Pnc AOM category were
carriers before the visit (21%) as contrasted to the children
in the without Pnc AOM category (45%). In both catego-
ries, there was a rapid increase of carriage in the ﬁnal
couple of weeks before the sick visits. This increase
broadly coincided with the onset of symptoms of viral
respiratory infection (Fig. 3).
The duration of symptoms leading to the sick visit was
similar whether Pnc AOM was diagnosed or not (median, 4
days). There was also little difference according to whether
the children carried Pnc or not at the sick visit (median, 4
days) or whether the carried serotype had been acquired after
start of the period (median, 5 days).
DISCUSSION
We studied the sequential relationship among Pnc car-
riage, respiratory infection and development of Pnc AOM
FIGURE 1. Occurrence of Pnc AOM at the first sick visit during
observation periods of 3 months according to carriage of Pnc
at start of the period. – – – – indicates that the serotype
present in the nasopharynx at the sick visit was already present
at start of the period (“established carriage”);OO, the sero-
type present in the nasopharynx at the sick visit was acquired
after start of the period (“newly acquired carriage”).
TABLE 1. The First Sick Visits During the 6 Observation Periods of 3 Months (N  1715), According to the Carriage
Status of Pnc at the Scheduled Visits at Start of the Period
Characteristics of the Sick Visits
Pnc Carriage at the Scheduled Visit
Yes (N  397) No (N  1318) Total (N  1715)
Sick visits, N (% of observation periods in the category) 185 (47) 589 (45) 774
Pnc carriage at the sick visit, N (% of the sick visits) 161 (87) 155 (26) 316
AOM* at the sick visit, N (% of the sick visits) 60 (32) 164 (28) 224
Pnc AOM at the sick visit, N (% of the observation periods in the category) 22 (6) 48 (4) 70
Time between start of the period and the sick visit (median, days) 42 37
Duration of symptoms leading to the sick visit (median, days) 4 4
*Haemophilus influenzae and Moraxella catarrhalis were found in at least 1 middle ear fluid during 39 and 53 of the 224 AOM cases, respectively.
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and found that the occurrence and clinical features of the sick
visits did not differ according to the preceding carriage status.
In 79% of the 70 Pnc AOM events, the serotype found in
MEF (and concurrently in the nasopharynx) was not present
in the NP at start of the observation period but was acquired
thereafter (newly acquired carriages). Carriage of serotypes
acquired after start of the period were 3.8-fold more likely to
proceed to Pnc AOM than carriage of serotypes present
already at start of the period, suggesting that Pnc AOM more
easily develops after recent acquisition than after long car-
riage. This ﬁnding conﬁrms, in a larger study material and in
more precision, the data of Gray et al,20 according to which
74% of 31 pneumococcal infections (mainly AOM) were
caused by a serotype that was carried 1 month or less before
the onset of acute illness. Our study focused on only part of
the sick visits in the FinOM Cohort Study (ie, the ﬁrst visits
in each observation period of 3 months). This selection was
made to reduce the confounding effect of repeated episodes
and to better allow comparisons across all periods. This could
have introduced a bias by minimizing the effect of an “otitis-
prone” condition. However, repeating the essential analyses
with the whole FinOM Cohort Study material did not change
the conclusions (unpublished data).
We addressed the duration of carriage before AOM by
focusing on the timing of the sick visit with Pnc carriage
during each observation period. A temporal association be-
tween acquisition of carriage and development of Pnc AOM
was evident because sick visits with Pnc AOM occurred on
average earlier than sick visits without Pnc AOM. The pres-
ence or absence of nonpneumococcal AOM did not inﬂuence
the ﬁnding. Although the precise date when the carriage had
been acquired is not known, at least one-half of the Pnc AOM
cases associated with newly acquired carriage must have
occurred in 1 month after acquisition (the median time
since the start of the period was 29 days). One-half of the Pnc
AOM cases associated with a carriage acquired before the
start of the period occurred within 15 days, indicating that
many of them could in reality be the result of relatively
recently acquired carriage. However, the data also show a
minority of cases in which Pnc AOM seems to have devel-
oped in association with prolonged (present for 1 month)
carriage, especially in the younger children. A similar subset
FIGURE 3. Preceding carriage of pneumococcal serotypes
carried at the sick visits with (OO, N  70) and without
(– – – –, N  259) Pnc AOM. The preceding carriage was
assessed with nasopharyngeal swabs obtained at the sched-
uled visits starting the observation periods (numbers in the
figure). Dots indicate the start of the symptoms leading to
the sick visit.
FIGURE 2. Timing between the start
of the observation period and the sick
visit because of respiratory symptoms
at which Pnc was carried, shown sepa-
rately for visits with and without Pnc
AOM. A indicates newly acquired car-
riage (ie, the serotype acquired after
the start of the observation period); B,
established carriage (ie, the same sero-
type carried already at the start of the
observation period).
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of Pnc infection developing after prolonged carriage was
reported by Gray et al.20
The short duration of carriage before Pnc AOM was
further shown by the retrospective analysis of pneumococcal
carriage before the sick visits: it was surprisingly low for
several weeks preceding the sick visits with Pnc AOM (Fig.
3). Neither the serotype in MEF nor any other serotype was
found in the 15 samples obtained 3–5 weeks before the Pnc
AOM, indicating that absence of Pnc from the nasopharynx
might be a risk factor for Pnc AOM. Antimicrobial treatment
is not likely to confound this conclusion, because the results
were very similar, when repeated after exclusion of the few
samples obtained during antimicrobial treatment (data not
shown).
The proportion of samples positive for Pnc was almost
twice as high at the sick visits as at the scheduled visits, in
accordance with data from the entire FinOM Cohort Study.24
The rapid increase in carriage before the sick visit was here
shown to broadly coincide with start of the symptoms of
respiratory infection (Fig. 3), raising a question whether
acquisition of Pnc caused the symptoms that lead to the sick
visit, or whether the symptomatic mucosal reaction to viral
infection facilitated acquisition of carriage. We thought that
the duration of symptoms before the sick visit is likely to
indicate their severity: the shorter the time, the more severe
were the symptoms prompting a sick visit. What we found,
however, was that the duration (and, by inference, the sever-
ity), of the symptoms before the sick visit did not correlate
with the presence or new appearance of pneumococci in the
nasopharynx. Thus the data did not support the hypothesis
that the acquisition had caused the symptoms leading to the
sick visit. Instead the data are consistent with the hypothesis
that viral respiratory infection caused the symptoms and
enhanced the acquisition of pneumococci. The primary role
of a viral infection has also been shown by Brimblecombe et
al,26 who assessed the temporal relationship between onset of
acute coryza and increase in Pnc carriage in a survey among
British families. In that study, Pnc carriage only started
increasing 1–2 days after the start of symptoms. This hypoth-
esis is indirectly supported by experimental studies showing
that viruses can increase the adherence of bacteria to human
epithelial cells11,40–41 and inﬂuenza A infection increases
pneumococcal colonization both in chinchillas and in human
volunteers.12,13
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